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Abstract 
 
A common consequence of the complications of pregnancy, such as preeclampsia, is 
reduced supply of nutrients, including oxygen, to the developing fetus. The 
consequences for the offspring are wide ranging, but include increased risk of 
cardiovascular disease. However, the mechanisms by which this occurs are poorly 
understood. Using a rodent model, this study has examined the regulation of blood 
vessels, particularly those supplying skeletal muscle, by local, endothelially-derived 
factors, and by the sympathetic nervous system, in adult rat offspring following 
chronic hypoxia in utero. 
 
The key findings include evidence that there are chronically high levels of oxidative 
stress in the skeletal muscle vasculature of the offspring. Further, the density of, and 
the activity in the sympathetic neurones supplying skeletal muscle blood vessels is 
markedly increased following chronic hypoxia in utero, but the vascular sensitivity to 
stimulation of these neurones is reduced. Following chronic hypoxia in utero, as the 
rats approached middle age, they became hypertensive relative to normal rats. Thus, 
the present study has offered some mechanistic insight, which adds to a growing 
body of literature, and which may help to explain why babies born of sub-optimal 
pregnancies are at higher risk of developing cardiovascular disease later in life. 
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Synopsis 
 
1- It is well known that a suboptimal in utero environment, such as that experienced 
by a fetus during preeclampsia, increases cardiovascular disease in humans. 
Experimental animal models using chronic hypoxia in utero have shown endothelial 
dysfunction in isolated blood vessels, in part at least, caused by oxidative stress. 
Recent evidence has shown that there is a reduced role for adenosine in hypoxia-
induced vasodilatation in vivo.  Further, there is limited evidence, in isolated blood 
vessels, that responses to sympathetic neurotransmitters may be enhanced. Studies 
in the near-term hypoxic chick embryo have shown that sympathetic innervation 
density is increased in the femoral artery. Thus this study sought to comprehensively 
examine whether there are alterations in the control of the skeletal muscle 
vasculature, in terms of locally mediated control by the endothelium, and autonomic 
control by the sympathetic nervous system 
 
2- Experiments were performed on 10-12 week old normal (N) Wistar rats, and on 
the 10-12 week offspring of pregnant Wistar dams who breathed 12%O2 from day 
10-20 of pregnancy, representing the second half of gestation (CHU rats). A further 
set of experiments was performed on N and CHU rats at 36-weeks of age. 
Experiments were performed under anaesthesia with the steroid anaesthetic Alfaxan. 
 
3 – The cardiovascular and respiratory response to breathing 8%O2 was similar in N 
and CHU rats, in that there was a marked increase in ventilation, and vasodilatation 
in skeletal muscle and cerebral vasculature.  The magnitude of vasodilatation in 
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cerebral or skeletal muscle vasculature was similar between N and CHU rats. 
Further, there was similar waning of the hyperventilatory response to acute systemic 
hypoxia in N and CHU rats, indicating that the response to systemic hypoxia is as 
robust in CHU rats as in N rats. The superoxide dismutase (SOD) inhibitor DETC 
significantly reduced hindlimb vascular tone, indicating tonic production of superoxide 
anions. 
 
4 – The hindlimb vasodilator response evoked by breathing 8%O2 for 5 minutes was 
examined under control conditions, following L-NAME, during infusion of the NO 
donor SNAP, and then following blockade of either the adenosine A1 or A2A receptor 
subtypes. Following NOS blockade with L-NAME, the hindlimb vasodilator response 
to acute systemic hypoxia in CHU rats was significantly enhanced, suggesting that by 
blocking NOS restoring background NO levels, oxidative stress is reduced, and 
vasodilator responsiveness is enhanced. This is further evidence of oxidative stress 
in skeletal muscle vasculature of the CHU rat. Following NOS blockade, blocking the 
A1 or A2A adenosine receptor subtypes had no significant effect on the hypoxia-
induced hindlimb vasodilatation, but blockade of both significantly reduced it. 
Blockade of the adenosine A1 receptor under control conditions reduced hypoxia-
induced hindlimb vasodilatation in both N and CHU rats, in contrast to that previously 
reported. 
 
5 – Muscle sympathetic nerve activity (MSNA) was measured in the sympathetic 
neurones on the surface of the arteries supplying the spinotrapezius skeletal muscle 
in N and CHU rats. Discriminated single unit recordings contained cardiac and 
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respiratory rhythmicity. Ongoing firing rate was significantly higher in CHU rats than 
in N rats (0.56±0.075 vs 0.33±0.036Hz, p<0.001), but the increases in MSNA evoked 
by baroreceptor unloading, or by graded systemic hypoxia, were similar between 
groups. The degree of respiratory and cardiac modulation of ongoing MSNA was 
similar between groups. Sympathetic innervation density was assessed in the tibial 
artery, which supplies skeletal muscle, using the glyoxylic acid staining technique, 
and was also found to be significantly higher. 
 
6 – In light of high ongoing MSNA and increased innervation density in CHU rats, the 
hindlimb vasoconstrictor response to lumbar sympathetic chain stimulation with a 
train of pulses at 2Hz, and bursts at 20 and 40Hz were tested. CHU rats showed 
smaller maximal vasoconstrictor responses to stimulation at all frequencies. In N rats, 
the neuropeptide Y Y1 receptor antagonist BIBP-3226 significantly reduced 
vasoconstrictor responses to sympathetic chain stimulation in N rats at all 
frequencies, but had no significant blunting effect on the response in CHU rats, 
indicating that the role of NPY in sympathetically evoked vasoconstriction is reduced 
in CHU rats. 
 
7 – Similar vasoconstrictor responses were tested in 36-week old N-A and CHU-A 
rats, to examine the effects of aging in CHU rats on sympathetic vasoconstriction. 
CHU-A rats were found to be hypertensive relative to N-A rats (139±3 vs 
126±3mmHg, p<0.01). Vasoconstrictor responses evoked by stimulation of the 
lumbar sympathetic chain were similar in N-A and CHU-A rats. Further, there was no 
significant blunting of the vasoconstrictor response to sympathetic chain stimulation 
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by the NPY Y1 receptor antagonist BIBP-3226. Thus, the reduced sensitivity to 
sympathetic chain stimulation seen in younger CHU rats is no longer evident by 36-
weeks of age, and may explain why CHU-A rats are hypertensive relative to their 
control counterparts. 
 
8 – In summary, this study presents evidence that there are high levels of oxidative 
stress in the skeletal muscle vasculature of the CHU rat. Further, ongoing 
sympathetic nerve activity in skeletal muscle vasculature is increased in CHU rats, as 
is the density of sympathetic neurones present on the surface of the tibial artery. 
Sensitivity to sympathetic nerve stimulation in the same vascular bed is reduced in 
CHU rats, and thus, ongoing vascular tone is similar to that of N rats. Arterial blood 
pressure is increased in middle aged CHU rats relative to middle aged N rats, 
indicating that along with the vascular dysfunction observed in the hindlimb 
vasculature, there may be dysfunction in other vascular beds, which may contribute 
to increased total peripheral resistance. 
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Chapter 1 - General Introduction 
  
? 
1.1 Setting the scene 
The paradigm that the environment to which a fetus is exposed during development 
affects its health later in life is well established Barker (1995). Factors such as 
macro- and micro-nutrient status (Barker, 1997), delivery of oxygen, maternal 
hormone levels (Owen et al., 2005), maternal autoimmune disease (Roche et al., 
1992), and even maternal psychiatric disorders (Chung et al., 2001) have all been 
found to affect the health outcomes of the progeny.   
 
Reduced supply of nutrients to the fetus leads to an increase in risk of developing 
hypertension or coronary heart disease (Barker, 1995; Ojeda et al., 2008). Of 
particular interest in the present study are the consequences of reduced fetal oxygen 
supply, which can occur as a result of preeclampsia, maternal anaemia, placenta 
previa, and the mechanisms by which this leads to cardiovascular disease. There is 
experimental evidence that chronic hypoxia in utero leads to endothelial dysfunction 
(Williams et al., 2005b; Morton et al., 2011), alterations in sympathetic innervation 
density (Ruijtenbeek et al., 2000) and alterations in sensitivity to sympathetic 
neurotransmitters (Herrera et al., 2007). Thus, the broad aims of the present study 
were to explore the roles of the endothelium and the sympathetic nervous system in 
the generation of cardiovascular pathology following fetal hypoxia.  
 
In order to consider the mechanisms by which cardiovascular disease might manifest 
following adverse in utero conditions, first, the normal mechanisms of cardiovascular 
regulation must be considered.  
 
? 
Thus, this Introduction provides an overview of the general anatomy and functioning 
of the cardiovascular system, a number of control systems that regulate 
cardiovascular homeostasis, including the sympathetic nervous system, local, 
endothelial control, and particularly the role of oxidative radicals. The cardiovascular 
baro- and chemo-reflexes are also considered. Finally, a review of current evidence 
of the consequences of an adverse in utero environment for the cardiovascular 
system is given, including evidence gleaned from animal models of fetal 
programming.  
 
1.2.1 The cardiovascular system 
Control of vascular tone is a balance between locally released endothelium and 
tissue-derived vasoactive substances, such as NO or adenosine, and substances 
released from the varicosities of the sympathetic nerves which innervate most blood 
vessels.   
 
1.2.2 Sympathetic nervous system 
At its most basic level the sympathetic nervous system (SNS) can be considered to 
comprised 5 different classes of neurons. There are primary afferents, which convey 
information from sensory bodies, which are discussed later. These primary afferents 
are not always strictly considered part of the sympathetic nervous system, but vital in 
the functioning of the SNS. These primary afferents make direct connections with 
sympathetic premotor neurons (also known as presympathetic neurones) or with 
interneurons within the brainstem that convey sensory information to higher brain 
? 
centers, other areas within the brainstem, and then back to the sympathetic premotor 
neurons. Sympathetic premotor neurones project within the intermediolateral cell 
column (IML) onto the cell bodies of the sympathetic preganglionic neurones (SPNs), 
which are usually within the sympathetic ganglia and give rise to the sympathetic 
postganglionic neurone (PGNs) which innervate the end organ (Dampney, 1994). 
The exception to the rule is the adrenal gland, which receives direct efferent 
innervation from sympathetic preganglionic neurones. 
 
1.2.3 Ongoing, rhythmic sympathetic nerve activity 
It is well known from nerve recordings that there is ongoing activity in PGNs, 
particularly those which supply the vasculature. Much work has been performed on 
how sympathetic tone is generated to different organs, but for the purpose of this 
thesis, the focus is on the cardiovascular system. The exact source of what is a 
rhythmic ongoing activity, is a matter of much discussion. However, substantial work 
by Gebber and colleagues demonstrated the intrinsic, rhythm-generating nature of 
the medulla, even in the absence of afferent input (see Gebber 1980 for review). 
Notably, section of the brain above this region produces no significant fall in arterial 
pressure, whereas section below the medulla produces a profound fall. Various 
techniques have been employed to demonstrate involvement of several key areas of 
the medulla in the generation of ongoing sympathetic tone. Although the details are 
beyond the scope of discussion in this thesis, the regions are the rostral ventrolateral 
medulla (RVLM), the rostral ventromedial medulla (RVMM), the caudal raphe nuclei, 
the A5 cell group, and the paraventricular nucleus (PVN). See Dampney (1994) for 
? 
review of the anatomical and functional arrangement of these medullary neurones, 
and Malpas (1998) for review of the rhythms they generate.  
 
The RVLM is clearly implicated in determining sympathetic outflow, as microinjection 
of the excitatory amino acid glutamate results in profound sympathoactivation 
(Willette et al., 1983, 1984), whilst bilateral lesion of this region markedly depresses 
sympathetic outflow. Antidromic stimulation and neuroanatomical tracking have 
shown that the RVLM has direct synaptic projections to SPNs of the IML (Dampney 
et al., 1982; Morrison et al., 1988). 
  
1.3 Autonomic afferent pathways 
1.3.1 Baroreceptors 
Arterial baroreceptors are located bilaterally in the carotid sinus, immediately distal to 
the carotid bifurcation, and in the aortic arch (Moore et al., 2009). Information from 
these pressure-sensitive organs is conveyed centrally via the 9th and 10th cranial 
nerves, the glossopharyngeal and vagus nerves respectively. Rises in blood 
pressure stimulate baroreceptor afferents which elicit a reflex increase in 
parasympathetic nerve activity, as well an inhibition of sympathetic outflow.  
 
These lead to bradycardia and a reduction in total peripheral resistance, and 
therefore lower blood pressure. The reverse is true when blood pressure falls from its 
normal values, leading to parasympathetic inhibition and sympathoexcitation which 
increases blood pressure (Berne et al., 2003). 
? 
 
1.3.2 Chemoreceptors 
The carotid chemoreceptors are also located at the bifurcations of the carotid 
arteries. They contain type I and II glomerular cells, the former of which detect 
changes in arterial O2 tension, amongst other variables (for review of oxygen sensing 
mechanisms see Prabhakar (2006), and for review of the polymodal nature of the 
carotid body see (2007)). The carotid bodies are innervated by the 9th cranial nerve. 
There is also similar chemosensitive tissue located in the aortic bodies which are 
found in the wall of the arch of the aorta; these are innervated by the 10th cranial 
nerve. The integrated response to chemostimulation is covered elsewhere in this 
introduction, but the primary cardiovascular reflex is bradycardia and 
vasoconstriction, which may be heavily modulated by alterations in ventilation.  
 
1.3.3 Central integration of afferent pathways 
Both baro- and chemo-receptor afferents in the 9th and 10th cranial nerves have been 
show to terminate in the nucleus of the solitary tract (NTS) in the medulla. In fact, 
many other primary afferents, spinal and cranial, as well as afferents from higher 
centers also terminate in the NTS. Indeed, the NTS plays an essential role in reflex 
control of the cardiovascular system (Loewy, 1990; Dampney, 1994). Antidromic 
mapping shows that chemoreceptor afferents terminate mainly in the caudal regions 
of the NTS, whilst baroreceptor afferents terminate more rostrally (Donoghue et al., 
1984). Many other afferents terminate at discrete locations in the NTS, and although 
each type of afferent appears to have its own primary site for termination, there is a 
large degree of overlap (Taylor et al., 1999). Efferent neurons of the NTS project 
? 
directly to the SPNs of the IML, but importantly, also project to other brainstem nuclei 
involved in generating and modulating the cardiovascular reflexes, particularly the 
RVLM and CVLM (See Loewy (1990) and Dampney (1994)).  
 
CVLM neurones have been demonstrated to be broadly sympathoinhibitory, but 
appear to lack direct projections onto the IML. The CVLM receives inputs from 
several other brainstem nuclei, as well as from the NTS, and has direct GABAergic 
projections onto the RVLM. Indeed, the sympatho-inhibitory action of baroreceptor 
stimulation appears to be mediated by the inhibitory action of CVLM neurones on 
RVLM neurones. Thus, blockade of the CVLM with kynurenic acid abolishes the 
baroreflex (Koshiya et al., 1993).  It is also known that sympathetic outflow is reduced 
during inspiration, and enhanced during expiration (Seals et al., 1990; Seals et al., 
1993). This is thought to be due to modulation of the baroreceptor input by central 
respiratory neurones projecting onto to the NTS, and the output from the NTS to the 
sympathoinhibitory CVLM (see Guyenet, 2000). 
 
1.3.4 Autonomic efferent outflow 
The generation of vasomotor tone by the ongoing activity observed in postganglionic 
sympathetic neurones innervating blood vessels, is a complex process. The RVLM 
plays a critical role, as inhibition of this area essentially abolishes such tone, and 
further, activity recorded in RVLM presympathetic neurones has been shown to 
largely mirror that seen in PGNs. However, the output of RVLM neurones is thought 
to be a complex interplay between the intrinsic activity of RVLM neurones and inputs 
from many subnuclei of the medulla, such as the CVLM, raphe nuclei, parabrachial 
? 
region and the lateral tegmental field, which interact to generate sympathetic tone 
(Guyenet, 2000) 
 
As indicated above, the RVLM neurones are particularly modulated by the respiratory 
networks, the activity of which is a result of interactions between the pre-Boetzinger 
nucleus, the so called ‘respiratory rhythm generator, and pools of interneurons. This 
explains why activity recorded from PGNs contains strong respiratory rhythm 
(Guyenet, 2000). The characteristics of activity recorded in PGNs, particularly in 
those supplying the vasculature of skeletal muscle, is discussed below.   
 
1.3.5 Reflex control of the cardiovascular system – baroreflex 
The primary afferents from the baroreceptors, the glossopharyngeal and vagal 
afferents, terminate in specific regions of the NTS (Taylor et al., 1999). A rise in ABP, 
which loads the arterial baroreceptors, causes an increase in afferent firing rate, 
which evokes a rise in parasympathetic outflow to the heart, via the cardiac vagal 
nerves, and a reduction in sympathetic nerve outflow to blood vessels, reducing total 
peripheral resistance, and lowering arterial blood pressure. Conversely, a fall in ABP 
unloads the baroreceptors, reducing afferent activity, removing the 
sympathoinhibition and reducing vagal outflow to the heart. It is known that the NTS 
is the major relay site for baroreceptor afferents in the medulla.  
 
It is also known that there is overlap between the central projections of baroreceptor 
afferents and the central respiratory neurones in the DRG and VRG. Thus, there is 
interaction between these groups, such that activity in baroreceptor afferents during 
? 
the expiratory phase of respiration evokes a vagally mediated fall in HR, but activity 
during the inspiratory phase does not (Spyer, 1996). Some of the mechanisms of this 
interaction are discussed by Dampney (1994), but are beyond the scope of this 
introduction.  
 
The manner in which the baroreflex modulates sympathetic outflow has been 
extensively studied by many authors in humans and rodent models (Yamada et al., 
1989; Schreihofer & Sved, 1992; Thrasher, 2002, 2005). It is known that it generates 
cardiac rhythmicity in muscle vasoconstrictor nerves (Habler et al., 1993, 1994). The 
effect of baroreceptor unloading on the activity in individual sympathetic nerves on 
the surface of arteries supplying skeletal muscle in the rat has recently been 
described by Hudson et al., (2011); unloading of the baroreceptors by an IV bolus of 
the nitric oxide donor SNP which reduced ABP resulted in a marked increase in 
muscle sympathetic nerve activity (MSNA) as was expected from previous 
observations of skeletal muscle arterial diameter responses to baroreceptor 
unloading (Hébert & Marshall, 1988).  
 
1.3.6 Reflex control of the cardiovascular system – the peripheral chemoreflex  
 
As indicated above, stimulation of the carotid body elicits the chemoreflex via the 
carotid sinus nerve (CSN) and the glossopharyngeal afferents, which terminate in the 
NTS. Excitatory NTS neurones then project onto the RVLM (Paton et al., 2001), and 
cause sympathoexcitation. Inhibition of the RVLM with a glutamate receptor 
antagonist blocks the chemoreflex (Koshiya et al., 1993), as does chemical inhibition 
?? 
of the neurones in the caudal aspects of the NTS (Vardhan et al., 1993). The 
neurones relaying chemosensitive information from the NTS to the RVLM do not 
display respiratory rhythm. However, they can directly control sympathetic outflow. 
However, whilst inhibition of respiratory rhythm generators such as the pre-
Boetzinger nuclei does not abolish the sympatho-excitation induced by the 
chemoreflex,  it does abolish its respiratory entrainment (see Guyenet, 2000).  
 
Another group of neurones shown to be important in chemoreflex activation is the A5 
cell group, a group of catecholaminergic neurones in the pons. These neurones are 
activated by peripheral chemoreceptor stimulation, and show strong respiratory 
rhythm (Guyenet et al., 1993), and inhibition of their activity reduces the 
sympathoexcitation of the chemoreflex by around 50% (Koshiya & Guyenet, 1994). 
Recent studies have shown that they are only weakly activated by central 
chemoreceptors, indicating that they are mainly involved in the peripheral, and not 
the central chemoreflex (Kanbar et al., 2011). Again, recent work by Hudson et al., 
(2011) has demonstrated that graded systemic hypoxia evokes a graded increase in 
MSNA recorded in individual sympathetic neurones on the surface of arteries 
supplying skeletal muscle.  
 
1.4.1 Characteristics of MSNA 
The characteristics of postganglionic sympathetic nerve activity were initially 
characterised in the cat, by extensive work by Janig and colleagues, who examined 
recordings from vasoconstrictor neurones identified as supplying skeletal muscle 
(MVCs), cutaneous vessels (CVCs), and sweat glands (sudomotor neurones) by the 
?? 
characteristics of their firing activity. On this basis, activity in both MVCs and CVCs 
has been found to posses both cardiac and respiratory rhythms, although respiratory 
rhythm was less strong in the CVCs than MVCs. As indicated above, stimulation of 
the arterial baroreceptors lead to depression of activity in both types of neurone, 
while stimulation of the arterial chemoreflex, by giving the animal a hypoxic 
hypercapnic mixture to breathe, lead to a profound increase in MVC activity but a fall 
in CVC activity (See Janig, 1985 for review). Ongoing activity in MVCs of the cat was 
found to be 0.5-1.5Hz, although some MVCs are in fact silent unless otherwise 
stimulated (Horeyseck & Jänig, 1974). Ongoing activity in CVCs of the cat was 0.1-
1.5Hz. 
 
Some of the earliest work characterizing the activity of PGNs in the rat was carried 
out by Coote and colleagues. A study by Yusof & Coote (1988) showed that nerve 
activity from sympathetic neurones identified as supplying either skin or skeletal 
muscle of the rat hindlimb displayed cardiac rhythmicity, and was inhibited when 
arterial baroreceptors were stimulated by a rise in ABP induced by systemic infusion 
of phenylephrine. They also found that in the rat, the degree to which activity varied 
between nerves supplying different vascular beds is smaller than that found in the 
cat, with a more uniform pattern of response to stimulation of the medial regions of 
the lower brainstem (Yusof & Coote, 1988).  
 
Later work carried out by Habler and colleages further characterised responses of 
PGNs to physiological stimuli in the rat (Habler et al., 1993, 1994). They 
discriminated single unit activity in multiunit recordings taken from the saphenous 
?? 
nerve, which contains fibres supplying cutaneous and skeletal muscle circulations. 
Single units that contained cardiac rhythmicity and were inhibited by the arterial 
baroreflex were identified as being sympathetic in nature, and then were classified as 
supplying muscle or skin based on the anatomical location of their projections.  
 
They found that whilst most MVC neurones contained cardiac rhythmicity (82% of 
neurones recorded from), the CVC neurones contained either weak or no cardiac 
rhythmicity at all (Habler et al., 1993). That said, the activity in both CVC and MVC 
neurones was inhibited by baroreceptor stimulation, although inhibition of CVC 
neurones by this reflex was slower than that of the MVC neurones. Around 90% of 
MVC and CVC neurones were found to contain respiratory rhythmicity, with 
facilitation being strongest during the post-inspiratory phase, but often extending 
through active expiration, and inhibition occurring during inspiration (Habler et al., 
1993). 
 
In a further study, the same authors sought to determine how the degree of cardiac 
rhythmicity in ongoing and stimulated sympathetic nerve activity might change 
(Habler et al., 1994). They used an arbitrary classification of strong, weak or absent 
to classify the degree of cardiac rhythm present, based on stimulus histograms, 
triggered by using peaks in the arterial pressure wave. They also quantified cardiac 
rhythm by examining the ratio between the peaks and nadirs of the stimulus 
histogram traces. The magnitude of cardiac rhythm was then used as an estimate of 
the degree to which sympathetic nerve activity is under the control of the arterial 
baroreflex. These authors also studied the effects of central chemoreceptor activation 
?? 
on SNA using inspiratory hypercapnia. They found a strong activation of MVCs, but 
only around 50% of CVCs were activated by central chemoreceptor stimulation, 
whilst 35% of CVCs showed a reduction in activity (Habler et al., 1993).  
 
In a separate, interesting part of the study, the Habler et al., (1994) also found little 
evidence that different anaesthetics, in this case pentobarbital, chlorolose and 
urethane, have different effects on ongoing SNA, although Pentobarbital did appear 
to slightly augment ongoing activity. This effect of barbiturate anaesthesia has been 
reported elsewhere (Tucker et al., 1982) but is far from unequivocally observed.   
 
1.4.2 Sympathetic nerve activity in pathology and in programming 
Despite the many studies that have implicated dysfunctional regulation of the 
sympathetic nervous system in states of cardiovascular pathology (Notarius et al., 
1999; Goso et al., 2001; Simms et al., 2009), to the authors knowledge, there have 
been no attempts to directly measure the effects of fetal programming on 
sympathetic nerve activity induced by any of the widely recognised stimuli.  
 
1.5 Sympathetic cotransmission 
The translation of sympathetic nerve activity to a functional response in the end 
organ is a complex process that is modulated by the patterning and intensity of nerve 
activity, the compliment of co-transmitters present in the post-ganglionic neurone, 
and by feedback mechanisms located around the neuroeffector junction. The 
synthesis, release mechanisms and actions of co-transmitters are discussed below.  
?? 
 
Burnstock and Holman (1960) published the first study demonstrating in isolated 
guinea pig vas deferens, that repetitive stimulation of the hypogastric nerve led to 
excitatory junctional potentials which resulted in small, summated depolarisations of 
the post junctional smooth muscle cells, and eventually to a full ‘junctional potential, 
depolarisation and contraction of the smooth muscle. This was the first 
demonstration of the coupling between sympathetic nerves and contraction of 
smooth muscle cells, forming what one can term ‘the sympathetic unit’. This concept 
was later demonstrated in blood vessels (Sneddon & Burnstock, 1985).  
 
That sympathetic nerves contained catecholamines was demonstrated much earlier, 
by Cajal (1905), and subsequently by many authors including Kuntz (1953), but it 
was Ulf von Euler’s Nobel prize-winning work, which demonstrated that the major 
catecholamine was in fact noradrenaline (Euler, 1946). These sympathetic nerves 
are varicose in nature, with most of the neurotransmitter in the varicosities (Norberg 
& Hamberger, 1964; Chamley et al., 1972). Later, by electronmicroscopy, vesicular 
storage of the main catecholamine present in sympathetic nerve terminals, 
noradrenaline (NA) was demonstrated, in dense-cored vesicles (Burnstock & 
Robinson, 1967).  Further, the necessary synthetic and reuptake pathways have 
been shown to be present. The vesicles containing catecholamine have been 
morphologically and histochemically divided into large dense-cored vesicles (LDVs) 
and small dense-cored vesicles (SDVs), with more LDVs being present in the 
periarterial sympathetic nerves (Dermietzel, 1971) as opposed to the sympathetic 
nerve trunks.  
?? 
 
Subsequently, it was demonstrated that ATP, which is now recognised as a major co-
transmitter in sympathetic nerves (Kennedy et al., 1986b; Burnstock, 1990b; 
Burnstock, 2009b; Burnstock, 2009a), is stored in both LDVs and SDVs (Lagercrantz 
& Stjarne, 1974; Fried, 1980), though predominantly in LDVs (Lagercrantz & Stjarne, 
1974).  Further, following the discovery of Neuropeptide Y (NPY) by Tatemoto 
(1982), co-localisation of NA, ATP and NPY was demonstrated within the LDVs 
present in sympathetic nerves (Lundberg et al., 1982). For review see Lundberg 
(1996).  
 
It is now well known that within the sympathetic neuroeffector junction of blood 
vessels, there are receptors for NA and ATP and NPY on the vascular smooth 
muscle and in the pre-junctional membrane innervated by sympathetic nerves 
(Burnstock, 1976; Drew & Whiting, 1979; Docherty & McGrath, 1980; Timmermans & 
Van Zwieten, 1980; Wahlestedt et al., 1986). 
 
The transmitters stored within the SDVs and LDVs are released into the 
neuroeffector junction by a process of exocytosis (Smith & Wrinkler, 1972) which is 
triggered by an increase in [Ca2+]i, secondary to depolarisation of the sympathetic 
neuron. It is important to note that the release of these so called ‘quanta’ into the 
neuroeffector junction is intermittent in nature, and it has been shown that at low 
frequency stimulation (1Hz), release of quanta from a particular varicosity can occur 
as rarely as once in 150 depolarisations (Cunnane & Stjärne, 1984), although the 
probability of transmitter release is increased with higher frequency stimulation. 
?? 
 
The exact composition of the vesicles released into the neuroeffector junction, and 
the receptors they go on to interact with varies with end-organ or tissue. Of interest 
here is the manner in which sympathetic nerve control vascular smooth muscle. In 
fact there are variations in the magnitude of response evoked by sympathetic 
stimulation and the neurotransmitter and receptor profiles at different levels of the 
vasculature (Marshall, 1982; Morris, 1994, 1999) 
 
1.5.1 Adrenergic transmission 
The effects of sympathetic nerve stimulation on the blood vessels supplying skeletal 
muscle were demonstrated at several levels of the vascular tree by Marshall 
(Marshall, 1982). Marshall demonstrated that the primary and secondary arterioles 
(the higher and middle order arterioles) showed the most profound vasoconstriction 
to topical noradrenaline and to stimulation of the sympathetic paravascular nerve 
fibres at 10Hz, while terminal arterioles constricted initially but then relaxed during 
continued stimulation. Kobinger & Pichler (1981) showed, by infusing phenylephrine 
and noradrenaline into the hindquarter of the rat, and by using α1- and α2-selective 
adrenoreceptor antagonists, that both α1 and α2 subtypes are present in the hindlimb 
vasculature of the rat. Much work has since focused on the roles are for the two 
receptor subtypes. It was shown many years ago that both α1 and α2 receptor 
subtypes are present post-junctionally (Drew & Whiting, 1979; Timmermans & Van 
Zwieten, 1981), although there has been wide acceptance that the α1 receptors are 
the most important post-junctional receptor, whereas the α2 receptors are more 
important prejunctionally (See Rang et al., (2003)). Yamamoto et al., (1984) showed 
?? 
that both receptor subtypes are involved in the pressor response to noradrenaline but 
found that in intestinal mesentry, only the α1 receptor was involved in the 
vasoconstrictor response to nerve stimulation. Nevertheless, Coney & Marshall 
(2007) recently demonstrated, in the rat hindlimb, that α2 receptors do play a 
significant role in the vasoconstriction evoked by stimulation of the sympathetic chain 
with low frequencies or with bursts of high frequency pulses. This finding is important 
in view of mounting evidence that post junctional α2 receptors are important in 
regulation of skeletal muscle vasculature.  
 
1.5.2 Local modulation of sympathetic noradrenergic transmission 
Studies carried out by intra vital microscopy on the arterioles supplying the rat 
cremaster muscle and on arterioles from the isolated cremaster muscle showed that 
α1 receptors are located predominantly in the proximal portions of the vasculature, 
along with α2 receptors, but in the more distal arterioles, only α2 receptors are 
present. Further, they found that the α2 mediated component of vasoconstriction 
evoked by locally applied noradrenaline is reduced or abolished by reduced blood 
flow, designed to mimic hypoxia, or by acidosis, while the α1 component is relatively 
resistant.  (McGillivray-Anderson & Faber, 1991; Muldowney & Faber, 1991).  
 
Other work has examined the blunting effect that local mechanisms have on 
sympathetically-evoked vasoconstriction in skeletal muscle during exercise, termed 
functional sympatholysis. This effect, was noted many years ago (Remensnyder et 
al., 1962), and much work in rat and in human studies (Hansen et al., 1994), has 
focused on elucidating the mechanisms. In rat cremaster muscle, Anderson and 
?? 
Faber (1991) showed that when locally applying noradrenaline, it was α2 mediated 
vasoconstriction that was most vulnerable to blunting during skeletal muscle 
contraction, likely due to the locally produced metabolic products. The α1 component 
of vasoconstriction also became blunted at more intense exercise stimuli. Similar 
results were found by Thomas et al. (1994a). Further, VanTeeffelen and Jurgen, 
(2003) demonstrated by using intravital miscroscopy that in skeletal muscle 
vasculature, it was the smaller, 2A and 3A arterioles which were most vulnerable to 
sympathetic ‘escape’ while main arteries and 1A arterioles were relatively resistant 
during muscle contraction. Taken together with the work of McGilliray-Anderson and 
Faber, suggesting that constriction of more distal vessels, such as the 2A and 3A 
arterioles, is mediated primarily by α2 receptors, and is vulnerable to local mediators 
such as acidity or hypoxia, this can be seen as a mechanism by which oxygen 
extraction can be increased without compromising systemic perfusion pressure. 3A 
arterioles control the number of perfused capillaries, and hence dilation of these 
arterioles, without upstream vasodilatation both increases effective capillary density, 
and slows flow in each capillary.  
 
The mechanisms by which sympathetic vasoconstriction is blunted during muscle 
contraction in rodents and in humans, is heavily reliant upon NO (Thomas & Victor, 
1998), and probably involves the activation of KATP channels by acidosis or hypoxia, 
which blunts the α2-mediated component (Tateishi & Faber, 1995). It is thought that 
these mechanisms may well in fact interact to produce sympatholysis (see. Hansen 
et al., 2000 for review). 
 
?? 
1.5.3 Purinotransmission 
Some of the earliest evidence that ATP is released during sympathetic nerve 
transmission came from Su et al., (1971), who showed that enteric nerve sympathetic 
varicosities take up radiolabelled adenosine, synthesize ATP from it, and release it 
from the nerve terminals upon stimulation. In fact, it has been shown that usually it is 
ATP released from sympathetic nerves that are responsible for the EJPs recorded at 
the neuroeffector junction, and that if ATP receptors are desensitized with α,ß-
methylene ATP, the EJP component of sympathetic cotransmission is abolished in 
the vas deferens (Sneddon & Burnstock, 1984). The contribution of ATP to 
cotransmission varies from one tissue and vascular bed to another, and also from 
species to species (see Burnstock (2008) for review). Early studies on isolated rat tail 
artery and mesenteric artery suggested that the role of ATP was predominately in 
initiating smooth muscle contraction to single impulses or couplets, and is not an 
important neurotransmitter during more sustained trains of sympathetic stimulation 
(Kennedy et al., 1986a; Sjoiblom-Widfeldt et al., 1990). However, more recent in vivo 
work in the rat hindlimb vasculature demonstrated that ATP plays a major role in 
cotransmission in response to lumbar sympathetic chain stimulation with both 
couplets in response to naturally-occuring patterns of sympathetic nerve activity 
(Johnson et al., 2001). In fact, as much as 50% of the response to couplets of activity 
was still attributable to the action of NA, while ≈40% of the response to longer trains 
of nerve activity was attributable to ATP.  
 
Both subclasses of P2 purinergic receptor are present at the sympathetic 
neuroeffector junction; the ATP-gated cation channel (P2X) and the G-protein 
?? 
coupled nucleotide (P2Y) receptor (see Boehm 2003  for review). The main post-
synaptic ATP receptor is the P2X receptor, which mediates the EJP in smooth 
muscle.  
 
P2Y receptors are present presynaptically, and inhibit the release of sympathetic 
neurotransmitter. P2X receptors are also present presynaptically, but they facilitate 
the neurotransmitter release (Miyahara & Suzuki, 1987; Boehm, 1999; Queiroz et al., 
2003) 
 
1.5.4 Neuropeptide Y  
NPY, predominantly found in LDVs and not SDVs in the sympathetic varicosity (Fried 
et al., 1985; Lundberg et al., 1989), acts on the post junctionally located NPY Y1 
receptor and the prejunctionally located NPY Y2 receptor (Wahlestedt et al., 1986).  
 
Post junctionally, in skeletal muscle and vascular beds, stimulation of Y1 receptors 
leads to vasoconstriction (Donoso et al., 1997; Ekelund & Erlinge, 1997), through 
increases in intracellular Ca2+ ([Ca2+]i) and through potentiation of NA-mediated 
vasoconstriction (Linder et al., 1996; Zhao et al., 1997). Prejunctionally, the Y2 
receptor, at least in the rat vas deferens, has an autoinhibitory role, with stimulation 
of Y2 receptors reducing release of NA from the sympathetic varicosity (Porter et al., 
1994).  
 
There is conflicting evidence on the role of NPY in regulation of normal muscle blood 
flow under resting conditions. Pernow et al., (1989) in pigs, and Coney and Marshall 
?? 
(2007) in rats, demonstrated in vivo, that the NPY Y1 receptor antagonist BIBP-3226 
has no effect on skeletal muscle vascular resistance under basal conditions. By 
contrast, Shoemakers group published evidence suggesting that NPY does play a 
role in regulating basal blood flow in the rat hindlimb muscle and human 
forarm(Jackson et al., 2004; Hodges et al., 2009; Jackson et al., 2010); in the rat at 
least, this disparity may be explained by different anaesthetics. This is discussed in 
more detail in Chapter 6.  
 
It has been shown that systemic plasma NPY concentration is not a viable option for 
measuring the contribution of NPY spillover from sympathetic nerves to basal 
skeletal muscle blood flow, as the gut and liver are major contributors to this level 
(Morris et al., 1997). However, even if this is considered, it is known that circulating 
plasma [NPY] under resting conditions is around 20pM at most. Moreover, in 
humans, it has been shown that infusions for NPY which raise plasma concentrations 
to 356pM have no cardiovascular effects (Pernow et al., 1987). NPY is considered to 
be most important during high frequency sympathetic nerve activity, such as that 
found following shock or myocardial infarction (Zukowska-Grojec & Vaz, 1988; 
Qureshi et al., 1998; Kuo & Zukowska, 2007), according with the results of Coney & 
Marshall (2007).  
 
Thus far, there has been no attempt to examine how the role of NPY is sympathetic 
vasoconstriction may be programmed by the in utero environment. This may be 
important, given evidence that responses to adrenergic agonists are altered following 
chronic hypoxia in utero (Rouwet et al., 2002; Herrera et al., 2007).   
?? 
 
1.6.1 Fetal development of the sympathetic nervous system 
 
The sympathetic nervous system originates from the migration and neurochemical 
differentiation of a longitudinal part of the neuroblast from the embryological neural 
crest (See Burnstock et al., (1981) for review), and is regulated largely by Nerve 
Growth Factor (NGF, (Storkebaum & Carmeliet, 2011)). Cochard et al., (1978; 1979) 
demonstrated that initial phenotypic characteristics, such as expression of tyrosine 
hydroxylase and catecholamine-related fluorescence, are evident in the developing 
rat embryo by day 11.5 of the 22 day gestation period, although these characteristics 
appear to be transient, and perhaps, are markers of developing sympathetic nerves, 
rather than of functioning enzymes. However, noradrenaline uptake mechanisms on 
nerve terminals are evident at day 12.5 and persist until at least day 17.5. (Jonakait 
et al., 1979). Further, by day 13, adrenal medullary cells were clearly identifiable, and 
in most major nerve bundles, axons which appeared to be of sympathetic nature, 
were visible. In the rabbit Cowen et al., (1982) demonstrated a perivascular 
sympathetic nerve plexus around the carotid and renal arteries at days 25 and 30 
respectively of gestation, which is around 30 days. It appears that in humans, more 
advanced sympathetic innervation may be present earlier in gestation than in other 
mammals. Thus, Pearson et al., (1980) and Edvinsson et al,. (1976) showed that 
there is a well developed sympathetic innervation of the carotid arteries, including 
terminal neurons, by 9-10 weeks of gestation in the developing human fetus, 
although they suggested that the cerebral circulation may become innervated earlier 
?? 
than other systems due to its proximity to the neural crest during embryonic 
development.  
 
An important point when considering the development of the sympathetic nervous 
system is the time at which the coordinated action of nerve, neurotransmitter, 
enzymes, pre- and post-junctional receptors, and reuptake mechanisms are able to 
work in a coordinated fashion, to form a ‘sympathetic unit’. In the vasculature, an 
important part of the sympathetic unit is the ability of the vascular smooth muscle to 
react to noradrenaline. Su et al., (1977b) demonstrated that at day 53 of the lamb’s 
147 day gestation period, ie. about a third of the way through gestation, the carotid 
artery can respond to exogenous NA. They went on to propose a time course of 
events at the ‘sympathetic unit’ in the vasculature, after studying the maturation of 
blood vessels in various vascular beds (Su et al., 1977a); see figure below.  
 
 
The time at which the whole sympathetic unit becomes functional is not entirely clear. 
Nuwayhit et al. (1975) demonstrated that α-adrenerenoreceptor blockade in lamb 
fetuses of less than 1600g in weight (birthweight is ≈5000g)  led to  fall in arterial 
pressure of ≈28%, indicating that even at this early age, there is a contribution of 
sympathetic tone to the maintenance of arterial pressure. Ganglionic blockade had 
similar, but less marked effects. Moreover, ganglionic stimulation of fetuses of 1100-
3700g increased heart rate and arterial pressure, indicating the capability of the 
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sympathetic nerves to control fetal heart rate.  Nuwayhit et al., (1975) concluded that 
the magnitude of sympathetic tone in the lamb fetus increases with the maturity of 
the fetus, but that full maturity is not achieved until sometime after birth. Thus, it is 
clear sub-optimal conditions during the period when sympathetic innervation of blood 
vessels is developing has the potential for profound consequences for the fetus as it 
matures post-partum. Such consequences are discussed and examined in chapter 5. 
 
1.6.2 Postnatal development of sympathetic control 
 
It is generally agreed that development of the full compliment of autonomic reflexes 
and control of the vasculature largely takes place postnatally. Studies carried out in 
the piglet, which the authors argue shares the characteristics of the developing 
human baby, demonstrated that constrictor responses can be evoked in the 
mesenteric vasculature by reflex activation of sympathetic nerves or direct 
stimulation in the neonate (Gootman et al., 1972; Gootman et al., 1978), but these 
responses were not completely mature until 2 months of age. Consistent with these 
findings, Buckley et al., (1976) demonstrated that there is ongoing activity in the 
splanchnic sympathetic nerves which is modulated by the respiratory cycle in 1 week 
old neonatal swine.  
 
The post-natal development and maintenance of the sympathetic innervation is less 
well understood. It is known that a variety of molecules produced by vascular smooth 
muscle cells, and sympathetic neurones maintain the integrity of the sympathetic 
innervation. Survival of perivascular sympathetic nerves is dependent on NGF (Chun 
?? 
& Patterson, 1977; Ruit et al., 1990; Orike et al., 2001). Thus, Stewart et al., (2008) 
found that in pelvic ganglia from newborn mice, neutotrophin-3 increased 
outbranching of sympathetic neurones, whilst Francis et al., (1999) found that 
targeted disruption of the NT-3 gene halved the number of superior cervical ganglion 
neurones that survived to birth. A number of molecules derived from the extracellular 
matrix of vascular smooth muscle cells have also been implicated in the post natal 
regulation of sympathetic innervation, in terms of regulating nerve density and 
neurotransmitter profile (See Storkebaum & Carmeliet (2011) for recent review). 
Recent evidence shows that vascular endothelial growth factor (VEGF) also plays an 
important role in maintaining the neuroeffector junction, as its neutralization in vivo 
leads to and failure of re-innervation following femoral artery denervation (Marko & 
Damon, 2008). Further, mice that genetically express low levels of VEGF are found 
to have structurally and functional defects in the sympathetic neurovascular junction 
(Storkebaum et al., 2010).  
 
Aside from regulating the structure and function of the sympathetic neurovascular 
junction, neurotrophin signaling can modulate the firing properties of sympathetic 
neurones. Treatment with NGF increases firing probability in superior cervical 
ganglion sympathetic neurones (Luther & Birren, 2009).Furthermore, various factors, 
including NGF and BDNF (brain derived neurotropic factor) are important in 
regulating ion channel expression, and thus firing probability, in sympathetic 
neurones during development (Raucher & Dryer, 1995) and in adulthood (Lei et al., 
2001; Ford et al., 2008).   
 
?? 
In the rat, postnatal development involves the initiation of vital autonomic 
cardiovascular reflexes, which take place in the first stages of postnatal growth. For 
example, the carotid chemoreflex, which is immature at birth, matures during the first 
14 days of life in the rat (Eden & Hanson, 1987b). These reflexes are present in the 
late gestation fetal lamb (Blanco et al., 1984), but occur post-natally in the rat. 
 
As indicated above, the development and post-natal maintenance of sympathetic 
control of the vasculature is a complex process. No attempt has yet been made to 
establish how the effects of an adverse pre-natal environment (Ruijtenbeek et al., 
2000; Rouwet et al., 2002; Anderson et al., 2006) are carried through adult life.  The 
correct maturation of cardiovascular and respiratory reflexes involving the 
sympathetic nervous system are vital for cardiorespiratory homeostasis. Thus, it is 
apparent that adverse developmental environment has the potential to perturb 
normal development, and disturb normal cardiovascular regulation. These 
possibilities are discussed in more detail in chapter 3.  
 
1.6.3 Sympathetic Innervation: Aged related changes 
It is now well established that sympathetic control of blood vessels changes with age, 
both in terms of innervation density and functioning (Burnstock, 1990a). Cowen et al., 
(1982) demonstrated that within a single species arteries from different vascular beds 
change differently with age. Thus, innervation density in the femoral artery, as 
assessed by fluorescent area and number of varicosities per unit area peaked at 6 
weeks of age, and then progressively fell through to 3 years of age. The same 
indices in the basilar artery increased progressively over the same period, while in 
?? 
the renal artery peaked at around 6 months of age, before falling sharply. In rats, the 
density of the perivascular nerve plexus in the arteries of the circle of Willis peaks 
around 1 month postnatally, and then falls. However, further to this, the NA content of 
the remaining nerves appears to fall with age in these arteries, although NPY 
expression remains constant (Mione et al., 1988). However, it appears that this 
pattern of change may be limited to the cerebral circulation. Recent studies by Omar 
and Marshall (2010) using 4-5, 10-11, and 42-44 week old young, mature and middle 
aged rats have shown that in the arteries supplying the brain, sympathetic 
innervation density declines as rats move into middle age (42-44 weeks). 
Conversely, in the caudal ventral tail artery and the femoral artery, innervation 
increases from 12 weeks of age and they progress towards middle age.  
 
There is evidence that chronic hypoxia in ovo increases the sympathetic innervation 
density of the femoral artery of the hypoxic chick embryo (Ruijtenbeek et al., 2000). 
However, no study has been performed of the equivalent effect of chronic hypoxia in 
utero and the subsequent effects in mammals in post-natal life. Thus, experiments 
examining this are presented in Chapter 5. 
 
1.7.1 The integrated autonomic and local response to acute systemic 
hypoxia 
 
Hypoxia occurs when tissue O2 delivery is inadequate for normal functioning. When 
this occurs in tissues across the body, it is termed systemic hypoxia. The respiratory 
and cardiovascular response to acute systemic hypoxia is a multifaceted response, 
?? 
involving local and neurohumoral factors. Generally, the outcome tends to maintain 
blood perfusion and O2 delivery to tissues, and to alleviate tissue hypoxia, although 
in certain conditions the local and neurohumoral responses are inadequate and thus, 
tissue hypoxia persists and ultimately, death may occur by circulatory and respiratory 
collapse (Thomas & Marshall, 1995). 
 
The mechanisms that contribute to the vascular elements of the response to acute 
systemic hypoxia include factors that are locally produced by the vascular 
endothelium, vascular smooth muscle, and the tissues surrounding these, that are 
superimposed on reflex, neural influences that are integrated in the central nervous 
system and which control the network of sympathetic nerves that innervate the 
vascular tree. 
 
1.7.2 Characterisation of the cardiovascular response to acute systemic hypoxia 
 
Comprehensive studies have been carried out to elucidate the cardiovascular 
response to acute systemic hypoxia. Marshall and Metcalfe (1988a) were the first to 
examine the cardiovascular responses of Saffan anaesthetised rats to graded levels 
of acute systemic hypoxia, breathing 15, 12, 8 or 6% O2 in N2 for 3 minute periods. 
They showed, in rats anaesthetised with the steroid anaesthetic Saffan, that graded 
hypoxia induced graded respiratory and cardiovascular changes, such that by the 
end of the 2nd minute of acutely breathing 8% O2 or 6% O2, PaO2 was reduced to 
~33mmHg. These changes comprised graded hyperventilation, a fall in systemic 
?? 
arterial blood pressure (ABP) and tachycardia, as well as graded vasodilatation in 
hind limb, mesenteric and renal vasculature. 
 
1.7.3 Longer periods of acute hypoxia 
Work carried out by Thomas & Marshall (1994) showed how these responses 
changed during longer 10 minute periods of acute systemic hypoxia (8% O2); they 
and also recorded internal carotid blood flow (CBF), as an index of brain blood flow. 
They demonstrated that the initial hyperventilation began to wane by the third-fifth 
minute of hypoxia, due mainly to a fall in tidal volume (VT) and the initial tachycardia 
waned towards or below the original control level. Concomitantly there was 
vasodilatation in the cerebral circulation, similar to that shown in the hindlimb, 
mesenteric and renal vascular beds. However, from the 5th min of hypoxia, CBF fell 
towards or below control level even though it was well maintained initially. It was also 
evident that ABP tended to fall further in the latter part of hypoxia over the time when 
ventilation, HR and CBF were falling. Thomas & Marshall proposed that this pattern 
of response would lead to a positive feedback loop and to death caused by 
respiratory failure, and cardiovascular collapse (see below for further discussion).  
 
1.7.4 Reflex changes induced by acute systemic by hypoxia 
Consiering the mechanisms underlying the pattern of respiratory and cardiovascular 
response described above, the hyperventilatory response to acute systemic hypoxia 
is attributable to stimulation of the peripheral chemoreceptors (Marshall, 1994). 
Moreover, a series of studies performed by Marshall and colleagues demonstrated 
some of the mechanisms underlying the other components of the biphasic response 
?? 
in the rat. It should be noted that at the time these studies were performed it was well 
established from experiments on dogs and cats, that hyperventilation evoked by 
peripheral chemoreceptor stimulation can lead to tachycardia evoked by lung stretch 
receptor stimulation, hypocapnia and increased central respiratory drive, and that this 
tachycardia can override the reflex bradycardia that is the primary reflex response to 
stimulation of the peripheral chemoreceptors, (Sapru & Krieger, 1977; Marshall, 
1987; Daly, 1997). It was also known that in the dog, stimulation of lung stretch 
receptors and hypocapnia evoked reflex vasodilatation predominantly in skeletal 
muscle. 
 
1.7.5 Interactions between respiratory and cardiovascular responses to acute 
hypoxia 
On testing the hypothesis that lung stretch receptor afferent stimulation underlies the 
initial tachycardia observed in acute hypoxia, Marshall & Metcalfe (1988a) 
demonstrated that in the rat, after vagotomy, when both lung stretch afferents and 
cardiac vagal efferents are sectioned, the tachycardia response remained intact. 
Further, hyperinflation induced by exerting positive pressure, to experimentally 
stimulate the lung stretch receptors, failed to induce significant tachycardia(Marshall 
& Metcalfe, 1988b). Moreover, addition of 300-400 p.p.m SO2 to the inspirate of 
spontaneously breathing, anaesthetised rats, which selectively inhibits pulmonary 
stretch receptors, had no effect on the hypoxia-induced tachycardia (Marshall & 
Metcalfe, 1988a). Finally, administration of guanethidine, which depletes sympathetic 
nerve terminal variscosities considerably blunted the tachycardia, suggesting the 
simple conclusion that it was mainly sympathetically-mediated, rather than due to 
?? 
inhibition of cardiac vagal activity. Taken together these findings indicated that lung 
stretch receptor stimulation makes little or no contribution to the tachycardia induced 
by acute systemic hypoxia in the rat. 
 
Further, Marshall & Metcalfe (1988a), showed that when eucapnia was maintained 
during systemic hypoxia in the rat by adding CO2 to the inspirate, tachycardia still 
occurred during hypoxia but it was attenuated, whereas bradycardia occurred in 
severe hypoxia. Further, during bilateral pneumothorax and constant ventilation, 
hypoxia evoked an attenuated initial tachycardia, followed by secondary bradycardia 
(Thomas & Marshall, 1994). Taken together, these results indicated that hypocapnia 
secondary to the chemoreceptor-induced hyperventilation contributes to the initial 
tachycardia of acute systemic hypoxia, but that the tachycardic effect of central 
inspiratory drive on cardiac vagal and cardiac sympathetic activities is also important. 
Although it could be surmised that bradycardia as a primary response to peripheral 
chemoreceptor stimulation contributes to the secondary bradycardia, the local effect 
of hypoxia on the heart could not be excluded. See below for further discussion. 
 
Importantly, it should be noted that none of the experimental interventions used to 
interfere with lung stretch receptors or PaCO2 had significant effects on the hypoxia-
induced fall in ABP or vasodilatation in the hindlimb muscle in the rat. Thus, there 
was no reason to suppose that lung inflation or hypocapnia secondary to 
hyperventilation induced reflex vasodilatation in skeletal muscle in the rat, as was 
shown in the dog (Daly, 1997). Further, it should be noted that peripheral 
chemoreceptor stimulation is generally considered to evoke a reflex increase in 
?? 
sympathetic nerve activity to all major vascular beds, including skeletal muscle, 
intestine and kidney which leads to vasoconstriction (see Marshall, 1994). Thus, the 
vasodilatation seen in these vascular beds during hypoxia can not be explained as a 
primary response to hypoxic stimulation of peripheral chemoreceptors. This raised 
the possibility that local factors contributed to the peripheral vasodilator response, 
and indeed to the fall in ABP and to the secondary bradycardia. 
 
Considering the cerebral vascular responses, it may also be noted that in the 
cerebral circulation the hypocapnia secondary to hyperventilation may limit the 
cerebral vasodilatation of systemic hypoxia (Thomas & Marshall, 1994). There is 
however, much evidence that local hypoxia per se is responsible for cerebral 
vasodilatation in systemic hypoxia (Kontos et al., 1978; Berne et al., 1981). The 
secondary fall in CBF that occurs during more prolonged systemic hypoxia (see 
above) was attributed to arterial pressure falling below the cerebral autoregulatory 
range (Thomas et al., 1994b) 
 
1.8.1 The role of local factors in hypoxia 
 
Berne and colleagues (Berne et al., 1983) published a review of early evidence 
indicating that adenosine is released in heart, skeletal muscle and brain when O2 
demand outstrips O2 supply, and that adenosine is an important mediator of 
vasodilatation in coronary, skeletal muscle and brain vasculature during increased 
cardiac work, or during local hypoxia (Berne et al., 1983). There is also evidence that 
adenosine can act on the sino-atrial node to produce bradycardia (Belardinelli et al., 
?? 
1988), and within the brain to produce hypoventilation (Eldridge et al., 1984). These 
pieces of information led Marshall and colleagues to carry out extensive work to 
investigate the role of adenosine in systemic hypoxia. 
 
In light of evidence available at the time, Neylon & Marshall, (1991) hypothesised that 
adenosine contributes to the secondary hypoventilation, bradycardia, and 
vasodilatation in cerebral and peripheral vascular beds induced by acute systemic 
hypoxia. Thus, they used theophylline, an adenosine receptor and 
phosphodiesterase (PDE) inhibitor which is used clinically, and 8-phenylthelophyline 
(8-PT), a selective adenosine receptor antagonist, which has negligible PDE activity. 
Both antagonists, in anaesthetized rats, abolished the secondary hypoventilation, 
secondary bradycardia, the muscle vasodilatation and the cerebral vasodilatation 
indicating that adenosine plays an important role in all of these components of the 
response. The results also suggested that theophylline acts predominantly by 
blocking adenosine receptors, rather than by inhibiting PDE.  
 
These experiments were extended by Thomas and Marshall (1994b). They tested the 
effect of 8-PT on artificially ventilated rats during 10 min periods of acute hypoxia. 
Under these conditions, 8-PT did not prevent the secondary bradycardia. Thus, it 
seems from these results that a major role of adenosine is in inhibiting ventilation, 
and that when secondary hypoventilation occurs in the spontaneously breathing 
animal, bradycardia occurs as a consequence of this. This conclusion was 
compatible with other findings by the same authors, in that 8-SPT (8-
sulfophenyltheophylline), a selective adenosine receptor antagonist that cannot cross 
?? 
the blood brain barrier, had no effect on the pattern of ventilatory response to 
hypoxia, nor the secondary bradycardia, (Thomas & Marshall, 1994). 
 
On the other hand, evidence that adenosine is released locally within the brain and 
acts directly on cerebral vessels to cause vasodilatation in hypoxia, has been 
provided by several studies which have shown that local application of adenosine 
receptor antagonists attenuate hypoxia-induced cerebral vasodilatation (Berne et al., 
1981; Morii et al., 1987; Coney & Marshall, 1998). Further, there is much evidence 
that in skeletal muscle, locally-released adenosine makes a major contribution to the 
muscle vasodilatation of acute systemic hypoxia, including evidence gained from 
local application (Mian & Marshall, 1991). 
 
Considering skeletal muscle in more detail, Skinner & Marshall (1996), showed in 
anaesthetized rats, that the NO-synthesis inhibitor NG- Nitro-L-arginine methyl ester 
(L-NAME) decreased baseline femoral vascular conductance (FVC; the femoral 
vascular bed mainly comprises that of skeletal muscle) in anaesthetised rats, 
attributable to blockade of the tonic dilator influence of NO. L-NAME also reduced the 
increase in FVC induced by systemic hypoxia by ~80%, and that induced by 
adenosine infusion by ~50%. This suggested that the adenosine component of 
hypoxia-induced muscle vasodilatation is NO-dependent and that there is an 
additional component that is NO-dependent but adenosine-independent (Skinner & 
Marshall, 1996). 
 
?? 
Subsequently, Bryan & Marshall (1999a), showed that although simulation of 
adenosine A1 and A2A receptors contributes equally to muscle vasodilatation induced 
by infusion of exogenous adenosine, only blockade of A1 adenosine receptors 
attenuated the increase in FVC induced by hypoxia, by ≈50%. They concluded that in 
the setting of acute systemic hypoxia, the A2A adenosine receptors are not 
stimulated, and it is the A1 receptor which is important (Bryan & Marshall, 1999a, b). 
They hypothesised that the disparity between the effects of exogenous adenosine 
and systemic hypoxia is attributable to the different location of A1 and A2A receptors, 
and/or the fact that A1 receptors have greater sensitivity to adenosine; the EC50 for 
adenosine at the A1 receptor is 0.31µM, and 0.73µM at the A2A receptor (Fredholm et 
al., 2001). 
 
In a second study, Bryan & Marshall (1999b) showed that the increase in FVC 
induced by infusion of both selective A1 and A2A receptor agonists are almost entirely 
NO-dependent, and were attenuated by glibenclamide, a KATP channel blocker. This 
extended the earlier finding that glibenclamide reduced the initial part of the increase 
in FVC induced by systemic hypoxia, and strengthened the hypothesis that the 
adenosine-mediated component of muscle vasodilatation in hypoxia is initiated by 
opening of KATP channels triggered by adenosine A1 receptor stimulation (Marshall et 
al., 1993). 
 
Building on all of the above, Ray et al., (2002) showed in vitro that adenosine can 
release NO from endothelium of rat aorta and iliac artery by stimulating either A1 or 
A2A receptor subtypes, as measured by an NO sensitive electrode. Further, Ray & 
?? 
Marshall, (2005) showed that both adenosine infusion and systemic hypoxia cause 
significant release of NO in the venous efflux of skeletal muscle, and this was 
blocked by L-NAME or blockade of adenosine A1 receptors. Together these findings 
led to the conclusion that the role of the adenosine in skeletal muscle during hypoxia 
is via the A1 receptor and is NO-mediated. 
 
1.8.2 Other vasodilator factors in skeletal muscle during systemic hypoxia 
In light of the fact that prostaglandin (PG) synthesis inhibition can reduce hypoxia-
induced vasodilatation of isolated skeletal muscle arterioles in vitro (Messina et al., 
1992), the role of prostaglandins in the response to systemic hypoxia was also 
investigated. Ray et al., (2002) showed that cyclooxygenase (COX) blockade with 
indomethacin reduced systemic hypoxia-induced muscle vasodilatation, as well as 
that of exogenous adenosine infusion. Further, diclofenac, another COX inhibitor, 
attenuated muscle vasodilatation induced by infusion of an adenosine A1 receptor. 
This in vivo evidence was consistent with in vitro findings made on excised aorta 
which showed that the A1, but not the A2A component of adenosine-mediated NO 
release was sensitive to diclofenac, and that A1 receptor stimulation caused PGI2 
synthesis release from the excised rat aorta. 
 
Further studies by Ray & Marshall, (2006) on the aorta showed that by acting on A1 
receptors, adenosine evokes KATP-channel-induced Ca2+ influx which stimulates 
PLA2 to liberate arachadonic acid (AA) from the plasma membrane, and so increases 
COX production of diffusible PGI2. Their evidence suggested that PGI2 acts back on 
IP receptors in the endothelial cell membrane, and hence produces an increase in 
?? 
[cAMP]i which stimulates phosphorylation of eNOS by PKA, so releasing NO. There 
may also be a component of A1 receptor-induced NO synthesis which is directly 
dependent on an increase in [Ca2+]i, increasing eNOS-derived NO production, 
although the fact that A1-mediated NO release is virtually abolished by COX inhibition 
suggests this is unlikely (Ray & Marshall, 2006). 
 
1.8.3 NO-mediated adenosine release 
Importantly, there is also evidence that NO plays a crucial role in adenosine release 
from endothelial cells during systemic hypoxia. At the mitochondrial cytochrome 
oxidase of endothelial and other cells, NO competes with molecular O2 for the same 
binding site (Clementi et al., 1999), and causes inhibition of ATP regeneration (Brown 
& Cooper, 1994; Cleeter et al., 1994; Schweizer & Richter, 1994). Following this up, 
Edmunds et al., (2003) provided evidence that during systemic hypoxia, the decrease 
in the O2 available to compete for the binding site on mitochondrial cytochrome 
oxidase during systemic hypoxia allows a relative increase in binding of the NO that 
is tonically generated by shear stress, increasing adenosine release, presumeably as 
a result of mitochondrial inhibition. Thus, they showed that hypoxia-induced, or 
adenosine-induced vasodilatation in the hindlimb could both be significantly 
attenuated by blockade of NOS with L-NAME, and adenosine- and hypoxia-induced 
vasodilatation were both restored when an NO donor was infused at a rate sufficient 
level to restore baseline FVC, and thus tonic levels of NO. However, hypoxia-induced 
vasodilatation was not restored by infusion of cGMP, the second messenger for NO 
signalling. This indicated that NO is required for adenosine to be released by 
hypoxia, whereas adenosine can act to produce vasodilatation providing the cGMP 
?? 
level is sufficiently high. Accordingly, in a perfused system of cultured aortic 
endothelial cells grown on microbeads, DETA-NO, an NO donor was able to cause 
adenosine release, in an L-NAME resistant manner, whereas bradykinin (BK) and 
agonist that is known to increase NO synthesis caused release of NO that was 
blocked by L-NAME. This suggested that the NO mimics hypoxia sensing in these 
cells (Edmunds et al., 2003). A detailed overview of them mechanisms by which 
adenosine, NO and prostaglandins interact in endothelial and vascular smooth 
muscle signaling is provided in Figure 1.    
 
1.8.4 Summary of the effects of acute systemic hypoxia 
Acute systemic hypoxia in the anaesthetised rat causes hyperventilation and an 
associated fall in PaCO2. It also causes transient tachycardia and vasodilatation in 
several major vascular beds, including skeletal muscle and brain, and is associated 
with a fall in ABP. As acute systemic hypoxia progresses, there is waning of the 
hyperventilation and the initial tachycardia. ABP tends to fall further and CBF falls. 
The secondary hypoventilation, bradycardia, muscle and cerebral vasodilatation have 
been attributed to local effects of adenosine released by brain and skeletal muscle. 
 
The majority of the studies described above were carried out in rats. However, 
studies in humans have demonstrated that similar mechanisms are evoked by acute 
systemic hypoxia in terms of interactions between NO and adenosine and 
prostaglandins (MacLean et al., 1998), and the role of NO (Mortensen et al., 2007; 
Mortensen et al., 2009a; Mortensen et al., 2009b; Nyberg et al., 2010). No studies 
have examined the effects of chronic hypoxia in utero on the pattern of respiratory 
?? 
and cardiovascular response to acute systemic hypoxia, or whether the mechanisms 
of vasodilatation induced by hypoxia are altered following this adverse in utero 
environment. This issue is of particular interest because chronic hypoxia from birth 
does change the responses evoked by acute hypoxia. 
 
1.8.5 Chronic Hypoxia from Birth 
After birth, there is normally a change from the fetal response to acute systemic 
hypoxia which includes inhibition of breathing movements in utero (Rudolph, 1984; 
Giussani et al., 1994), to the adult response which allows hyperventilation (Hanson et 
al., 1989). But, work in cats and rats showed that chronic hypoxia from birth (CHB, 
induced by rearing the newborn in 12%O2) delays the onset of the reflex 
hyperventilatory responses to acute hypoxia, in part by impeding the normal increase 
in peripheral chemoreceptor sensitivity to hypoxia, but also by impairing 
disappearance of the central inhibitory effects of hypoxia (Eden & Hanson, 1987a; 
Landauer et al., 1995). Further, by experiments on rat pups that were similarly made 
chronically hypoxic from birth (CHB rats), Thomas and Marshall (1995) showed that 
at 8 weeks of age CHB rats not only showed an accentuated secondary 
hypoventilation, but also accentuated secondary bradycardia relative to the N rat, 
when breathing 8%O2 for 10 minutes. Concomitantly, they showed muscle 
vasodilatation and cerebral vasodilatation, but in contrast to N rats, CHB rats showed 
a progressive fall in CBF (see chapter 3 for further detail). In other words, CHB rats 
showed accentuation of the components of the response to acute hypoxia that lead 
to a positive feedback loop which may eventually lead to respiratory and circulatory 
collapse. Indeed, Thomas & Marshall, (1995) proposed that this may be the 
?? 
mechanism behind cot death in human infants. Interestingly, the adenosine receptor 
antagonist 8-PT attenuated the secondary hypoventilation and secondary 
bradycardia in CHB rats as in N rats, but had no effect on hypoxia-induced muscle or 
cerebral vasodilatation in hypoxia. Therefore, it seems that adenosine does not 
explain vasodilatation of acute hypoxia in CHB rats. This raises the question as to 
whether similar changes occur as a consequence of chronic hypoxia in utero. This is 
further examined in Chapter 3. 
 
1.8.6 Reactive O2 species and cardiovascular disease 
 
Reactive O2 species have recently become an important focus of research into the 
origins of cardiovascular disease. O2 free radicals, such as superoxide anions (O2-⋅) 
and NO⋅, as well as other reactive O2 species such as peroxynitrite (ONOO-) and 
hydrogen peroxide (H2O2) are now recognised to be important in modulating cell 
signaling pathways (Cai & Harrison, 2000). However, accentuated production of 
reactive O2 species (ROS) is implicated in atherosclerotic plaque generation, insulin 
resistance, and in impaired endothelium-dependent vasodilatation with hypertension, 
aging and the menopause (Mugge et al., 1991; Taddei et al., 2001). 
 
At a molecular level, O2- has high affinity for bioactive NO. Indeed, O2- has at least 3 
times higher affinity for NO than for the enzyme superoxide dismutase (SOD), which 
dismutes this potent oxidative molecule into the less potent H2O2. Thus, excessive 
levels of O2- not only result in increased interaction of O2- and NO, to produce the 
potentially damaging molecule, peroxynitrite (ONOO-), but also reduce the 
?? 
bioavailability of NO, and thus its dilator influence. Since SOD is very important in 
regulating the final concentration of O2- generated by all sources, some attention is 
given below to the functioning of SOD, before considering the sources of O2-. 
 
1.8.7 Superoxide Dismutase (SOD) 
The SODs are a family of three metalloenzymes, which dismute the O2- into O2 and 
H2O2. The SOD1 isoform, Cu-Zn-SOD, exists predominantly in the cytosolic 
compartment, while SOD2, or Mn-SOD, is mitochondrial. SOD3, another Cu-Zn-
SOD, is found in the extracellular space as well as plasma and hence, is often known 
as ecSOD; it is also found in the space between the endothelium and vascular 
smooth muscle. The ecSOD in the endothelium-vascular smooth muscle space is 
very important as it is this space that NO must traverse to reach vascular smooth 
muscle cells (VSMCs). Thus, ecSOD can essentially regulate NO bioavailability for 
the vascular smooth muscle through modulation of O2- levels (Jung et al., 2003; 
Nozik-Grayck et al., 2005). 
 
It has been shown that NO also regulates ecSOD expression in cell lines of VSMCs, 
in that increased NO levels upregulated ecSOD expression (Fukai et al., 2000). This 
relationship has been confirmed in vivo in that eNOS-/- mice have low levels of 
ecSOD. Thus, it was concluded that the relationship between NO and SOD acts as a 
feed-forward mechanism that protects against increased NO production while the NO 
crosses the extracellular space en route to adjacent VSMCs. In further support of this 
relationship, the same group demonstrated that exercise training in mice not only 
increased eNOS protein expression, but was associated with increased ecSOD 
?? 
protein expression. In contrast, in eNOS-/- mice, and hence in the absence of 
endothelial derived NO, exercise had no effect on ecSOD expression, showing the 
importance of normal interaction of NO with ecSOD (Fukai et al., 2000).This 
interaction is important when considering potential sources of increased generation 
of ROS and the effect this may have on cardiovascular function. 
 
1.8.8 Sources of ROS 
There are several sources of ROS, particularly of the superoxide anion (O2⋅-), that 
have been implicated in cardiovascular pathology. These are reviewed below. 
 
Xanthine Oxidase 
Xanthine Oxidase (XO) is an enzyme that is highly localized to the vascular 
endothelium, and can exist in its XO form as well as Xanthine Dehydrogenase (XD). 
The XO form metabolises hypoxanthine, which is a product of adenosine 
metabolism, into xanthine and uric acid, and this step is coupled to the generation of 
a superoxide anion (O2-). It has been demonstrated that there is increased O2- 
production in aortae of the spontaneously hypertensive rat, which is attributable to 
XO metabolism of hypoxanthine, for the O2- production was reversed by the XO 
inhibitor oxypurinol (Nakazono et al., 1991). Adenosine is of course implicated in the 
muscle and cerebral vasodilator response to acute hypoxia, and thus, this is a 
potential source of O2- in systemic hypoxia. 
 
NAD(P)H Oxidase 
?? 
The non-phagocytic form of the multi-subunit, membrane-bound enzyme NAD(P)H 
Oxidase (Nox) has also been recognized as a source of vascular ROS and increased 
levels of Nox-derived ROS have been implicated in vascular aging (RodrÌguez-
MaÒas et al., 2009). However, Nox-derived ROS have also been shown to be 
integral to healthy physiological vascular regulation (For review see Paravicini & 
Touyz (2006, 2008). For example, vasodilatation induced by bradykinin in coronary 
arterioles has been attributed to H2O2 derived from O2- (Larsen et al., 2009). 
Increased Nox derived ROS has been demonstrated with angiotensin II or thrombin 
stimulation in rat vasculature (Rajagopalan et al., 1996). The role of Nox-derived 
ROS in normal vascular regulation, and in vascular pathology have been discussed 
by many authors (Paravicini & Touyz, 2006, 2008). The role of Nox-derived ROS in 
systemic hypoxia have received little attention in young or older individuals.  
 
Mitochondrial respiratory chain 
It has long been accepted that the mitochondrial respiratory chain generates reactive 
oxygen species. The role of these free radicals is still not completely clear, and it 
appears that they have both intra- and extra-mitochondrial activities. In cardiac 
myocytes, significant numbers of mitochondria-derived superoxide anions can 
escape the mitochondrial membrane into the cytoplasm, indicating that their role 
could be either within or outside the mitochondria (Nohl & Hegner, 1978). There is 
also significant evidence that they are involved in O2 sensing in pulmonary artery 
vascular smooth muscle cells (PAVSMCs) and therefore in hypoxia-induced 
pulmonary vasoconstriction: H2O2 derived from mitochondrial SOD stimulates 
membrane bound KATP channel opening (Moudgil et al., 2005). 
?? 
 
As described above, Clementi et al., (1999) demonstrated that NO can inhibit 
mitochondrial complex IV (cytochrome c oxidase). Further, there is evidence in 
isolated mitochondria that inhibition of mitochondrial complex IV facilitates O2- 
generation at complex I and III (Dawson et al., 1993). Thus, there is a clear possibility 
that hypoxia-induced NO production not only inhibits mitochondrial complex IV so 
leading to decreased ATP synthesis and adenosine release (Edmunds et al., 2003), 
but also increases complex I- and III-derived O2-. 
 
Cyclooxygenase 
Kukreja et al., (1986) demonstrated the capacity for prostaglandin H synthase to 
produce the superoxide anion, and Holland et al., (1990) showed that BK stimulation 
of human endothelial cells resulted in superoxide production that was partly sensitive 
to cyclooxygenase inhibition. As indicated above, stimulation of endothelial COX by 
adenosine A1 receptors is an integral part of the mechanism by which acute hypoxia 
causes muscle vasodilatation. Thus, COX is another potential source of O2- in acute 
hypoxia. 
 
Endothelial nitric oxide synthase - eNOS 
The endothelial isoform of the NOS family, eNOS, is a dimer, the first subunit of 
which catalyses the hydroxylation of L-Arginine to form NG-hydroxy-L- arginine. The 
second subunit transfers an electron from NADPH onto the hydroxylated L-arginine 
to form L-citrulline and NO (Andrew & Mayer, 1999). It is this electron transfer step 
that gives eNOS the capability to generate O2-, for when the two subunits become 
?? 
unlinked, or uncoupled, the electron that is normally transferred from NADPH to form 
the NO free radical is instead transferred to molecular O2 to form the O2-. Uncoupling 
usually occurs in states in which availability of the cofactor tetrahydrobiopterin (BH4) 
or the substrate L-arginine are decreased (Andrew & Mayer, 1999). 
 
For example, Landmesser et al., (2003) used lucigenin-fluorescence to monitor O2- 
production and demonstrated an increase in ROS production in arterial vessels taken 
from rats with deoxycorticosterone acetate (DOCA) salt-induced hypertension, 
compared to normal rats, and the ROS production was sensitive to NOS inhibition. 
However, while the nNOS-/- mouse shows a similar increase in ROS production 
during DOCA salt-induced hypertension, the eNOS-/- mouse does not, indicating that 
the increased ROS production is probably due to uncoupled eNOS. Accordingly, 
measurements of BH4 content, and its oxidized counterpart BH2 in homogenized 
aorta, demonstrated increased BH2 and decreased BH4 content in those isolated 
from the DOCA salt-treated mice, relative to the sham operated mice, whereas 
dietary supplementation with BH4 substantially reduced O2- production. These 
findings led to the cascade hypothesis of hypertension, which proposes that 
increased ROS production by Nox and NO production by eNOS, leads to increased 
levels of ONOO-. Both ONOO-, and the O2-, oxidize BH4, reducing the bioavailability 
of this cofactor for eNOS, so leading to its uncoupling, and perpetuating O2- 
production, and hence endothelial dysfunction (Landmesser et al., 2003) 
 
Landmesser et al., (2003) also demonstrated that arteries from DOCA salt-treated 
hypertensive rats, which already showed impaired endothelium-dependent 
?? 
vasodilatation, were more dependent on H2O2 for this vasodilatation than control rats. 
Thus, there was a further reduction in endothelium-dependent vasodilatation on 
catalase treatment in DOCA salt-treated rats, which was not observed in controls. 
This suggests that the increased production of O2- is to some extent compensated by 
the action of SOD-mediated production of H2O2, effectively masking the underlying 
vascular dysfunction, which may well be more severe than many measurements of 
endothelial dysfunction currently suggest (Landmesser et al., 2003). 
 
There is also evidence that whereas phosphorylation of eNOS in its coupled state by 
various agonists results in increased NO production, phosphorylation of the 
uncoupled eNOS results in an increase in O2- production (Chen et al., 2008). 
 
Given that activation of eNOS is an integral part of the muscle vasodilator response 
to systemic hypoxia, questions arise as to whether eNOS activation also generates 
O2- and/or whether the ability of eNOS to generate O2- in hypoxia may be facilitated 
by O2- generated from other sources by uncoupling of eNOS, and/or whether the 
effects of O2- in hypoxia are regulated by SOD. 
 
1.8.9 The role of reactive oxygen species in the response to acute systemic hypoxia 
With the knowledge that reactive oxygen species can be produced by several 
systems involved with vacular regulation (see above), Pyner et al., (2003) sought to 
assess the role of free radicals in muscle vasodilatation of systemic hypoxia. 
Focusing initially on the role of XO, as hypoxia can increase conversion of XD to XO, 
which acts to metabolise adenosine (Kayyali et al., 2001), they showed that inhibition 
?? 
of XO with oxypurinol decreased the magnitude of hypoxia-induced muscle 
vasodilatation induced by a 5 minute period of systemic hypoxia, whilst infusion of 
exogenous SOD increased the magnitude of the muscle vasodilatation. These results 
suggested that O2- derived from XO during hypoxia is dismuted by endogenous SOD 
to H2O2, which then contributes to the muscle vasodilatation. The fact that exogenous 
SOD enhanced hypoxia-induced muscle vasodilatation suggested that excess O2- 
were generated during hypoxia which decreased the bioavailability of dilator NO by 
forming ONOO-, or that O2- were generated by uncoupled eNOS. That acute 
systemic hypoxia can generate ROS was supported by the observation that the 
application of dihydroethidium (DHE) to the spinotrapezius muscle in vivo allowed 
ethidium fluorescence to be seen in and around endothelial cells of vasculature at the 
end of a 5 minute period of hypoxia (Pyner et al., 2003). DHE is converted to 
ethidium bromide in the presence of ROS and is particularly sensitive to O2-. 
 
1.9 Developmental Programming 
 
There is extensive evidence that a sub-optimal environment in utero leads to 
vascular dysfunction in adult offspring, both at the endothelial and smooth muscle 
level, which may, or may not lead to hypertension (Byrne & Phillips, 2000; Franco et 
al., 2003b). In the western human population, preeclampsia (PE) is a leading cause 
of intra uterine growth restriction (IUGR) and it is well known that  PE is either caused 
by, or causes, reduced uterine perfusion (Page (1939), see Roberts and Gammill 
(2005) or Alexander (2007) for recent review). IUGR is a major risk factor for later 
?? 
disease in the child. The potential mechanisms, and methods of modeling this 
complex syndrome and its consequences are discussed below.  
1.9.1 The role of nutrition in programming 
In 1944-45, for 15 months, in a localized region of Holland, the Dutch population ate 
rations that accounted for less than a quarter of their recommended daily intake, 
because they were sieged by the Nazis. The offspring born of pregnancies during 
this period, known as “the Dutch famine,” have been extensively studied to 
investigate the role of maternal nutrition on health outcomes (Barker, 1991; Barker, 
1995; Barker, 1998). Amongst many other observations, it has been found that 
coronary artery disease was diagnosed, on average, 3 years earlier in this group, 
compared to age-matched controls, clearly demonstrating a link between the prenatal 
environment and cardiovascular pathology in adult life (Painter, 2006; Painter et al., 
2006). In fact, so extensive are studies of this cohort, and the many other cohorts 
that have been studied as a result of this seminal work that the term ‘The Barker 
Hypothesis’ is now widely used. The volume of work in this area has increased so 
much that recently the Journal of the Developmental Origins of Health and Disease 
(J DOHAD) began print. It publishes epidemiological work and papers resulting from 
the vast amount of basic scientific studies designed to elucidate the mechanisms 
underlying these epidemiological observations in models of such diseases. Further, 
such is the importance of this work that recently ‘Horizon: The nine months that made 
you’ was aired on BBC2, bringing about much increased public awareness of the 
consequences of a poor fetal environment. 
 
?? 
In order to investigate the underlying mechanisms of this epidemiological link, various 
animal models of nutritional programming have been developed using in utero 
protein restriction in pregnant rats. In such studies, Torrens et al., (2003) showed 
impaired endothelium-dependent vasodilator function in mesenteric resistance 
vessels in adult rats that had been exposed to protein restriction in utero throughout 
pregnancy. They observed reduced sensitivity to ACh and to isoprenaline from a 
preconstricted state in an isolated vessel myography set up of resistance vessels, but 
also that conduit vessel (aorta) function was not affected by maternal protein 
restriction (Torrens et al., 2003). 
 
In a study using the same model of nutritional programming, Rodford et al., (2008), 
sought to elucidate the role of O2- in attenuating endothelium-dependent 
vasodilatation, by assessing the responses of isolated mesenteric resistance vessels 
to ACh in the presence of the free radical scavenger tempol (Rodford et al., 2008). 
They concluded that endothelial dysfunction could not be simply explained by 
increased O2- generation, as Tempol had no effect on responses evoked by ACh in 
mesenteric vessels from programmed rats. However, they did demonstrate reduced 
antioxidant enzyme expression in the liver of the rats suggesting that they may have 
reduced antioxidant protection at a systemic level. They therefore proposed that  they 
may be more susceptible to damage from physiological levels of ROS (Rodford et al., 
2008).  
 
On the other hand, Franco and colleagues have demonstrated increased Nox-
derived O2- generation in mesenteric arterioles in adult female Wistar rat offspring 
?? 
from pregnant rats who were fed 50% of the dietary intake of matched controls. 
These animals also became hypertensive by 14 weeks of age. Further, by using 
intravital microscopy to measure the diameter of second order mesenteric arterioles, 
they found that either the cell permeant SOD mimetic MnTMPyP or apocynin, which 
inhibits Nox, significantly improved endothelium-dependent vasodilatation. They also 
showed increased presence of O2- in these vessels in the absence of increased SOD 
activity, and which is reversed by blocking Nox (Franco et al., 2003a; Franco et al., 
2007).  
 
At 1 year of age, Sathishkumar et al., (2009) found that the female rat offspring from 
protein restricted pregnancy were hypertensive relative to the control rat. At this 
stage the programmed rat showed impaired endothelium-dependent responses to 
ACh, and reduced basal and agonist stimulated nitrate/nitrite production, concurring 
with other studies indicating endothelial dysfunction, and supporting the idea that 
hypertension also develops with age following in utero insult. 
 
In another study Brawley et al., (2003), examined male rat offspring from the same 
model of protein-restricted pregnancy used by Torrens et al., (2003), at 87 and 164 
days of age. More generalised vascular dysfunction was found, both at the 
endothelial and vascular smooth muscle level, and in terms of responses to 
vasoconstrictors and vasodilators. These programmed male rats developed 
hypertension when compared to normal controls, as measured in the conscious 
animal at 130 days of age.   
 
?? 
Thus, studies such as those described above consistently demonstrate endothelial 
dysfunction in offspring of general- and protein-nutrient restricted pregnancy. 
Although the exact underlying mechanisms differ slightly between studies, there is a 
strong running theme of oxidative stress.  
 
1.9.2 Models of developmental programming 
Many animal models of developmental programming centre around the production of 
the IUGR phenotype that is known to lead to increased rates of cardiovascular 
disease. In pregnant sheep, there are at least five models which are well 
characterised and which lead to IUGR; placental carunclectomy, partial placental 
embolization, maternal hyperthermia, umbilical artery ligation and maternal 
overfeeding following embryonic transplant into and adolescent ewe (See Morrison et 
al., 2008 for review). Each model has its limitations, and produces the IUGR 
phenotype in different ways. Placental embolization is known to induce fetal 
hypoxaemia (Murotsuki et al., 1996), as does single umbilical artery ligation 
(Supramaniam et al., 2006) and uterine carunclectomy (Edwards et al., 1999), 
although in all cases this is concomitant with nutrient restriction and activation of the 
hypothalamic-pituatary-adrenal (HPA) axis. A sixth, different model in sheep involves 
the pregnant ewe undergoing gestation at high altitude, as used by Hererra and 
colleagues (Herrera et al., 2007), although this has involved sheep which have spent 
at least 50 generations at altitude. There is a similar Llama model used by Llanos 
and colleagues, for the Llama is a species genetically adapted over many 
generations to living at high altitude (Llanos et al., 2003).  
 
?? 
The hypoxic chick egg model has also been used to eliminate the secondary effects 
of reduced dietary intake on the pregnant mother, and has been studied by groups 
led by Le Noble, De Mey and Giussani (Ruijtenbeek et al., 2000; Rouwet et al., 2002; 
Giussani et al., 2007). However, no studies to date have examined the long term 
effects of hypoxia in ovo in chickens, they have tested only the consequences at the 
pre-hatching stage.  
 
More useful for mechanistic studies, particularly for studies of the offspring, are 
rodent models, because rodents have a short life span relative to longer-living 
species such as sheep. Maternal protein or nutrient intake restriction are used by 
many laboratories to induce IUGR in rodents as indicated above (Langley & Jackson, 
1994; Torrens et al., 2003; Franco et al., 2007). Surgically-induced reductions in 
uterine perfusion have also been employed, by occlusion of the uterine arteries 
(Alexander, 2003). The chronic hypoxia in utero model of IUGR are used by several 
research groups to investigate the mechanisms by which hypoxia may lead to IUGR 
and increase the risk of cardiovascular disease. The main variant in these hypoxic 
models is the severity and duration of hypoxia within the 21 day gestation period of 
the rat. Studies by Davidge and colleagues have used 12% inspired O2 from days 
15-21 of pregnancy (Morton et al., 2010), while work by Marshall and colleagues 
used 12% inspired O2 from day 11-21 (Coney & Marshall, 2010). Giussani and 
colleagues used 14% inspired O2 from days 6-21 of pregnancy (Camm & Giussani, 
2010), whilst the earlier work of Rosenfeld used 13-14% inspired O2 from days 14-21 
(Tapanainen et al., 1994).  
 
?? 
1.9.3 Chronic hypoxia in utero and fetal programming 
 
It is widely accepted that fetal hypoxaemia induced by chronic hypoxia of the 
pregnant female is another example of fetal programming of adult cardiovascular 
function (Louey & Thornburg, 2005). Fetal hypoxia is commonly incurred as a result 
of placental insufficiency, but also occurs in fetal anaemia and in pregnancy at 
altitude. Indeed, it is known that in women who are not acclimatized to it, pregnancy 
at altitude is linked with reduced birth weight of the offspring (Postigo et al., 2009). 
Moreover, mothers with a lower haemoglobin concentration during pregnancy give 
birth to children who have higher blood pressure by 4.5 years of age than their 
counterparts from pregnancies with normal levels of haemoglobin (Law et al., 1991), 
although recent evidence suggests this may not always be the case (Brion et al., 
2008). It is clear that reduced birth weight is associated with increased risk of 
cardiovascular disease (Painter, 2006), and it is well proven that restriction of 
substrates during gestation almost always lead to IUGR (Thompson & Weiner, 1999; 
Bae et al., 2003; Williams et al., 2005b; Morrison, 2008). What is not clear, however, 
is whether the observed programming effects of hypoxia are caused by hypoxia per 
se or by the possible secondary effects on dietary intake of the pregnant female who 
is made hypoxic, the endocrine adaptations to such physiological insults, and on 
placental nutrient transport. It seems clear that both elements of substrate restriction 
contribute in the hypoxia model, as studies have shown differences in vascular 
function with and without changes in birth weight even after matching of food intake 
during pregnancy (Thompson & Weiner, 1999; Williams et al., 2005b). These studies 
?? 
do not rule out changes that are secondary to changes in makeup of total body 
weight as the offspring grow. 
 
Williams and colleagues sought to differentiate the effects of chronic hypoxia in utero 
(CHU) and the secondary effects on of reduced maternal dietary intake. They 
compared rats born of normal pregnancies (N rats) to rats exposed to chronic 
hypoxia in utero (d15-21, CHU rats), and rats exposed to normoxia in utero, but the 
same level of maternal dietary intake seen in the pregnant dams of the CHU group 
(NR rats). They found that at 4 months of age, mesenteric resistance vessels taken 
from CHU rats showed attenuated endothelium-dependent vasodilatation compared 
to control or nutrient restricted (NR) offspring, although by 7 months of age this 
difference was no longer apparent. However, at 7 months of age, the NOS inhibitor 
L-NAME caused a significantly smaller reduction in endothelium-dependent 
vasodilatation in the CHU arteries than the NR or control arteries, indicating that the 
role of NO was reduced. By using exogenous SOD, to reduce O2- levels, they 
showed that SOD had no effect on endothelium-dependent relaxations in mesenteric 
arteries of N rats. By contrast, in CHU arteries SOD significantly enhanced 
relaxations induced by low concentrations of methacholine, such that it reduced the 
EC20, but had no effect on relaxations induced by higher concentrations. Therefore 
they suggested that there may be a small, but significant increase in basal O2- 
generation in the mesenteric arteries of CHU rats, which decreases the role of NO in 
endothelium-dependent relaxations in the mesenteric circulation. This idea is 
consistent with the findings made in the protein restriction in utero models discussed 
above, which indicated that in utero stressors lead to changes in the oxidative stress 
?? 
in arterial vessels, so altering NO-related mechanisms. How these described effects 
translate into changes in functional responses in vivo has not been investigated.  
 
Ruijtenbeek et al., (2003) carried out a similar study to Williams et al., (2005b) by 
using a chick embryo model, in which fertilized hens’ eggs were either incubated in 
15% O2 for 14 days of their 21 day gestation, or had 10% of their albumin removed to 
model protein restriction. The vascular function of the femoral arteries taken from 
chicks at day 19 of gestation was then assessed. Whilst both conditions led to 
significant growth retardation, only the chronic hypoxic condition led to vascular 
dysfunction: reduced arterial sensitivity to ACh in the femoral artery. The 
mechanisms underlying this dysfunction were not investigated.  
 
Whilst these studies represent further evidence that CHU has programming effects 
that are distinct from nutritional aspects, it is not clear in this model whether the 
vascular dysfunction evident at day 19 of gestation persists into adulthood and leads 
to cardiovascular pathophysiology. Further, it is not clear whether the changes 
observed in the femoral artery are evident in mammals.  
 
1.9.4 The effect of chronic hypoxia in utero on the sympathetic nervous system 
To the authors knowledge, there are no studies examining the effect of chronic 
hypoxia in utero on sympathetic nervous control of the peripheral vasculature in the 
offspring. Work on the hypoxic chick embryo has found that in the late gestation fetus 
the femoral artery is hyperinnervated with catacholaminergic neurones relative to 
control chicks, shown directly (Ruijtenbeek et al., 2000) and functionally (Rouwet et 
?? 
al., 2002). Similarly, Herrera et al (2007) found that isolated femoral arteries taken 
from newborn sheep from high altitude pregnancies showed increased maximum 
responses to an α1-adrenoreceptor agonist and increased maximal response and 
sensitivity to noradrenaline. It was also shown that following placental caruclectomy 
in sheep, levels of circulating catecholamines in the fetal circulation are higher than in 
a normal pregnancy throughout late gestation. This has been attributed to increased 
catecholamine synthesis in developing sympathetic nerves, although no direct 
evidence for this was produced (Simonetta et al., 1997). However, this finding 
concurred with similar results in the placental embolization model in the same 
species (Gagnon et al., 1994). It is of course possible, given the results of 
Ruijtenbeek et al., (2000) that the increased plasma catecholamine is a consequence 
of an increased density of sympathetic nerves. What is not clear from current 
evidence is whether such alterations that are manifest during pregnancy persist, or 
have an effect on the offspring of these adverse pregnancies. To date, nobody has 
investigated the effect of hypoxia in utero on the in vivo function of the sympathetic 
nervous system in adults.  
 
1.10 General aims 
The aims of the present study were to examine the effects of CHU on: 
1. The pattern of cardiovascular and respiratory response to acute systemic 
hypoxia. 
2. The role of endothelially-derived relaxing factors on baseline cardiovascular 
regulation, and in the cerebral and skeletal muscle vasculature in response to 
?? 
acute hypoxia in vivo, with particular with respect to NO, adenosine, and 
reactive oxygen species 
3. Sympathetic nerve activity in those fibres that supply skeletal muscle 
vasculature. 
4. Sympathetic innervation density and vascular responsiveness to sympathetic 
nerve stimulation in vivo. 
5. Aging of the cardiovascular system in Wistar rats, with particular focus on the 
mechanisms of sympathetic vasoconstriction.  
 
The particular hypotheses that were tested are explained in the relevant chapters. 
  
?? 
Figure 1.1 
Schematic representation of the production of vasoactive substances from 
endothelial cells of the skeletal muscle vasculature, and their interaction with the 
vascular smooth muscle.  
 
5’AMP – adenosine-5-monophosphate 
BKCa – Calcium-sensitive potassium channel 
A1 – adenosine A1 receptor 
A2A – adenosine A2A receptor 
ATP – adenosine-triphosphate 
P2Y – purinergic P2Y receptor subtype 
AC – adenylate cyclase 
COX – cyclooxygenase 
cAMP – cyclic adenosine-monophosphate 
eNOS – endothelial nitric oxide synthase 
GS – stimulatory G-protein subunit 
IP – AC-linked prostacyclin receptor 
IP3R – inositol triphosphate receptor 
KATP – ATP-sensitive potassium channel 
MSB – Myosin-binding subunit 
MLCK – myosin light-chain kinase 
NO – nitric oxide 
PDE3 – phosphodiesterase 3 
RBCs – red blood cells 
sGC – soluable guanylate cyclase 
 
Adapted from Olsson & Pearson (1990), Merkel et al., (1992), Carvajal et al., (2000) 
Hofmann et al., (2000) Lynge & Hellsten (2000), Sausbier et al., (2000), Klinger et al., 
(2002), Edmunds et al., (2003), Rybalkin et al., (2003), Ray & Marshall, (2006), Kass 
et al., (2007), Sprague et al., (2010).  
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Chapter 2 - General Methods  
?? 
All experiments were carried out in accordance with the UK Home Office Animals 
(Scientific Procedures) Act of 1986, under an approved project, site, and personal 
licence.  
 
2.1.1 Experimental Animals 
All animals used in this study are Wistar rats, originally supplied by Charles River 
Laboratories (Kent, UK). Control normoxic (N) rats used in the studies were 
predominantly those purchased from Charles River Laboratories as 8-week old male 
Wistar rats. Three litters of N rats were bred on-site at the Biomedical Services Unit, 
University of Birmingham from male and female Wistar rats purchased from Charles 
River Laboratories.  
 
For generation of CHU rats, ‘timed-mated’ female Wistar rats were purchased from 
Charles River Laboratories, and delivered to the Biomedical Services Unit, University 
of Birmingham, 6 days after confirmation of pregnancy by the presence of a vaginal 
plug. At day 10 of pregnancy the pregnancy rat was placed, within her cage, in a 
hypoxic chamber, containing 11.5-12.5% O2 (See below for details). At gestational 
day 20, the pregnant dam was removed from the hypoxic chamber, and housed in 
standard laboratory conditions. Pregnant dams gave birth 1 or 2 days following 
removal from the hypoxic chamber. Chronic hypoxia from days 10-20 of gestation 
was chosen as it represents a period of gestation as close to that during which, in a 
human fetus, the adverse effects of preeclampsia are experienced. Previous 
unpublished work by this laboratory found that chronic hypoxia from days 0-20 was 
?? 
rarely lead to a completed pregnancy. Chronic hypoxia during the first half of 
pregnancy produced an improved, but still significant rate of failed pregnancies, but 
importantly, is less likely to model the adverse consequences of conditions such as 
preeclampsia. As part of the hypoxic ventilatory response to breathing 12%O2 it is 
likely that the fetuses were exposed to a degree of hypocapnia during the period of 
chronic hypoxia in utero. It was chosen not to try to monitor or modulate this, firstly 
because in the conscious, pregnant mother, it would have been impractical to 
monitor end-tidal CO2 without significantly affecting the pregnancy, and introducing 
effects on the period of gestation that were a result of the invasive monitoring rather 
than the hypoxic insult itself. Secondly, making such a change to the previously used 
model would have made the results substantially less comparable with those of other 
research groups using similar models. Finally, making such a methodological change 
to previously used methods would have required significant validation, which was not 
practical.  
 
Following birth, the offspring of the pregnant dams that had been in the hypoxic 
chamber (CHU rats) were raised under standard laboratory conditions, with food and 
water available ad libatum. Acute experiments were performed on N and CHU rats at 
10-12 weeks of age, with a final group of experiments being performed on a group of 
N and CHU rats at 36-weeks of age.  
 
2.1.2 Hypoxic chamber 
Figure 2.1 is a schematic diagram showing the construction of the custom-built 
hypoxic chamber into which the pregnant dams were placed. An O2 sensor 
?? 
(Biospherix, Lacona, NY, USA) was placed in a large Perspex chamber 
(approximately 1x1x2m, WxDxH) and connected to an O2 controller unit (ProOx 
P110, Biospherix, Lacona, NY, USA). A large cylinder of N2 (BOC Gasses, West 
Bromwich, Birmingham, UK) was also connected to the Oxygen controller unit, which 
controlled the flow of N2 into the chamber, to maintain the within-chamber O2 level at 
∼12% O2 (11.5-12.5%). The chamber was deliberately ‘leaky’ such that if the N2 
supply failed, O2 concentration within the chamber would rise. Excess pressure 
development was further prevented with a pressure trap. In order to control humidity 
levels, air from within the chamber was drawn through a refrigerator followed by 
Silica Gel (SG). Humidity remained between 45 and 60%. Further, to remove 
ammonia, gas was passed through a molecular sieve (MS), and to remove excess 
CO2, gas was passed through soda lime (SL). Air was circulated within the chamber 
with a small electric fan. O2 level was recorded via a MacLab data acquisistion 
system (ADInstruments Ltd., Oxford, UK), on an Apple Mac computer (Apple Inc, CA, 
USA). 
 
2.2.1 Surgical preparation 
The basic anaesthetic regimen for the in vivo experiments described in this thesis is 
described here, as is the generic procedure for cannulation of arterial or venous 
vessels. 
 
Anaesthesia was initially induced by placing the rat in an enclosed flow-through box, 
as part of a custom-made anaesthetic rig. The box was filled with ∼3.5% Isofuorane 
(Isoflurane – VET, Merial Animal Health Ltd., Harlow, Essex, UK) in O2, via an 
?? 
anaesthetic vapouriser unit (General Anaesthetic Services, Keighly, West Yorkshire, 
UK). Once anaesthetised, the rat was placed supine on a homeothermic blanket 
(Harvard Apparatus, Kent, UK) and a mixture of 3.5% Isoflurane in 2L/min O2 (BOC 
gasses, West Bromwich, Birmingham, UK) was provided via a facemask, connected 
to an anaesthetic scavenger unit (Harvard, Kent, UK). Surgical anaesthesia was 
assessed by absence of the paw pinch reflex. 
 
Once surgical anaesthesia was achieved, a rectal thermometer, connected to the 
homeothermic blanket, was inserted using petroleum jelly, and used to maintain body 
temperature at 37.5°C. Next, the right jugular vein was isolated superior to the 
thoracic cage, and lateral to the midline, via a small transverse incision made with 
surgical dissecting scissors, followed by blunt dissection. Once isolated, the jugular 
vein was permanently occluded by a surgical knot at the distal end of the isolated 
portion of the vessel, with 6-0 gauge silk surgical suture (Surgical Specialties 
Corporation, Reading, PA, USA, via Harvard Apparatus, Kent, UK). The proximal end 
was occluded, but not tied, using a loop of 6-0 suture under gentle tension, and a 
small cut was made in the jugular vein.  
 
A length of silicon tube (0.5mm Bore x0.5mm wall, Sterilin Ltd, Caerphilly, UK), filled 
with a solution of Alfaxan (3.5mg.ml-1, Vetoquinol, Buckingham, UK) in saline (0.9% 
NaCl in distilled water) was inserted, which was in turn connected to a 50ml syringe 
with a 21G needle (BD Biosciences, Oxford, UK), ensuring no air was present in the 
cannula. The 50ml syringe, filled with Alfaxan solution was connected to an 
anaesthetic infusion pump (Perfusor compact S, B. Braun Melsungen AG, Germany). 
?? 
The cannula was secured in place within the vessel distally and proximal with the 6-0 
sutures previously mentioned. The Isoflurane gas was then withdrawn, and small 
boluses (0.05ml) of Alfaxan were given so as to maintain anaesthesia. Once 
respiratory rate was suitably recovered from the depression induced by boluses of 
Alfaxan on top of residual effects of Isoflurane, indicating that the continuing effects 
of Isoflurane had worn off, continuous infusion of Alfaxan solution was commenced, 
at approximately 1.0-1.5ml.hr-1, to maintain surgical anaesthesia.  
 
For maintenance of a patent airway, and for control of inspiratory gasses (see 
below), a tracheal cannula (T-shaped metal cannula, custom built, Biosciences 
workshop, University of Birmingham, UK) was passed into the trachea. The trachea 
was isolated from the surrounding muscle using blunt dissection, via the same skin 
incision made for isolating the jugular vein. A length of 4-0 suture (Surgical 
Specialties Corporation, Reading, PA, USA, via Harvard Apparatus, Kent, UK ) was 
passed around the trachea, a small cut was made in the trachea, the cannula 
introduced, advanced approximately 5mm proximally, and then tied in place with the 
suture. The tracheal cannula was of approximately 15mm in length, and 3mm in 
internal diameter.   
 
The other blood vessel cannulations carried out in each animal were dependent on 
the specific requirements of each experiment. However, the procedure for 
cannulation of each vessel was the same, in that the blood vessel was isolated by 
blunt dissection, the proximal and distal ends were occluded, a small cut was made 
with fine scissors and a heparinised saline (10IU/ml in 0.9% NaCl in dH2O) filled 
?? 
cannula was introduced and advanced, and then the cannula secured with surgical 
suture. The tubing used is detailed below. 
 
Table 2.1 – Tubing used to cannula arteries and veins 
Vessel Tubing External 
Diameter 
Internal 
Diameter 
Needle 
attachment 
Brachial Artery Portex 
Polythene 
0.8mm 0.4mm 25G 
Femoral Artery Portex 
Polythene 
0.96mm 0.58mm 23G 
Caudal Ventral 
Tail Artery 
Portex 
Polythene 
0.8mm 0.4mm 25G 
Femoral Vein Sterilin Silicon 
tube 
1.5mm 0.5mm 21G 
 
For cannulation of the brachial artery, an incision was made in the axilla, and the 
vessel isolated with blunt dissection. For cannulation of the femoral artery or vein, an 
incision was made half way between the knee joint and the penis, followed by blunt 
dissection in a superiomedial manner. For cannulation of the caudal ventral tail artery 
a midline incision was made in the proximal third of the tail, followed by blunt 
dissection. The connective tissue covering the vessel was cut using fine surgical 
scissors, and the vessel exposed.  
 
2.2.2 Manipulation of inspiratory gasses 
During the experiments described in the following chapters, in which manipulation of 
inspiratory gasses was required, this was achieved by using a system of Rotameters 
?? 
(Cole Parmer, Niles, IL, USA) connected via tubing to gas cylinders containing N2 
and O2 (BOC Gasses, West Bromwich, Birmingham, UK). The mixture of gasses 
inspired by the animals was  controlled by adjusting the ratio of O2 and N2 by using 
the rotameter. This was connected to the side arm of the tracheal cannula via flexible 
silicon tubing, such that the mixture of gasses was blown cross the opening of the 
sidearm, at a flow rate that excessed the animals inspiratory intake, such that it 
inspired the mixture of gasses blown over the side arm.  
 
2.2.3 Measurement of respiratory parameters 
For measurement of ventilatory tidal volume and respiratory frequency, a small 
animal spirometer head (FE141, AD Instruments, Oxford, UK) was fitted in series 
between the tracheal cannula, and the tube delivering inspiratory gasses. This was 
calibrated online (see ‘data acquisition’).   
Arterial blood gas measurements 
Where appropriate, blood gasses were measured using a Gem4000 blood gas 
analyser (Instrumentation Laboratory, Warrington, UK). Arterial blood was sampled 
via an arterial cannulation. The solution of saline and blood within the cannula was 
run out, and then ‘fresh’ arterial blood was run into a glass capillary tube 
(Instrumentation Laboratory, Warrington, UK), and was then immediately inserted 
into the blood gas analyser. PaO2, PaCO2 and PH were measured. 
 
2.2.4 Blood Flow measurement 
For measurement of blood flow in the femoral artery the femoral artery was exposed 
and freed from surrounding tissue as described above for cannulation of the femoral 
?? 
artery. A small flow probe head (Model 0.7B, Transonic Systems via Linton 
Instrumentation, Norfolk, UK) was mounted on a manipulator (Narishige, Japan), and 
arranged such that the femoral artery, distal to the inguinal fat pad, lay in the ‘hook’ of 
the flow probe, covered in acoustic medium (H-R Lubricating Jelly, Mohawk Medical 
Supply, Utica, NY, USA). The probe was connected to a small animal blood flow 
meter (T206, Transonic Systems via Linton Instrumentation, Norfolk, UK).  
 
For measurement of blood flow in the carotid artery, the carotid artery was exposed 
via an extension of the incision made for the cannulation of the jugular vein in the 
distal direction, lateral to the midline of the neck. Blunt dissection was used to isolate 
the artery, care being taken around the area of the carotid body and sinus, to ensure 
no damage occurred. The external carotid branch of the common carotid artery was 
ligated with 6-0 suture distal to the carotid bifurcation, as far distal as was practically 
possible. Thus, flow measured in the common carotid artery is largely representative 
of internal carotid artery blood flow, as has been previously described (Thomas & 
Marshall, 1995). The flow probe (Model 0.7B, Transonic Systems via Linton 
Instrumentation, Norfolk, UK) was placed on the common carotid artery with acoustic 
medium, and connected to the second channel of the T206 small animal blood flow 
meter mentioned above.  
 
2.3 Data acquisition 
For experiments in chapter 3, 4, 6 and 7, recordings of cardiovascular and respiratory 
variables were acquired using the AD Instruments PowerLab hardware, and 
LabChart software. For recording arterial blood pressure (ABP), a pressure 
?? 
transducer (DTX Plus disposable pressure transducer, BD Biosciences, Oxford, UK) 
was connected to an either a brachial or femoral artery. The pressure transducter 
was connected to a MacLab bridge amplifier (ADInstruments Ltd, Oxford, UK), which 
was connected to a Powerlab 4/20 data acquisition system (ADInstruments, Oxford, 
UK). For recording of femoral or carotid blood flow (FBF and CBF respectively), the 
output of the T206 flowmeter was connected to two channels of the Powerlab 4/20. 
For recording of respiratory variables, the spirometer was connected to another 
channel of the PowerLab 4/20.  
 
The PowerLab 4/20 was connected to an Apple Computer (Apple Inc., Cupertino, 
CA, USA) via USB cable. LabChart (v6.1, ADInstruments, Oxford, UK). Arterial blood 
pressure (ABP), femoral blood flow (FBF), carotid blood flow (CBF), and air flux (raw 
data from spirometer) were all recorded online at a 1kHz sampling rate. Femoral 
vascular conductance (FVC), femoral vascular resistance (FVR), carotid vascular 
conductance (CVC), heart rate (HR), mean FBF (MFBF), mean CBF (MCBF), mean 
ABP (MABP), ventilatory tidal volume (VT) and respiratory frequency (RF) were all 
derived online. FVC and CVC is computed online by dividing MFBF or MCBF by 
MABP. VT was computed by the cyclical integration of calibrated air flux measured in 
the spirometer RF and HR are calculated online from the peaks in the respiratory and 
ABP traces.   
 
  
?? 
Figure 2.1 
Schematic representation of the hypoxic chamber used to induce CHU 
 
SG; silica gel, MS; molecular sieve, SL; soda lime, N2; nitrogen gas.   
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Chapter 3 – Cardiovascular responses to acute systemic hypoxia, and 
the role of oxidative stress  
?? 
3.1 Introduction 
Reduced fetal oxygenation can result from pregnancy at altitude, but also from the 
placental insufficiency incurred in pre eclampsia (Gagnon, 2003). Although placental 
insufficiency results in both reduced oxygen and nutrient supply to the fetus, the fetal 
hypoxaemia itself has been shown to have cardiovascular consequences for the 
adult offspring distinct from under nutrition alone (Williams et al., 2005b).  
 
Notably, femoral arteries taken from chick embryos that were incubated at high 
altitude, and therefore exposed to reduced oxygenation, showed reduced sensitivity 
to the endothelium-dependent vasodilator acetylcholine (Ruijtenbeek et al., 2003). 
Futher, Williams et al (2005a) showed that arteries from different tissues taken from 
neonatal rats were not all affected in the same way by chronic hypoxia in utero. Thus, 
in neonatal CHU rats, exposed to 12%O2 during day 15-21 of pregnancy, carotid 
arteries showed blunted responses to both phenylephrine and endothelin, whereas 
the femoral arteries showed enhanced vasoconstriction to phenylephrine relative to 
femoral arteries of control (N) rats. Such in vitro studies of conduit vessels give an 
indication that there may be differences in the manner in which different vascular 
beds are affected by chronic hypoxia during fetal development, but they cannot of 
course predict how more distal sections of the vascular tree may behave. 
 
Further studies by Williams et al. (2005b) demonstrated that isolated mesenteric 
resistance arteries taken from 4-month old CHU offspring show reduced 
endothelium-dependent vasodilatation to methacholine relative to those of control 
rats, that was reversed by the presence of exogenous superoxide dismutase (SOD). 
?? 
This suggested that oxidative stress contributed to the reduced vasodilatation, i.e. O2-
may have reduced the bioavailability of NO and SOD may have prevented this by 
dismuting the O2- into H2O2.  In accord with this interpretation, in mesenteric arteries 
taken from CHU rats at 7 months of age, the NOS inhibitor L-NAME had no blunting 
effect on endothelium-dependent dilatation, whereas it attenuated the dilatation in N 
rats, indicating a reduced role for NO in arteries from CHU. Thus, it seems that in the 
mesenteric arteries of CHU rats, by 7 months of age, the functional role of NO was 
taken over by other endothelially-derived vasodilators.  
 
Much work by Marshall and collaborators has demonstrated that the adenosine A1 
receptor is important in mediating a large proportion of the vasodilatation induced in 
skeletal muscle by acute systemic hypoxia, and that it is mediated by NO release 
(Skinner & Marshall, 1996; Bryan & Marshall, 1999a, b; Ray et al., 2002). By 
contrast, recent in vivo studies on CHU rats have shown that there is no role for the 
adenosine A1 receptor in mediating the hypoxia-induced muscle vasodilatation 
(Coney & Marshall, 2010), even though the vasodilatation was comparable in 
magnitude to that of N rats, and adenosine still evoked muscle vasodilatation via A1 
receptor in CHU rats. This suggested that other mechanisms of vasodilatation 
compensate in the hypoxia-induced vasodilatation, and raised the possibility that the 
mechanism of release and action of adenosine are disrupted in CHU rats; in N rats 
both are NO dependent (see General Introduction).  
 
In view of these findings, and taking into consideration the results of Williams et al., 
(2005a; 2005b), we hypothesised that in CHU rats, the vasodilator H2O2 (Rubanyi & 
?? 
Vanhoutte, 1986; Matoba et al., 2000) produced by SOD (Matoba & Hiroaki, 2003) 
from O2- generated during systemic hypoxia contribute to vasodilatation induced by 
systemic hypoxia, as has been shown by Pyner et al., (2003), and that this 
contribution is much greater in CHU rats than in N rats. Therefore, this hypothesis 
was investigated in the present study in anaesthetised CHU and N rats by using 
DETC to inhibit SOD.  Further experiments exploring the mechanisms underlying 
hypoxia-induced vasodilatation in CHU rats are described in Chapter 4. 
 
In designing a study to elucidate the potential role of H2O2, it was decided to take the 
opportunity of investigating the effect of chronic hypoxia in utero on the respiratory 
and cardiovascular response evoked by longer lasting periods of acute systemic 
hypoxia, and to consider the cerebral circulation as well as the skeletal muscle 
circulation, for the reasons discussed below.  
 
Eden and Hanson (1987b) showed that in conscious 5- and 14-day old rat pups that 
breathed 12% O2 from birth (CHB rats), there was no significant respiratory response 
to acute systemic hypoxia hypoxia (12 or 8%O2), while in the N rat pup at the same 
ages, a biphasic respiratory response occurred; initial hyperventilation which waned 
with time. By 5-10 weeks of age, it was found that breathing 8%O2 only, and not 
12%O2, evoked a biphasic response in CHB rats, whereas in the N rats, the biphasic 
hypoxic response was evident at both 12 and 8%O2. At this age also, recordings 
from the afferent carotid sinus nerve of CHB and N rats showed that both had a 
similar excitatory response to acute isocapnic hypoxia, indicating that the impairment 
of hypoxic respiratory response was likely of central origin. 
?? 
 
Building on this work, Thomas & Marshall (1995) studied the respiratory and 
cardiovascular responses evoked by 10 minutes of acute hypoxia, comparing 
responses between 7-8 week old N rats, and CHB rats that breathed 12%O2 from 
birth. When anaesthetised CHB rats were switched from continuously breathing 
12%O2 to 8%O2 for 10 minutes, they showed a more marked secondary fall in 
ventilation and in heart rate than occurred in N rats when they were exposed to the 
greater change of switching from breathing 21% to 8%O2. CHB rats also showed an 
exaggerated fall in brain blood flow (CBF). Thomas & Marshall (1995) therefore 
proposed that chronic hypoxia from birth may enhance vulnerability to the positive 
feedback loop described in the General Introduction, which leads to cardiovascular 
collapse as a result of falls in ventilation, HR and CBF. 
 
Turning to the effects of CHU on the respiratory response to acute systemic hypoxia, 
Peyronnet et al (2000) showed that at 3 weeks of age, CHU rats exposed to 10%O2 
in utero showed an enhanced increase in ventilation during acute hypoxic episodes, 
but by 9 weeks of age, this had reversed such that the respiratory response was 
diminished relative to the same response in N rats of the same age.  
 
Thus, there is already evidence that chronic hypoxia during development, before or 
after birth, can have serious consequences for the developing offspring’s ability to 
hyperventilate in response to acute systemic hypoxia. There is strong evidence that 
chronic hypoxia from birth affects the cardiovascular, particularly the 
cerebrovascular, response to acute systemic hypoxia, in a detrimental way. Thus, it 
?? 
was reasonable to hypothesise that chronic hypoxia in utero would similarly affect the 
cardiovascular and respiratory response to acute systemic hypoxia in the offspring. 
 
Therefore, the present study tested cardiovascular and respiratory responses to 10 
minutes of acute systemic hypoxia (8%O2) in N and CHU rats before and during SOD 
inhibition, testing the hypotheses that: 
 
1. CHU rats will show a reduced ventilatory response, and reduced ability to 
maintain HR and CBF during acute systemic hypoxia 
2. Oxidative stress is present in CHU rats, and that it limits endothelial function, 
and hence the vasodilatation evoked by acute systemic hypoxia in the 
hindlimb and cerebral vascular beds.   
?? 
3.2 Methods 
In vivo and in vitro experiments were carried out in this study. The in vivo 
experiments were performed on 12 N rats (298±15g, 70±2 days old) and 11 CHU 
rats (348±14g, 5 litters, 71±1 days old). The in vitro experiment, an analysis of frozen 
sections of skeletal muscle, were performed on samples of skeletal muscle obtained 
from 6 N rats (431±9g) and 6 CHU rats (411±14g, 6 litters).  
 
3.2.1 In vivo experiments 
 
The basic surgical preparation and data acquisition protocols, including anaesthetic 
regimen for induction and maintenance, and recording of cardiovascular and 
respiratory variables are described in Chapter 2. ABP was measured from the right 
brachial artery and arterial blood for blood gas analysis was sampled from the left 
brachial artery. Drug infusion was given via the left femoral vein.  
 
FBF was recorded from the right femoral artery, and CBF from the right common 
carotid artery, following ligation of the external carotid artery. Femoral and carotid 
vascular conductance (FVC and CVC) were calculated online by dividing MFBF or 
MCBF by MAPB. 
 
Tracheal air flux was measured using a MacLab spirometer, and RF, VT and VE were 
calculated in the manner described in Chapter 2.  
 
?? 
3.2.2 Protocol 
After a stabilisation period of 40 minutes following surgery, when animals breathed 
21%O2, inspiratory O2 was switched from 21% O2 to 8% O2 in N2 for 10 minutes and 
then switched back. Arterial blood samples were taken for blood gas analysis during 
the final minute before hypoxia, and during the final minute of the 10-minute hypoxic 
period. Once a steady baseline was re-established during normoxia, infusion of the 
cell permeable SOD inhibitor diethyl-dithiocarbamate (DETC, Sigma Aldrich, UK) was 
commenced (5mg.kg-1.min-1 i.v.). At least 10 minutes after steady baselines had 
been re-established, the inspirate was once again switched to 8% O2 for 10 minutes, 
and arterial blood samples for blood gas analysis were taken as described above, 
whilst the infusion of DETC continued.  
 
3.2.3 Data Analysis and statistics 
All data are presented as mean±SEM of N or CHU rats. MABP, HR, FBF, CBF, FVC, 
CVC, RF, VT and VE are presented as mean values across the 10 minute period of 
hypoxia, and as means of the 10 second period at each minute during the 10 
minutes. The magnitude of the vasodilatation was computed offline as the integral of 
FVC or CVC during the 10 minute period immediately before the hypoxic period 
minus the integral of FVC or CVC during the 10 minute period of hypoxia (∆intFVC 
and ∆intCVC). This calculation indicates how much vascular conductance changed 
during the hypoxic period, and has been described previously (Coney & Marshall, 
2010). The intFVC presented in the minute by minute analysis represents integrated 
FVC in the final 10 seconds of each minute, compared to the 10 seconds 
immediately preceding the bout of hypoxia.  
?? 
Statistical analysis was carried out using Statview 5 (SAS Institude Inc., NC, USA) on 
an Apple Mac computer (Apple Inc, CA, USA). Comparisons of baseline variables 
between groups, and before and during infusion of DETC within groups, were made 
with a mixed design two way ANOVA with Scheffé post hoc test. Comparisons of 
how the respiratory and cardiovascular variables changed over the 10-minute period 
of hypoxia were made using a repeated measures ANOVA with Scheffé post hoc 
test. Particular attention was paid to the differences observed between the normoxic 
baseline, and values recorded at the end of the 1st minute, and end of the 10th 
minute of breathing 8%O2, as these allowed comparison of the initial changes 
caused by acute systemic hypoxia, and the secondary changes induced by more 
prolonged hypoxia, allowing this study to address the first hypothesis put forward in 
the introduction. This time-based comparisons were made using a repeated 
measured ANOVA and Scheffé post hoc test. Comparisons of blood gasses between 
groups, and within groups before and during DETC infusion, were made using a 2-
way mixed design ANOVA with Scheffé post hoc test. Comparison of body mass 
between groups was made using Students unpaired samples t-test.  
 
3.2.4 Ex vivo analysis of oxidative stress 
To examine the levels of oxidative stress in the small arteries and arterioles 
supplying hindlimb skeletal muscle, a variation upon the method published by Yang 
et al (2009) was used.  Immunohistochemistry was used to colocalise 3-nitrotyrosine, 
a marker of oxidative stress, and α-smooth muscle actin, a marker of the smooth 
muscle in arterial vessels, in transverse sections of the tibialis anterior (TA) muscle 
from N and CHU rats. NB. These were not the same rats used for the in vivo study.  
?? 
 
3.2.5 Tissue isolation 
Following cervical dislocation under isofluorane anaesthesia the proximal portion of 
the left TA was carefully freed by blunt dissection from surrounding tissue, and 
removed with the aid of a scalpel. The proximal third was mounted on cork with OCT 
(Optimal cutting temperature compound, Thermo Scientific, Northumberland, UK), 
and frozen in liquid N2 cooled isopentane (2-methylbutane, Sigma Aldrich, MO, 
USA). When frozen, samples were stored at -86°C. Sections were cut (10µm at -
23°C) from TA blocks using a cryostat (Clinicut 60, Bright Instruments Co ltd., 
Huntingdon, UK), and mounted onto Polysine-coated glass slides (VWR 
International, PA, USA) for staining. After 30 minutes at room temperature, when 
sections were dried, they were stored in a sealed box at -86°C.  
 
3.2.6 Staining protocol 
Slides were allowed to warm to room temperature for 30 minutes before slide boxes 
were opened. Slides were fixed in ice-cooled acetone for 5 minutes, then washed in 
0.1M phosphate buffered saline (PBS Sigma Aldrich, MO, USA) for 5 minutes, 
followed by two 5 minute washes in PBST (PBS with 1% Tween-20, Sigma Aldrich, 
MO, USA) to wash and permeabilise the tissue sections. Slides were then placed into 
a slide incubation rack, and sections were circled with a wax pen, and a blocking 
solution (1% Bovine Serum Albumin (IHC grade), Sigma Aldrich, MO, USA, in 
PBST,) was applied for 1 hour at room temperature in a humidified chamber (Thermo 
Fisher Scientific, Northumberland, UK) to prevent drying.  
 
?? 
After 1 hour, the blocking solution was allowed to run off, and a solution containing 
primary antibodies was applied, which contained the following 0.1M PBS, 1% 
Tween20, 0.1% bovine serum albumin, Mouse monoclonal IgG against 3-
nitrotyrosine at a 1/1000 dilution (ab61392, Abcam, Cambridge, UK) and Rabbit 
polyclonal IgG against α-smooth muscle actin – 1/500 dilution (ab5694, Abcam, 
Cambridge, UK) 
 
This staining solution was applied overnight at 4°C in a humidified chamber. 
Following this primary staining, slides were washed three times for 5 minutes in 
PBST, and then, in a darkened room, a solution containing secondary antibodies was 
applied. This solution contained: 0.1M PBS, 1% Tween20, 0.1% bovine serum 
albumin, tetramethylrhodamine-conjugated Goat polyclonal IgG against mouse IgG in 
a 1/500 dilution (T-2762, Invitrogen, Paisley, UK) and fluorescein isothiocyanate-
conjugated sheep polyclonal IgG against rabbit IgG in a 1/1000 dilution (ab6791, 
Abcam, Cambridge, UK). 
 
Slides were incubated with the solution of secondary antibodies for 1 hour at room 
temperature in a humidified chamber in the dark. Following incubation slides were 
washed once in PBST for 5 minutes, followed by two, 5-minute washes in PBS. After 
washing, excess fluid was tapped off, and glass coverslips were mounted with 
Vectashield mounting medium containing DAPI (Vector laboratories Ltd, 
Peterborough, UK).  Coverslips were secured with clear nail varnish, and stored in 
the dark at 4°C until visualization. 
 
?? 
Unless otherwise stated all materials were obtained from Sigma Aldrich (MO, USA) 
 
3.2.7 Visualization of fluoresense 
Slides were visualized using a Carl Zeiss Axioskop2 fluorescence microscope (Carl 
Zeiss, Oberkochen, Germany) with an Osram HB100W fluorescent bulb (Osram AG, 
Munich, Germany) using a 20X objective (Carl Zeiss, Oberkochen, Germany). 
Exposure was optimized such that all exposure under each filterset was the same for 
all slides, and the optical intensity of all images was within the dynamic range, and 
not saturated. For visualisation of DAPI staining, filterset 1, 400ms exposure was 
used. For visualization of α-SMA staining, filterset 9, 400ms exposure, and for 
visualization of 3-NT staining, Filterset 14, 800ms exposure (Filtersets from Carl 
Zeiss, Oberkochen, Germany).  
 
Photomicrographs were acquired using the Axio-vision software (v4.1, Image 
Associates Ltd) on a computer attached to a 1.3 megapixel AxioCam MRc (Carl 
Zeiss, Oberkochen, Germany) which was connected to the microscope.  
 
All isolation and sectioning procedures described above were identical, the antibody 
staining was done in parallel in one batch for all the samples, and exposure settings 
identical. Thus, any differences in the integrated optical density of the images 
acquired can be considered to represent different quantities of protein present. This 
means that direct comparisons can be made between images of sections from N and 
CHU rats.  
 
?? 
3.2.8 Image analysis 
Images were processed using ImageJ software (v1.44, NIH, USA). The “region of 
interest” function was used to select areas representing the vascular wall of skeletal 
muscle arterioles; i.e. areas which showed positive αSMA staining, which matched 
the vessel morphology expected of a small artery or arteriole, and contained spots of 
DAPI staining indicating a mass of cells. This region of interest was then overlayed 
onto the equivalent image displaying 3-NT staining, and this area was measured for 
integrated optical density. The integrated optical density was divided by the size of 
the area of interest, giving a measure of the optical intensity of 3-NT staining. In each 
image there were many small traces of αSMA staining, which probably reflected 
small arteriole staining, but these were too small to be reliably differentiated from 
background staining.  
 
There were usually 3-5 regions in each section that were suitably clear, and 
discernable from background staining in the surrounding tissue. In each case, 
photomicrographs of the three clearest regions were obtained from each section. 
Three sections from each rat were stained and analysed, meaning that overall 9 
regions of arteriolar staining were analysed in each rat. For analysis, the relative 
intensity of staining was averaged within each section analysed, and then the 3 mean 
values were averaged to give an average value for each rat. This value from each rat 
was grouped, to form group mean±SEM for either N or CHU rats. The same analysis 
was performed on tissue from 36-week old N and CHU rats (described in Chapter 7) 
and hence, statistical comparisons between mean staining in N and CHU rats, at this 
?? 
age and at 36-weeks of age, were made by factorial ANOVA and Scheffé post hoc 
test. 
   
?? 
3.3 Results  
3.3.1 In vivo studies 
3.3.2 Comparison of baselines 
The cardiovascular and respiratory baseline values for N and CHU rats breathing 
21%O2 are shown in Tables 3.1 and 3.2, and arterial blood gasses and pH in Table 
3.3. There were no significant differences between baselines, although PaO2 showed 
a strong tendency to be lower in CHU than N (p=0.06).  
 
3.3.3 Responses to breathing 8% oxygen for 10 minutes 
 
As expected, by the 10th minute of breathing 8% O2, PaO2 had fallen substantially in 
both N and CHU, and the concomitant hyperventilation resulted in hypocapnia as 
well as alkalosis in both groups, (see Table 3.3). The effects on respiratory and 
cardiovascular variables can be seen in Figures 3.1-3.3. Figure 3.1 shows an original 
recording from an N rat during 10 minutes of acute Hypoxia. Figure 3.2 shows the 
mean absolute values in normoxia and systemic hypoxia in N and CHU rats, and 
figure 3.3 shows the changes evoked from normoxic baselines by breathing 8%O2. In 
Figure 3.2 symbols are used to show differences between the responses evoked in N 
and CHU rats. In Figure 3.3 symbols are used to show differences between the 
changes recorded between baselines and the 1st minute of hypoxia, and baselines 
and the 10th minute of hypoxia, and changes between the 1st and 10th minutes of 
hypoxia.  
 
?? 
In both N and CHU, hypoxia resulted in an initial increase in RF at 1 min, which 
waned to baseline levels by the 10th minute of hypoxia (Figures 3.1 & 3.3). By 
contrast, the concomitant initial increase in VT was sustained in hypoxia in both N 
and CHU, although ΔVT was of a larger magnitude in CHU than N (Figure 3.2). As a 
result, VE was significantly raised in both N and CHU throughout the 10-minute 
period of hypoxia, although ΔVE was significantly less at the 10th minute than at the 
1st minute in both N and CHU (Figure 3.3). 
 
Concomitantly, hypoxia induced a profound fall in ABP in both N and CHU. In N, 
there was a sustained increase in intFVC, indicating hindlimb vasodilatation, and 
such that FBF was maintained. In CHU, the increase in intFVC during hypoxia was 
not significantly different from that of the N rats. However, the fall in ABP tended to 
be greater in CHU than N rats (p=0.06, Figure 3.2), and when FBF was expressed as 
change from baseline, there was a significant difference between N and CHU in the 
FBF response to acute hypoxia (Fig. 3.2). IntCVC was modestly increased in both 
groups, but only reached statistical significance in CHU (Figure 3.3). This was not 
sufficient to counteract the fall in ABP, and therefore, although CBF was initially 
maintained, by the 10th minute of hypoxia it had fallen significantly from baseline in 
both groups (N: -0.66±0.19, p<0.01, CHU: -0.83±0.23, p<0.01, ml.min-1, figure 3.3).  
 
3.3.4 The effect of DETC on cardiovascular and respiratory baselines 
The cardiovascular and respiratory baseline values recorded during infusion of DETC 
are shown in Tables 3.1 and 3.2, whilst arterial blood gasses sampled during DETC 
infusion are shown in Table 3.3. Of note, DETC significantly reduced PaO2 in 
?? 
normoxia in both N and CHU such that PaO2 values became comparable in N and 
CHU (Table 3.3). DETC infusion significantly reduced PaCO2 in CHU, but this effect 
did not reach significance in N (p=0.06). DETC had no significant effect on baseline 
VE (see table 3.1) in either group, although it tended to reduce baseline RF (N: 
p=0.15, CHU: p=0.11) and increased VT (N: p<0.05 CHU: p=0.07).  
 
DETC infusion had no significant effect on baseline ABP. Of particular importance, 
DETC had no effect on baseline FVC in N rats, but caused a significant decrease in 
baseline intFVC in CHU rats (p<0.001, Table 3.1), indicating an increase in baseline 
vasoconstrictor tone in CHU rats. This was accompanied by a significant reduction in 
FBF in CHU, but not in N rats (p<0.001, Table 3.1). DETC had no significant effect on 
CVC or CBF in the N or CHU rats.   
 
3.3.5 Effects of DETC on the cardiorespiratory response evoked by acute hypoxia 
 
During DETC infusion, PaO2 fell to a significantly lower level in hypoxia in both N and 
CHU during acute hypoxia than under control conditions. PaCO2 fell to similar level to 
those seen during the control response (Table 3.3). 
 
In N rats, DETC infusion had no significant effect on the respiratory response to 
hypoxia. There was still a significant increase in RF and VT, and the increase in RF 
waned by the 10th minute of hypoxia (Figure 3.4), as it did before DETC (Figure 3.3). 
However, in CHU rats, DETC significantly blunted the increase in RF evoked by acute 
?? 
hypoxia, and as a consequence the hypoxia-induced increase in VE over the full 10 
minutes was also significantly blunted compared to control conditions (Figure 3.4).  
 
During DETC infusion, ABP was better maintained during hypoxia in N than under 
control conditions. In contrast, any effect of DETC on the fall in ABP evoked by 
systemic hypoxia in CHU rats did not reach statistical significance (Figure 3.4). DETC 
had no significant effect increase in intFVC during hypoxia in either N or CHU rats. 
However, as a result of a tendency for ABP to be slightly better maintained during 
hypoxia with DETC infusion in CHU rats, and the increase in intFVC to be slightly 
greater than control conditions. In CHU rats, FBF was significantly higher during 
hypoxia with DETC infusion compared to the control condition (Figure 3.4). DETC 
infusion did not have any significant effect on the increase in intCVC during hypoxia 
in either N or CHU rats. However, in both N and CHU, the significant fall in CBF by 
the 10th minute of hypoxia that occurred under the control conditions (Figure 3.3), did 
not occur during hypoxia with DETC infusion in either group. This was largely 
attributable to better maintenance of ABP  (Figure 3.4).  
 
3.3.6 In vitro experiments 
This study used histochemical colocalisation of staining for the marker of oxidative 
stress, 3-nitrotyrosine, an α smooth muscle actin as a marker of vascular smooth 
muscle, to examine the level of vascular oxidative stress in CHU rats relative to N 
rats. DAPI was used to visualise cell nuclei.  
 
?? 
When analysing photomicrographs of the staining, it was clear that there was 
significantly more staining of all kinds in the wall of the arterial vessels than there is in 
the skeletal muscle cells surrounding them (See figure 3.6). In the examples shown, 
the blood vessels are surrounded by skeletal muscle fibres, as indicated by the blue 
DAPI stained nuclei, and the level of background 3-NT staining, which is likely to be 
specific staining of 3-NT in skeletal muscle cells, rather than non-specific staining. 
However, αSMA staining was isolated only to areas that resembled arterial or 
arteriolar morphology.  
 
Where arterial vessels were particularly small (<50µm in external) diameter, it was 
difficult to resolve the 3NT staining associated with the vessel from that of the 
surrounding skeletal muscle cells and therefore they were not included in the 
quantative analysis. The lumen of all vessels (a clear example of which is shown in 
Figure 3.6A-C), no matter what angle they were sectioned at, was excluded.  
 
There was marked variation in the angles at which the arteries and arterioles were 
sectioned, due to the branching nature of the vascular supply to the TA muscle, with 
some sectioned obliquely to give an elliptical view (Figure 3.7 C&G), and some being 
sectioned more or less transversely to give a circular cross-section. It is also possible 
that some the elliptically shaped vessels were thinner walled venous vessels that 
were sectioned transversely, although in most cases, arterial and venous vessels ran 
close together, and so differentiation by eye, based on the vessel wall morphology, 
was obvious. It is also possible that some vessels were sections in an almost-parallel 
fashion, giving rise to long sections of what may be an arterial vessel curving (see 
?? 
figure 3.7 B&F). Examples of the images obtained by transecting vessels at different 
angles are shown in figure 3.7. Because the angle at which vessels were sectioned 
was often not clear, making an accurate assessment of the lumen diameter was not 
possible, except in those vessels that were obviously sectioned exactly transversely, 
such as those shown in figure 3.6. The majority of these transversely sectioned 
vessels had a lumen of approximately 20-30µm, although on occasion they were 
smaller, at around 10µm (∼10 times in total). Given the thickness of the vascular wall 
it seems like these vessels were all arterial vessels rather than venous vessels.  
 
This study used negative controls of primary-only and secondary-only staining 
protocols to determine whether the primary or secondary antibodies led to non-
specific fluorescence in muscle sections (as shown in figure 3.5). What appeared to 
be a low level of non-specific fluorescent staining was found on the innermost layer 
of the larger arteries studied, as shown in Figure 3.5 D, F and H. This layer was 
excluded from the region of interest analysis. Thus, 3-NT staining analysis represents 
a measurement of oxidative stress in the vascular smooth muscle wall, not the 
endothelium. Further, cross reactivity of each secondary antibody with the opposite 
primary antibody was checked, and found to give very low levels of non-specific 
fluorescence, and none in the vascular wall, the region of interest.  
 
Figure 3.6 shows examples of the levels of staining achieved with the 3-NT antibody. 
When merged with the image of the staining of α-smooth muscle actin, it is clear that 
the staining was localized to the vascular smooth muscle of the small artery shown. 
Yellow staining in the merged images (figure 3.6 D & H) indicates co-staining of 
?? 
vascular smooth muscle and the marker of oxidative stress, 3-NT. Figure 3.8 A 
shows the quantification of fluorescent intensity achieved with 3-NT staining and 
shows that there is no significant difference in the level of staining achieved in N and 
CHU rats.  It was not possible to resolve the endothelium of these vessels. Thus, no 
comment can be made on the level of oxidative stress in the endothelium of either N 
or CHU rats. 
 
The level of 3-NT staining in areas representing the smooth muscle of the vascular 
wall within sections of proximal TA was not different between N and CHU rats (figure 
3.6).
?? 
Table 3.1 – Mean cardiovascular baselines in N and CHU rats before and during 
infusion of a SOD inhibitor 
 
Condition ABP  (mmHg) 
HR  
(beats.min-1) 
intFVC 
(CU) 
FBF  
(ml.min-1) 
intCVC 
(CU) 
CBF  
(ml.min-1) 
N 136.0 ±3.4 
467 
±14 
7.54 
±1.10 
1.58 
±0.18 
13.2 
±1.5 
2.9 
±0.28 
CHU 144.6 ±3.8 
458 
±6 
6.38 
±0.85 
1.52 
±0.17 
13.5 
±1.6 
2.86 
±0.40 
N+DETC 137.2 ±3.0 
484 
±10 
7.27 
±0.75 
1.50 
±0.12 
19.2 
±2.9 
3.23 
±0.28 
CHU+DETC 148.2 ±2.2†† 
478 
±10 
4.48 
±0.49** 
1.13 
±0.13*** 
17.4 
±3.0 
2.93 
±0.47 
 
Mean cardiovascular baselines in N and CHU rats before (N, CHU) and during DETC 
infusion (N+DECT, CHU+DETC) whilst breathing 21% O2.  
 
ABP; arterial blood pressure, HR; heart rate, intFVC; integrated femoral vascular 
conductance, FBF; femoral blood flow, intCVC; integrated carotid vascular 
conductance, CBF; carotid blood flow. Values shown are mean±SEM (N: n=12, CHU: 
n=11) 
 
*, **, *** - P<0.05, P<0.01 and P<0.001 vs control conditions respectively  
†† - p<0.01 N vs CHU under same condition 
  
?? 
Table 3.2 – Mean respiratory baselines in N and CHU rats before and during infusion 
of a SOD inhibitor 
Condition RF (breaths.min-1) 
VT 
(ml.kg-1) 
VE 
(ml.min.kg-1) 
N 97.6±3.3 2.46±0.15 241±20 
CHU 93.3±3.1 2.23±0.12 207±12 
N+DETC 93.2±3.6 2.66±0.18 250±22 
CHU+DETC 86.9±4.3 2.39±0.15 207±16 
 
Mean respiratory baselines in N and CHU rats before (N, CHU) and during DETC 
infusion (N+DETC, CHU+DETC) whilst breathing 21% O2. 
 
RF; respiratory frequency, VT; ventilatory tidal volume, VE; respiratory minute 
ventilation. Values shown are mean±SEM (N: n=12, CHU: n=11). 
  
?? 
Table 3.3 – Arterial blood gasses in N and CHU rats during normoxia and hypoxia 
before and during infusion of a SOD inhibitor.  
 
Condition PaO2 (mmHg) 
PaO2 
(mmHg) 
PaCO2 
(mmHg) 
PaCO2 
(mmHg) pHa pHa 
 Normoxia Hypoxia Normoxia Hypoxia Normoxia Hypoxia 
N 85.0 ±2.2 
29.4 
±1.5 
38.8 
±1.2 
24.6 
±0.8 
7.427 
±0.004 
7.503 
±0.024 
CHU 
80.1 
±1.6 
(p=0.06) 
30.4 
±1.6 
41.5 
±1.1 
25.5 
±0.9 
7.438 
±0.010 
7.482 
±0.023 
N+DETC 71.8 ±2.3*** 
23.0 
±1.2** 
36.5 
±1.4 
p=0.062 
24.3 
±1.2 
7.465 
±0.010** 
7.544 
±0.017 
CHU+DETC 72.4 ±1.9*** 
24.5 
±1.4** 
38.6 
±1.0* 
26.1 
±0.8 
7.456 
±0.010* 
7.511 
±0.014 
 
 
Mean arterial blood gasses (PaO2, PaCO2, pHa) in N and CHU rats breathing 21% O2 
and 8% O2 (Hypoxia) before and during DETC infusion. Values shown are 
mean±SEM (N: n=12, CHU: n=11) 
 
 *, **, *** - p<0.05, p<0.01, p<0.001 respectively,  vs control condition  
p=0.062 – CHU vs N 
 
  
?? 
Figure 3.1 – Original recording of cardiovascular and respiratory variables during a 
10 minute period of acute systemic hypoxia (breathing 8%O2) in an N rat. 
 
The bar beneath the trace indicates the period during which the rat was breathing 
8%O2. 
 
Abbreviations as per Tables 3.1 and 3.2.   
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Figure 3.2 – Mean cardiovascular and respiratory variables recorded at 1 minute 
intervals during acute systemic hypoxia in N and CHU rats. 
 
Data presented as mean±SEM N (n=12, filled squares) and CHU (n=11, filled 
circles). 
Abbreviations as per Tables 3.1 and 3.2.   
** - P<0.01, N vs CHU hypoxia response. 
P=0.06 – N vs CHU hypoxia response.  
 
  
???????????
??
???
??
??
??
???
??
???
??
??
? ??
???
??
???
??
???
? ??
???
??
???
??
??
??
???
??
??
??
???
??
??
???
? ??
??
???
??
??
???
? ??
? ??
??
????
?? ??
? ??
??
????
?? ??
???
? ??
B
B
B
B
B B B B B B
B
J
J J
J
J J J J J
J J
0 1 2 3 4 5 6 7 8 9 10
75
100
125
150
B
B
B
B B B
B B B B B
J
J
J
J
J J J J J J J
0 1 2 3 4 5 6 7 8 9 10
0
150
300
450
600
B
B
B B B
B B
B B B B
J
J
J J J J J J J
J
J
0 1 2 3 4 5 6 7 8 9 10
0
1
2
3
4
5
B
B
B B B B B
B B B B
J
J
J J J J J J J J J
0
50
100
150
B B B B B B B
B B B B
J
J
J J J J J J J J J
350
450
550
B
B B B
B B B B B B
B
J
J J J J J J J J J
J
0
0.25
0.5
B
B
B B B B B B B B B
J
J
J J J J J J J J J
0
0.25
0.5
B B B B B
B B
B B B B
J J
J J J J J J J J J
0
1
2
3
4
B
B
B B B B B B B B B
J J
J J J J J J J J J
0
1
2
3
4
?? ?????????
?? ??????????? ?????????
???
???
???????
?? 
Figure 3.3 - Mean changes from baseline in cardiovascular and respiratory variables 
recorded at 1-minute intervals during acute systemic hypoxia. 
 
All values are presented as the mean±SEM change (∆) from the mean baseline of 
the minute preceding acute systemic hypoxia, in N (n=12, filled squares) and CHU 
(n=11, filled circles). 
 
Abbreviations as per Tables 3.1 and 3.2 
 
*, *** - p<0.05 and p<0.001 respectively, between time points in N rats. 
§, §§, §§§ - p<0.05, p<0.01 and p<0.001 respectively, between time points in CHU 
rats.  
 
NB. Statistical differences between variables recorded at minutes 0 and 10 are 
described in the results section of this chapter.  
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Figure 3.4 - Mean changes from baseline in cardiovascular and respiratory variables 
recorded at one minute intervals during acute systemic hypoxia before and during 
infusion of a SOD inhibitor. 
 
All values are presented as the mean±SEM change (∆) from the mean baseline of 
the minute preceding acute systemic hypoxia, in N (n=12, filled squares) and CHU 
(n=11, filled circles), before (closed symbols) and during (open symbols) infusion of 
the SOD inhibitor DETC.  
 
Abbreviations as per Table 3.1 and 3.2. 
 
*, **, *** - p<0.05, p<0.01 and p<0.001 between time points in N rats during DETC 
infusion 
§, §§, §§§ - p<0.05, p<0.01 and p<0.001 between time points in CHU rats during 
DETC infusion 
NB. Statistical differences between time points under control conditions can be found 
in Figure 3.3. 
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Figure 3.5 - Example photomicrographs of negative controls for 
immunohistochemical colocalisation of αSMA and 3-NT in transverse sections of 
small arterial vessels within the tibialis anterior muscle.  
 
A, C, E, G – DAPI staining, showing cell nuclei. 
 
B: Same field as in A. Visualization following incubation with rabbit polyclonal anti-
αSMA1°Ab only, demonstrating no visible fluorescence. 
 
D: Same field as in C. Visualization following incubation with sheep-anti-rabbit IgG-
FITC conjugate 2° antibody, with no primary antibody, demonstrating only low levels 
of non-specific staining of the endothelium, and very little staining of the arterial 
smooth muscle, or surrounding tissue.  
 
F: Same field as in E. Visualization following incubation mouse monoclonal anti-3NT. 
1°AB only, demonstrating low levels of background fluorescence, particularly in the 
region of the endothelium. 
 
H: Same field as in G. Visualization following incubation with goat-anti-mouse IgG-
rhodamine conjugate 2° antibody, with no primary antibody, demonstrating only low 
levels of non-specific staining of the endothelium, and very little staining of the 
arterial smooth muscle, or surrounding tissue.  
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Figure 3.6 - Representative dual αSMA and 3NT staining of arterial vessels within 
transverse sections of TA muscle from 10-12 week old N and CHU rats 
 
A & E: DAPI staining in N and CHU rats respectively 
B & F: α-SMA staining in N and CHU rats respectively 
C & G: 3-NT staining in N and CHU rats respectively 
D & H: Merge of all three staining images. Yellow denotes combined α-SMA and 3-
NT staining, indicating vascular interaction with peroxynitrite.  
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Figure 3.7 - Examples of stained vessels with different morphology, and the 
associated 3-NT staining. Images A, D, E and H are taken from N rats, whereas 
images B, C, F and G are taken from CHU rats. Left panels indicate αSMA staining, 
right hand panels indicate 3-NT staining.  
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Figure 3.8 – Comparison of oxidative stress levels in arterial vessels in N and CHU 
rats. 
 
Fluorescent intensity in selected ‘regions of interest’ (See section 3.3, arbitrary units, 
mean±SEM) of 3-NT staining in 10-12 week old N (n=6) and CHU (n=6, 6 litters) rats, 
indicating the level of peroxynitrite present in the vessels wall of arterial vessels of TA 
muscle. Fluorescent intensity is similar in N and CHU rats. There was no significant 
difference in fluorescent intensity measured in N and CHU rats.  
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3.4 Discussion 
3.4.1 Main Findings 
These main findings of the present experiments were that at 10-12 weeks of age, the 
baseline cardiorespiratory variables measured under Alfaxan anaesthesia were 
similar in N and CHU rats. Further, the CHU rats show an equally robust response to 
a 10 minute period of relatively severe hypoxaemia (breathing 8%O2) to that seen in 
the normal N rat, in that RF and CBF showed a similar waning during systemic 
hypoxia in N and CHU rats. However, when DETC was used to inhibit SOD, there 
was a reduction in baseline intFVC and FBF in CHU rats only, indicating an increase 
in baseline vasoconstrictor tone. DETC did not significantly affect the cardiovascular 
responses evokd by acute systemic hypoxia, but in CHU rats, DETC reduced the 
increase in RF evoked by breathing 8%O2, and hence reduced the hyperventilation 
evoked by systemic hypoxia. In contrast, DETC did not significantly affect the 
respiratory response to systemic hypoxia in N rats.  Ex vivo analysis of vascular 
oxidative stress in the vascular smooth muscle of small arteries and arterioles of the 
TA muscle showed similar levels of 3-nitrotyrosine staining in the N and CHU rats. 
 
 
3.4.2 Cardiorespiratory baselines relative to other studies 
Several points must be considered before interpreting these results. The surgical 
preparation used in the present study is based on that described by Thomas and 
Marshall (1994). However, their study on N rats was conducted using Saffan 
anaesthesia, a mixture of alfaxolone and alphadolone, which is no longer 
??? 
commercially available, rather than Alfaxan, which contains only alfaxalone. 
Nevertheless, all the baseline cardiovascular and respiratory characteristics 
measured in the N rats used in the two studies were similar. The pattern of response 
evoked by acute systemic hypoxia in this study was also similar to that of the 
previous study, but there were some key differences.  
 
Firstly, Thomas and Marshall (1994) found that during acute systemic hypoxia VE 
substantially increased, and then waned towards the latter stages of the hypoxic 
period, due to a waning of VT but not RF. By contrast, in the present study, although 
VE waned in a similar fashion in N rats, it was because RF fell; VT was well 
maintained throughout the hypoxic period (see figure 3.2 & 3.3). This might be due to 
the different anaesthetics. However, it seems more likely to reflect natural changes in 
the neural processing in the Wistar strain of rat, as these studies were conducted 15 
years apart. Thus, in a recent study conducted by Hudson et al., (2011) examining 
cardiorespiratory and autonomic variables in N rats which were under Saffan 
anaesthesia, the baseline variables were similar to those reported in the present 
study, and as in the present study, when 8%O2 was breathed for 10 minutes, it was 
RF that began to wane whereas VT was well maintained. It may be noted that there is 
considerable variation between published studies as to whether RF, VT or both wane 
during hypoxia when the hypoxic period is maintained (See Teppema & Dahan, 
2010).  
 
Secondly, HR was relatively well maintained throughout the 10 minute period of 
hypoxia in N rats of the present study, whereas results of previous studies have 
??? 
shown a secondary fall after initial tachycardia (Neylon & Marshall, 1991; Thomas & 
Marshall, 1994). This may be attributed to the different anaesthetic regimens; the 
recent study by Hudson et al., (2011), also conducted under Saffan anaesthesia, as 
the previous studies were, also showed a secondary fall in HR. The disparity cannot 
be attributed to the differences in the ventilatory response to hypoxia, for it was VT 
that fell in the studies by Thomas & Marshall, and Neylon & Marshall, but RF that fell 
in the study of Hudson et al.  
 
Thirdly, CBF showed a more profound fall throughout hypoxia in the present study 
than in previous studies (Neylon & Marshall, 1991; Thomas & Marshall, 1994), where 
CBF was maintained until at least the second minute of hypoxia. This may be related 
to the fact that ABP fell further, to less than 50mmHg, by the first minute of hypoxia in 
the present study, and thus may be below the autoregulatory range for the 
maintenance of brain blood flow.   
 
Although the differences between the present study on N rats, and previous similar 
studies that some of the hypotheses are based on are unfortunate, they do not affect 
the outcome of the present study, as the aim was to compare the mechanisms of the 
cardiovascular and respiratory response evoked by acute systemic hypoxia between 
N and CHU rats, and to establish how the contribution of oxidative stress may be 
altered in CHU rats.  
 
??? 
3.4.3 Comparison of responses evoked by a 10-minute period of hypoxia in N and 
CHU rats 
Overall patterns of response to acute systemic hypoxia were very similar between N 
and CHU rats; hyperventilation which waned with time, little change in HR, a fall in 
ABP, and vasodilatation in skeletal muscle and brain which allowed FBF to be 
maintained, but CBF fell. Addressing the first hypothesis, that CHU rats are more 
prone to cardiovascular collapse during severe acute hypoxia (see General 
Introduction) in the present study, the N rats showed similar patterns of response to 
those observed by Thomas and Marshall (Thomas & Marshall, 1994, 1995). There 
was still a substantial hyperventilatory response, associated with vasodilatation in 
both cerebral and femoral vascular beds. However, in contrast to the results of 
Thomas & Marshall, CBF fell significantly by the 10th minute of breathing 8%O2, 
despite substantial vasodilatation. Thomas & Marshall (1994) found that CBF was 
still maintained at the 10th minute of hypoxia in Wistar rats of a similar size (∼350g). 
However, in the 7-8 week old N rats used by Thomas & Marshall (1995) by the 5th 
minute of breathing 8%O2, CBF already showed a strong tendency to be reduced, 
relative the baseline recorded during normoxia. 
 
The changes measured in blood gasses whilst breathing 8%O2 were comparable 
between N and CHU rats, and the hyperventilation seen in CHU was no more prone 
to waning over the 10 minutes examined than it is in N. CBF fell over 10 minutes in 
both N and CHU rats, despite the substantial increase in CVC (figure 3.3), but HR 
was maintained throughout.  
 
??? 
Thus, this study found no evidence that CHU rats are more prone to respiratory and 
cardiovascular collapse than N rats. It is possible that the positive feedback loop, 
described by Thomas & Marshall (1995), of falling ventilation, heart rate and 
brainblood flow would have been observed in both the N and CHU rats in this study if 
the period of hypoxia had been longer or more severe. There is certainly no reason 
to argue that chronic hypoxia in utero leads to an accentuation of the local, 
deleterious effects of hypoxia on ventilation, HR and thereby on ABP and CBF, as 
chronic hypoxia from birth does. Thus, the first hypothesis of this study is largely 
disproved. 
 
3.4.4 Use of DETC as an inhibitor of SOD 
DETC inhibits SOD by acting as a copper chelator, hence removing the copper 
cofactor required for activity of the cytosolic and extracellular SOD (see General 
Introduction). The dose of DETC used in this study, 5mg.kg-1.min-1, was the same as 
that used in vivo by Zou et al., (2001) in rats to inhibit SOD activity in the renal 
medulla, which was based on in vitro studies where similar plasma concentrations 
have been shown to produce 80-100% inhibition of SOD in cultured spinal neurones 
(Rothstein et al., 1994). Given that DETC is cell permeant, intracellular 
concentrations are likely to have been similar to those found in the plasma, and as 
such the concentrations needed in cell culture are likely similar to those required in 
vivo. A continuous infusion of DETC was used in the present study to ensure 
maximal inhibition continued, as DETC has been reported to have a short half-life 
(Voll et al., 1999). However, it was not possible to prove the inhibition of SOD without 
an in vitro assay of SOD activity, which was not easily available. It should be noted 
??? 
that DETC likely had non-selective effects, beyond inhibition of SOD. Copper is a 
cofactor for cytochrome C oxidase (complex IV), and for dopamine ß-hydroxlase 
(Hamza & Gitlin, 2002). However, as the choice of compounds available for in vivo 
manipulation of oxidant systems is limited, such non-selective effects are difficult to 
avoid, if they occurred under the conditions of the present study.  
 
A further difficulty with the use of DETC is that at low doses it can act as an 
antioxidant and as a reductant (Liu et al., 1996) and has therefore been used in the 
treatment of oxygen toxicity (Frank et al., 1978). If the hypothesis, that CHU rats 
experience chronically high levels of oxidants in the vasculature is true, then 
administration of DETC to inhibit SOD would be expected to decrease the 
dismutation of O2- to H2O2 by SOD, i.e. to have a pro-oxidant effect and acutely 
accentuate the effect of excess levels of superoxide anions. However, if it is also 
acting directly as an anti-oxidant, then this pro-oxidant effect may be masked.  
 
3.4.5 Effects of DETC during normoxia 
With these provisos, it is clear that in the present study DETC reduced baseline FVC 
indicating an increase in basal vasoconstrictor tone in the femoral vasculature in 
CHU rats, but not N rats. This finding is consistent with the proposed hypothesis, that 
CHU rats experience chronically high levels of oxidative stress, for, by inhibiting 
SOD, DETC would be expected to lead to high levels of O2-, which would reduce NO 
bioavailability, and reduce the ongoing vasodilator effect of shear stress-induced NO 
release, which is uncovered in N rats when NOS is inhibited with L-NAME (Skinner & 
Marshall, 1996). In addition, by inhibiting SOD, DETC may also have attenuated an 
??? 
ongoing vasodilator effect of H2O2 produced from O2-. This mechanism is well 
characterised in the coronary circulation of pigs, humans and dogs (Matoba & 
Hiroaki, 2003; Miura et al., 2003; Yada et al., 2003); SOD dismutes endothelially 
derived O2- into H2O2, which move into the subendothelial space, increase the open 
probability of vascular smooth muscle KCa2+ channels, so decreasing vascular tone 
(Matoba et al., 2000; Shimokawa & Matoba, 2004).  
 
In further support of the interpretation of the effects of DETC, each of the non-
selective effects of DETC mentioned above would likely have vasodilator effects. 
Inhibition of cytochrome C oxidase would lead to increased release of adenosine 
(Edmunds et al., 2003), whilst inhibition of dopamine ß-hydroxylase would lead to 
failure of synthesis of adrenaline and noradrenaline. Moreover, such effects would 
have been expected in N rats, as well as CHU rats. Thus, the vasoconstrictor effect 
of DETC in CHU rats is likely to be a result of DETC inhibiting SOD and not a non-
selective affect. Whether it achieved its main effect in CHU rats by decreasing the 
bioavailability of tonically released NO, or by decreasing the production of H2O2 
cannot be deduced from the present findings. However, the present finding does 
allow the conclusion that there is a chronically higher level of oxidative stress in the 
femoral vascular bed in CHU rats than in N rats, which is consistent with the work of 
Williams et al., (2005b).  
 
Interestingly, in the present study, DETC had no significant effect on baseline CVC, 
but did significantly increase ABP in CHU rats. Thus, there is no reason to suppose 
that tonic oxidative stress was present in the cerebral vasculature of CHU rats. 
??? 
Therefore, the increase in ABP may be a sign that DETC is having a similar 
vasoconstrictor effect in other tissues, such as the mesenteric vascular bed that 
Williams et al., (2005b) examined, and therefore having an affect on total peripheral 
resistance.   
 
DETC significantly reduced PaO2 in both N and CHU rats. Given that baseline RF and 
VT did not change, this raises the possibility that DETC attenuated the respiratory 
response to hypoxic stimulation of the peripheral chemoreceptors, even though the 
fall in PaO2 was too small to have a significant effect on ventilation. This is likely a 
non-specific effect of DETC, as it occurred equally in N and CHU rats. It is known 
that SOD-derived H2O2 is a possible mechanism involved in hypoxic pulmonary 
vasoconstriction (Waypa et al., 2001; Waypa et al., 2006), and thus, it is possible that 
by inhibiting SOD with DETC, inappropriate blood flow distribution within the lung 
may have resulted in this reduction in PaO2. Further, the possibility that DETC caused 
pulmonary oedema, or another such oxygen-transport limiting effect in the lungs, 
cannot be ruled out. However, the limited in vivo use of DETC makes it difficult to 
comment further on this finding in the context of any literature.  
 
3.4.6 The effect of DETC on cardiovascular and respiratory response evoked by 
acute systemic hypoxia 
 
In N rats, DETC had relatively small effects on the response to acute systemic 
hypoxia in N rats. The fall in ABP during acute system hypoxia was slightly 
attenuated, although during DETC infusion, the increase in femoral or cerebral 
??? 
vascular conductance was unaltered. This suggests that there may have been a 
smaller hypoxia-induced vasodilatation in vasculature other than skeletal muscle and 
brain, which leads to total peripheral resistance not falling as much as under control 
conditions, or a reduction in cardiac output. In N rats, there was no effect of DETC on 
the magnitude of increase in ventilation evoked by breathing 8%O2, even though 
PaO2 fell to a lower value than under control conditions. This is surprising, given that 
the ventilatory response is initiated by the fall in PaO2 acting on peripheral 
chemoreceptors (Marshall, 1994). It raises the possibility that DETC may have 
inhibited the ventilatory response to hypoxia by acting peripherally or centrally, in N 
rats, as previously suggested by the fall in baseline PaO2 induced by DETC.  
 
By contrast, during DETC infusion in CHU rats, there is a tendency for ABP to fall 
less than under control conditions, and for FVC to rise further; consequently, FBF is 
better maintained during DETC infusion than control conditions. The reasons for this 
are not easily explained. If we propose that there was an increased rate of O2- 
accumulation under control conditions in CHU rats, then whilst breathing 8%O2, the 
hypoxia-induced increase in intFVC would be smaller, because DETC inhibited the 
dismuting of O2- to H2O2. Indeed, Pyner et al., (2003) presented evidence 
demonstrating that in skeletal muscle vasculature of the N rat, systemic hypoxia-
induced an increase in O2- formation, and showed that the xanthine oxidase inhibitior 
oxypurinol inhibited O2- formation from adenosine. Exogenous SOD accentuated the 
hypoxia-induced muscle vasodilatation, indicating a role for H2O2 in hypoxia-induced 
vasodilatation in the rat hindlimb, and proposed that it is likely that these superoxide 
anions are tonically dismuted to form vasodilator H2O2.  
??? 
 
An alternative possibility is that during DETC infusion in CHU rats not only was SOD 
inhibited, but the non-selective inhibitory effects of DETC on mitochondrial 
cytochrome C oxidase (see above) led to an increase in adenosine release during 
systemic hypoxia, in the same fashion as that proposed for NO by Edmunds et al., 
(2003). Thus the vasoconstrictor effects of O2- were attenuated, and the hypoxia-
induced muscle vasodilatation accentuated, and this lead to a non-significant trend 
for FVC to increase further than under control conditions. The possible roles of 
adenosine and NO in the hypoxia-induced increases in FVC are explored in Chapter 
4.  
 
The striking effect of DETC in CHU rats, was that it greatly reduced the hypoxia-
induced increase in RF, but had no affect on VT; as a result, the increase in VE 
evoked by breathing 8%O2 was significantly blunted. The mechanism by which this 
occurs is not clear. The most obvious possibilities are that DETC inhibited the 
stimulatory effect of hypoxia on the carotid body, or in some way altered the central 
response to carotid body activity, such that the rise in RF during stimulation was 
blunted. The role of reactive oxygen species in oxygen sensing, particularly in the 
carotid body, are poorly understood. The generation of O2- and H2O2 by SOD in 
pulmonary artery smooth muscle cells has been shown to play a role in oxygen 
sensing (Waypa et al., 2001; Waypa et al., 2006), and some argue that the presence 
of mitochondrial ROS are required for oxygen sensing (Brunelle et al., 2005). In the 
carotid bodies of rabbits with pacing-induced heart failure, albeit a model of disease, 
O2- has been shown to enhance the sensitivity of the carotid bodies (Ding et al., 
??? 
2009a; Ding et al., 2009b). In the present study, if DETC is increasing the 
accumulation of O2- in the carotid bodies of CHU rats, the opposite effect is 
observed.  However, if it were argued that the high levels of O2- were reducing the 
bioavailability of NO, then the mechanism of O2 sensing described by Edmunds et 
al., (2003) may be impaired following SOD inhibition, and this may explain the 
blunting of the hypoxia-induced increase in ventilation. It is not possible to make firm 
conclusions from the findings of this study, but investigation into the role of ROS in 
O2 sensing, and the hypoxia-induced increase in ventilation require further 
exploration.  
 
3.4.7 Ex vivo analysis of oxidative stress 
The immunohistochemical analysis of 3-nitrotyrosine levels in the skeletal muscle 
vasculature was intended to independently examine whether there is chronically 
increased oxidative stress in CHU rats, as 3-nitrosylated tyrosine residues are 
formed when peroxynitrite reacts with tyrosine. The limitations of the methods used 
must be considered before any attempt is made to interpret the results. First, it 
should be noted that the initial aim was to examine oxidative stress in medium and 
small arterioles, but it became clear that because of the ongoing role of free radicals 
as signaling molecules in skeletal muscle (Jackson et al., 2007), it was difficult to 
differentiate 3NT staining in small vessels lying between skeletal muscle fibers from 
staining within the skeletal muscle fibres. Thus, analysis had to be focussed on larger 
vessels where the smooth muscle vascular wall was more obviously distinguishable.  
 
??? 
This study did not have a positive control to confirm the specificity of the 3-NT 
antibody. To the author’s knowledge, there is no published study on sections of any 
tissue that has employed a positive control for nitrotyrosine expression. The study by 
Yang et al., (2009) on mesenteric arterial vessels, on which this analysis was based, 
did not show positive or negative controls for 3NT staining. Other studies have been 
published with the same methodology used here but in other tissues (Khan et al., 
2008; Rump et al., 2010).  
 
The outcome of the image analysis was that there was no significant difference in the 
level of 3-NT staining observed in the vascular smooth muscle layer of arterial 
vessels within the TA muscle in N and CHU rats. As argued above, the simplest 
conclusion to draw from the in vivo experiment involving DETC, is that there was 
increased tonic production of O2- from the skeletal muscle vasculature of CHU rats 
relative to N rats. If it is the correct conclusion, then the results of the 
immunohistochemical analysis indicate that it is likely that the oxidative stress 
present is confined to the endothelium, where it can influence endothelial 
mechanisms that regulate vascular tone, and does not cause marked effects in the 
vascular wall of larger arterioles and small arteries. This does not rule out the 
possibility of effects on the vascular smooth muscle of smaller arterioles, where the 
proportion of vascular smooth muscle cells to endothelial cells is smaller. 
 
Confirming increased rates of superoxide formation in skeletal muscle vasculature, at 
the level of the small arterioles will remain technically challenging for the reasons 
indicated above. However, open vessel preparations of larger arterial vessels could 
??? 
be employed to test this hypothesis, that the endothelium is the site of generation of 
O2-, by using 3NT staining, or other techniques for monitoring O2- production. Further, 
analysis of markers of oxidative stress, such as 3NT in venous efflux from skeletal 
muscle vasculature during normoxic and hypoxic conditions, may also provide further 
insight.  
 
In conclusion, the results presented from the experiments in this Chapter suggest 
that may be a tonically increased level of oxidative stress in the skeletal muscle 
vasculature of CHU rats, which has the net effect of inducing tonic vasodilatation via 
the action of H2O2 from SOD. The source of the O2- is likely to lie within the vascular 
endothelium. The studies indicate that CHU rats are not more prone to 
cardiovascular or respiratory failure during severe acute hypoxia than N rats. 
However, DETC inhibits the SOD isoforms in the extracellular space and in the 
cytoplasm, and has effects the ventilatory response evoked by hypoxia in CHU rats, 
which are as yet unexplained. 
 
 
  
??? 
 
 
 
 
 
  
??? 
Chapter 4 – Chronic hypoxia in utero and the role of adenosine 
??? 
4.1 Introduction 
As discussed in the General Introduction, there is much evidence that a suboptimal 
environment in utero can result in endothelial dysfunction in several different vascular 
beds in the offspring.  
 
Thus, Williams et al (2005b) found that in small mesenteric arteries isolated from 7 
month old rats subjected to CHU from days 15-21 of pregnancy, exogenous SOD 
increased endothelium-derived relaxations to methacholine, but had no effect on the 
equivalent arteries taken from control (N) rats. This suggested that there is either 
tonic or increased agonist induced-production of O2- in this vascular bed after 
exposure to the in utero stressor. The results of chapter 3 are consistent with these 
findings, as they suggest that in vivo, H2O2 generated from O2- exerts a tonic dilator 
influence on skeletal muscle vasculature of 1-12 week old CHU rats. A pilot study in 
this laboratory showed that whilst in anaesthetised N rats, L-NAME significantly 
reduced hypoxia induced vasodilatation in the rat hindlimb, it did not significantly 
reduce it in CHU rats, suggesting that there may be a reduction in the contribution of 
NO to the hindlimb vasodilatation induced by systemic hypoxia in CHU rats (Rook et 
al., 2008a).  Further, a very recent study by Morton et al., (2011) showed that the role 
of NO in flow-mediated dilatation of the small mesenteric arteries was abolished in 
rats that had been exposed to hypoxia in the latter third of pregnancy, again 
suggesting impaired NO bioavailability. 
 
As described in the General Introduction, in N rats, during systemic hypoxia, 
adenosine acts on A1 receptors to induce dilatation in the arteries supplying skeletal 
??? 
muscle. Stimulation of the adenosine A1 receptor on the endothelium releases NO, in 
part by generating PGI2 as an intermediate. This has been demonstrated during 
acute systemic hypoxia in rats and in humans in vivo (Ralevic, 2002; Ray & Marshall, 
2006; Markwald et al., 2011). Further, Edmunds et al., (2003) provided evidence that 
the mechanism by which endothelial cells release adenosine in systemic hypoxia is 
dependent on the interaction between O2 and NO at complex IV of the electron 
transport chain, which leads to reduced ATP resynthesis and release of adenosine 
when O2 levels fall, providing that a tonic level of NO is present, such as that 
generated by ongoing shear stress. 
 
In contrast to these findings, Coney & Marshall (2010) recently found that in CHU 
rats, acute systemic hypoxia-induced hindlimb vasodilation that was as large as that 
in N rats, but found that blockade of the A1 receptor did not result in any impairment 
of the hypoxia-induced dilatation. However, infusion of adenosine in CHU rats 
resulted in a similar magnitude of vasodilatation to that seen in N rats, and this 
dilatation was partly attenuated by A1 receptor blockade as it is in N rats. In view of 
these findings, Coney & Marshall (2010) suggested that decreased bioavailability of 
NO in CHU rats may impair the release mechanism of adenosine from the 
endothelium during systemic hypoxia. Thus, the aims of the experiments described in 
this chapter were to explore the roles of NO and adenosine in the vasodilatation 
induced in the muscle vasculature by acute systemic hypoxia in CHU rats, comparing 
the findings with those observed in N rats. 
 
Hypotheses 
??? 
1. The role of NO in hypoxia-induced vasodilatation is smaller in CHU rats than N 
rats because the bioavailability of NO is lower in CHU rats. 
 
2. Because the bioavailability of NO is lower in CHU rats, the sensitivity of the 
endothelium to a fall in PO2 is decreased, and less adenosine is released 
during systemic hypoxia. This decreases the role for the adenosine A1 
receptor in hypoxia-induced vasodilatation, as seen by Coney & Marshall 
(2010). Therefore, if background levels of NO are restored with the NO donor 
SNAP, after NO synthesis inhibition, adenosine release and the role of the 
adenosine A1 receptor in hypoxia-induced vasodilatation will be restored. 
These hypotheses were tested by recording vascular responses evoked by 
acute systemic hypoxia before and after L-NAME, then after the influence of 
NO was restored by infusion of the NO donor SNAP, and then in the presence 
of the adenosine A1 receptor antagonist DPCPX.  
 
Unexpectedly, during SNAP infusion, the vasodilatation was restored in CHU, 
as well as N rats, but DPCPX did not reduce the vasodilatation during 
systemic hypoxia in either N or CHU rats, in contrast to previous findings on N 
rats (Edmunds et al., 2003). Therefore, the effectiveness of DPCPX as an 
adenosine A1 receptor antagonist was checked in both N and CHU rats. 
Having established that the DPCPX being used in the present study was an 
effective A1 receptor antagonist in both N and CHU rats, it was hypothesized 
that: 
??? 
3. There is large redundancy in the mechanisms of hypoxia-induced muscle 
vasodilatation, and that under the condition of SNAP infusion after NOS 
inhibition hypoxia-induced vasodilatation may be mediated by adenosine 
acting on A2A receptors in N and/or CHU rats. To test this hypothesis the effect 
of the adenosine A2A receptor antagonist ZM-241,385 on hypoxia-induced 
muscle vasodilatation was investigated during SNAP infusion following NOS 
inhibition. As a final step, the effect of DPCPX was tested after ZM-241,385. 
 
 
 
  
??? 
4.2 Methods 
4.2.1 General characteristics of the animals used 
A total of 63 rats were used in this experiment. They consisted of 3 study groups; 
Study one was performed on 12 N rats (weight 385±11g, age 66±1 days) and 14 
CHU rats (weight 388±12g, age 65±1day, 5 litters). Study 2 was performed on 5 N 
rats (weight 384±11g) and 6 CHU rats (weight 394±13g, age 71±2 days, 3 litters). 
Study 3 was performed on 12 N rats (weight 356±14g, age 78±1day) and 14 CHU 
rats (weight 389±7g, age 84±3 days, 4 litters).  
 
4.2.2 Animal preparation 
The surgical preparation used for each rat in these studies is described in Chapter 2. 
In study groups 1 and 3, ABP was measured via the right brachial artery, whilst blood 
for arterial blood gas measurements was sampled via the left brachial artery. Drug 
infusions were given via the caudal ventral tail artery, or via the left femoral vein. FBF 
was recorded from the right femoral artery. FVC and HR was calculated as described 
in Chapter 2. Airflux was recorded from the side arm of the tracheal cannula, RF, VT 
and VE derived as described in chapter 2.  
 
A similar preparation was used in the rats that are part of study 2. ABP was 
measured from the right brachial artery. Drug infusions were given via the left femoral 
vein, whilst FBF was recorded from the right femoral artery.  
 
??? 
In all rats where arterial blood gasses were sampled, normoxic values were obtained 
from blood samples taken in the final minute before hypoxia, and hypoxic values 
were obtained from blood taken in the final minute of breathing 8%O2.  
 
4.2.3 Protocols 
4.2.4 Study  1 – The role of NO and the adenosine A1 receptors 
At least 30 minutes after the completion of the surgical preparation rats, were 
exposed to 5 minutes of breathing 8% O2 in N2. This was repeated two to three 
times, with at least 15 minutes between stimuli, to ensure the response to acute 
systemic hypoxia was consistent. The NO synthase (NOS) inhibitor L-NG-
Nitroarginine methyl ester (L-NAME 10mg.kg-1 i.a.) was then given via the tail artery. 
At least 20 minutes later, and when cardiovascular baselines had become stable at 
their new levels, the response to 8%O2 was recorded again. After cardiovascular 
variables had returned to their resting values again, an infusion of S-nitroso-N-
acetylpenicillamine (SNAP, ~10μg.min-1.kg-1 i.a.) was commenced, infused a rate 
sufficient to restore baseline FVC to a level similar to that seen in control conditions; 
this was adjusted as appropriate in each animal. Once this was achieved and stable 
for at least 10 minutes, the response to 8%O2 was re-tested. Following this the 
adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 
0.1mg.kg-1 i.v.) was given. This dose was sufficient to reverse responses to the 
selective A1 receptor agonist CCPA (Bryan & Marshall, 1999a). At least 20 minutes 
later, after cardiovascular variables had stabilised once more, the response to acute 
systemic hypoxia was re-tested.  
 
??? 
4.2.5 Study 2 – The functional roles of adenosine A1 receptors in N and CHU  
To ensure that the effect of DPCPX in N and CHU rats was consistent with the 
findings of previous studies (Bryan & Marshall, 1999a; Coney & Marshall, 2010) the 
cardiovascular responses to acute systemic hypoxia and infusion of adenosine were 
tested in N and CHU rats before and after the adenosine A1 receptor antagonist 
DPCPX. Following a 30-minute equilibration period, the responses evoked by 
breathing 8% O2 in N2 for 5 minutes, and by infusion of adenosine (0.5mg.kg-1.min-1 
i.a.) given via the caudal ventral tail artery were tested, in a randomised order. After 
consistent responses to the stimuli were achieved, the DPCPX was given, at the 
same dose as used in study 1. After 30 minutes, the response evoked by infusion of 
adenosine and by 8%O2 were re-tested. 
 
4.2.6 Study 3 – the role of the Adenosine A2A receptors 
After a 30 minute period of equilibration control responses evoked by acute systemic 
hypoxia and by infusion of adenosine (0.5mg.kg-1.min-1 i.a.) were recorded in a 
randomised order, as in study 2. Then, as in study 1, L-NAME (10mg.kg-1 i.a.) was 
given via the caudal ventral tail artery. At least 20 minutes later, responses to 
infusion of adenosine or acute systemic hypoxia were retested. Following this, as in 
study 1, SNAP was infused at a rate sufficient to restore baseline FVC to that of 
control conditions. Once this was achieved, responses to infusion of adenosine and 
to acute systemic hypoxia were re-tested before and after the selective adenosine 
A2A receptor antagonist ZM241385 (0.05 mg kg−1, I.V. as described by Bryan & 
Marshall(1999a)) was given. Finally, both responses were re-tested at least 20 
minutes after DPCPX was given.  
??? 
 
4.2.7 Data analysis and statistics 
All data are presented as mean±SEM of N or CHU rats. MABP, HR, FBF and FVC 
are presented as mean values across the 5-minute periods of hypoxia or adenosine 
infusion. The magnitude of vasodilatation was computed offline as the integral of 
FVC during the 5 minute period immediately before the hypoxia or adenosine 
response subtracted from the integral of the FVC recorded during hypoxia or 
adenosine infusion, and is presented as ∆intFVC. Only mean baseline RF, VT and VE 
are presented, as the focus of the studies was on vascular responses evoked in the 
hindlimb. Mean RF, VT and VE presented was that recorded in the 5-minute period 
preceding the first stimuli.  
 
Statistics analysis was carried out using Aable 20/20 data vision v3.0.5 software 
(Gigawiz, Tulka, OK, USA). Comparison of blood gasses and cardiovascular 
baselines between N and CHU rats was made with Students unpaired t-test. Within 
group comparisons of blood gasses and responses evoked under different conditions 
was made using repeated measures ANOVA with Scheffés post hoc test. 
 
 
  
??? 
4.3 Results 
 
4.3.1 Study 1 - The role of NO and the adenosine A1 receptors 
Baseline ABP, FBF and FVC were similar in the N and CHU rats of group 1 (see 
Table 4.1). However, HR was significantly lower in CHU than in N, as was VT and VE. 
Arterial blood gasses (PaO2, PaCO2 and PHa) were similar between groups. (Table 
4.2).  
 
4.3.2 Responses evoked by acute systemic hypoxia 
In N rats, acute systemic hypoxia caused the expected substantial fall in PaO2, and a 
fall in PaCO2, while pHa rose as a result of the hyperventilation induced (Table 4.2). 
There was an increase in HR and an increase in intFVC indicating muscle 
vasodilatation, whilst ABP fell; FBF was maintained over the 5 minute period (Figure 
4.1, left hand panels). The pattern of response evoked by hypoxia in CHU rats was 
very similar (cf. Tables 4.1, 4.2 and Figure 4.1). The magnitude of response in all 
variables recorded was similar between N and CHU rats, as previously reported 
(Coney & Marshall, 2010). 
 
4.3.3 Effect of L-NAME 
Administration of L-NAME caused an increase in baseline ABP and a fall in HR and 
in baseline intFVC, in N and CHU rats. (cf. Figure 4.1). Under this condition, the 
increase in intFVC evoked by breathing 8%O2 was substantially decreased in both N 
and CHU rats (cf. Figure 4.1 I & J). The values of PaO2, PaCO2 and pHa were not 
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significantly affected by administration of L-NAME in either N or CHU rats (Table 
4.2).  
 
4.3.4 Effect of SNAP infusion 
As intended, the NO donor SNAP was infused at a rate sufficient to restore FVC to a 
similar level to that recorded before L-NAME (Figure 4.1 cf. E&F). However, ABP 
was significantly lower than before L-NAME in N and CHU rats (Figure 4.1 cf. A&B), 
and HR was significantly increased (Figure 4.1 cf. C&D).  
 
During infusion of SNAP in N rats, the increase in intFVC evoked by breathing 8%O2 
was restored to a magnitude similar to that seen before L-NAME. By contrast, under 
the same conditions in CHU rats, the magnitude increased in intFVC was significantly 
increased relative to that seen before L-NAME (p<0.01, cf. figure 4.1 I & J). ABP fell 
and HR was increased during hypoxia in both N and CHU rats as under the control 
condition.  
 
4.3.5 Effect of adenosine A1 receptor inhibition 
During infusion of SNAP in N rats, DPCPX significantly reduced baseline intFVC 
(Figure 4.1 cf. E&F), and significantly increased baseline ABP (Figure 4.1 cf. A) and 
HR (Figure 4.1 cf. C) relative to baselines during SNAP infusion. The magnitude of 
the increase in intFVC evoked by breathing 8%O2 was not affected by DPCPX 
(Figure 4.1 cf. I), nor was the magnitude of the fall in ABP (Figure 4.1 cf. A).  
 
??? 
By contrast, in CHU rats during SNAP infusion, there was no effect of DPCPX on 
baseline intFVC (Figure 4.1 cf. F). DPCPX significantly increased baseline ABP, HR, 
and FBF (Figure 4.1 cf. B, D and H). As in N rats, DPCPX had no significant effect on 
the magnitude of hypoxia-induced increase in intFVC (Figure 4.1 cf. J).   
 
 
4.3.6 Study 2 – The effect of DPCPX 
 
In this study, baseline ABP, FBF and FVC were similar between groups of N and 
CHU (Table 4.1). In contrast to study 1, HR was significantly higher in CHU than N 
rats (Table 4.1).  
 
In N rats, infusion of adenosine caused a significant fall in ABP (p<0.001, Figure 
4.2A) and HR (p<0.05, Figure 4.2C). Adenosine induced a significant increase in 
intFVC (p<0.05), and FBF was maintained.  Acute systemic hypoxia, induced by 
breathing 8%O2, evoked a significant fall in ABP (p<0.001, Figure 4.2A), and a rise in 
HR (n.s. Figure 4.2C). There was a significant rise in intFVC (p<0.05); FBF was 
maintained.  
 
In CHU rats, infusion of adenosine caused a comparable fall in ABP and HR, and 
increase in intFVC as in N rats (Figure 4.2H). By contrast, FBF fell significantly during 
adenosine infusion (p<0.01). Further, the increase in intFVC evoked by breathing 
8%O2 was comparable to that recorded in N rats, as was the fall in ABP and rise in 
HR (Figure 4.2 B,D & H). FBF was maintained during acute hypoxia (Figure 4.2F).  
??? 
 
DPCPX had no significant effect of baseline ABP, HR, FBF or intFVC in N rats (data 
not shown), although it did tend to result in higher HR (p=0.052). Similarly, in CHU 
rats, there was no significant effect of DPCPX on baselines, and HR was unchanged 
(p>0.5).  
 
Following DPCPX, in N rats the adenosine induced-increase in intFVC was 
significantly reduced (Figure 4.2G) and the fall in ABP was blunted (Figure 4.2A) and 
the bradycardia was reversed to a tachycardia (Figure 4.2C). The increase in intFVC 
evoked by breathing 8%O2 tended to be attenuated following DPCPX in N rats 
(Figure 4.2E, p=0.08). The fall in ABP was attenuated (Figure 4.2A), but the hypoxia-
induced tachycardia was unchanged (Figure 4.2C).  
 
In CHU rats the adenosine-induced increase in intFVC was significantly reduced 
(Figure 4.2F) and the fall in was ABP attenuated (Figure 4.2B) and HR was 
significantly increased rather than decreased (Figure 4.2D). The increased in intFVC 
evoked by breathing 8%O2 was significantly attenuated (Figure 4.2F), and the fall in 
ABP was blunted (Figure 4.2A).  
 
4.3.7 Study 3 – The effect of an adenosine A2A receptor antagonist 
Baseline ABP, HR, FBF, FVC, RF VT and VE were again similar between the N and 
CHU rats used in group 3 of this study (Table 4.1) and PaO2, PaCO2 and PH were 
also similar between groups (Table 4.2). 
 
??? 
In N rats, the pattern of response evoked by breathing 8%O2 was similar in nature 
and in magnitude to that described for study 1; ABP fell but there was an increase in 
intFVC, and increased HR (figure 4.3, left hand panels). The pattern of response 
evoked by breathing 8%O2 was comparable in the CHU rats. The increase in FVC 
evoked by hypoxia in N and CHU rats were not significantly different (Figure 4.3 cf. 
I&J)  
 
Similarly, in both N and CHU rats, under control conditions, infusion of adenosine 
evoked a fall in ABP and a small fall in HR (Figure 4.4 A-D), and an increase in 
intFVC (Figure 4.4 cf. E&F). The increases in intFVC evoked by infusion of 
adenosine were not significantly different in N and CHU rats (Figure 4.4 cf. I&J). 
 
4.3.8 The effect of L-NAME 
The effects of L-NAME were comparable to those described in study 1: In N and 
CHU groups baseline intFVC, FBF and HR were reduced, whilst ABP was increased 
(Figure 4.3 A-H). Arterial blood gasses were not significantly affected by L-NAME 
(Table 4.2).  
 
Following L-NAME, breathing 8%O2 evoked a fall in ABP (Figure 4.3A&B), and rise in 
HR (Figure 4.3C&D), but the increase in intFVC was significantly attenuated in both 
N and CHU rats (Figure 4.3 cf. I&J).  
 
Similarly, following L-NAME there was still a fall in ABP during adenosine infusion in 
N and CHU rats (Figure 4.4A&B). In contrast, adenosine infusion evoked an increase 
??? 
in HR (Figure 4.4C&D). The increase in intFVC evoked by adenosine infusion was 
abolished by L-NAME in N rats (Figure 4.4 I), and significantly attenuated in CHU 
rats (p<0.001, Figure 4.4J).  
 
4.3.9 Effect of SNAP infusion 
The effect of SNAP infusion on baselines was similar to that described in study 1. 
Baseline FVC was restored to similar level to control conditions both N and CHU rats. 
However, as is shown in Figure 4.3 E and F, the restoration of FVC to control values 
was not as satisfactory as that achieved in study 1.  PaO2 tended to be increased 
compared to before L-NAME in N rats, and was significantly increased compared to 
before L-NAME in CHU rats (Table 4.3). PaCO2 was significantly lower than before 
L-NAME in N and CHU (Table 4.3). 
 
As in study 1, in N rats of study 3, during SNAP infusion, breathing 8%O2 evoked a 
fall in ABP, and rise in HR, and the magnitude of increase in intFVC was similar to 
that seen before L-NAME (p>0.5, Figure 4.3 cf. A, C & I).  
 
Further, during SNAP infusion, the responses evoked by adenosine infusion in N rats 
was similar in nature to that of control conditions; a fall in ABP (Figure 4.4 cf. A), a fall 
in HR (figure 4.4 cf. C) and an increase in intFVC (Figure 4.4 cf. E). However, the 
adenosine-induced increase in intFVC was significantly larger than before L-NAME 
(Figure 4.4 cf. I).  
 
??? 
In CHU rats, during SNAP infusion, breathing 8%O2 again evoked a fall in ABP, rise 
in HR, whilst intFVC increased. In contrast to the results of study 1, the magnitude of 
the increase in intFVC evoked by breathing 8%O2 was similar to before L-NAME.  
 
In CHU rats, during SNAP infusion, similar results were obtained during infusion of 
adenosine to those observed in N rats; a fall in ABP, fall in HR, and a rise in intFVC 
(Figure 4.4 B, D & F). Similarly to N rats, the increase in intFVC substantially larger 
than recorded before L-NAME (p<0.01, Figure 4.4 J). 
 
4.3.10 The effect of ZM241385 
The adenosine A2A receptor antagonist ZM241385 increased baseline ABP in bothN 
and CHU rats (Figure 4.3 cf. A&B) and HR (Figure 4.3 cf. C&D). There was no 
significant effect on baseline intFVC in N or CHU rats (Figure 4.3 I&J) or on PaO2, 
PaCO2, or pH relative those seen during SNAP infusion (Table 4.3). ZM241385 had 
no effect on the hypoxia-induced increase in intFVC in either N or CHU rats (Figure 
4.3 cf. I&J). However, ZM241385 caused a significant reduction in the magnitude of 
the adenosine-induced increase in intFVC in both N and CHU rats (Figure 4.4 cf. 
I&J).  
 
4.3.11 Effect of DPCPX 
DPCPX, given after ZM241385, had no effect on baseline ABP in N or CHU rats 
(figure 4.3 A&B), caused a small increase in HR in N rats (Figure 4.3C). IntFVC was 
reduced in CHU rats only (Figure 4.3 cf. F).  
 
??? 
After DPCPX, the increase in intFVC evoked by breathing 8%O2 showed a strong 
tendency to be reduced relative to that following ZM241385 in N rats (p=0.052, 
Figure 4.3 I), and was significantly reduced in CHU rats (p<0.001, figure 4.3J). The 
hypoxia-induced fall in ABP was not significantly affected.  
 
After DPCPX, infusion of adenosine did not induce a significant increase in intFVC in 
either N or CHU rats (p>0.05, Figure 4.4 E&F), and as such the change in intFVC 
induced by adenosine was significantly reduced from that evoked after ZM241385 in 
both N and CHU rats (Figure 4.4 cf. I&J).  
??? 
Table 4.1 – Baseline cardiovascular variables in N and CHU rats used in study 1, 2 
and 3.  
G
ro
up
 
Drug 
regimen Group 
ABP 
(mmHg) 
HR 
(bpm) 
FBF 
(ml.min-1) 
FVC 
(ml.min-1 
.mmHg-1) 
RF 
(bpm) 
VT 
(ml.kg-1) 
VE 
(ml.min-1 
.kg-1) 
1 
L-NAME 
SNAP 
DPCPX 
N 
(n=12) 
139 
±3.8 
433 
±9 
1.67 
±0.1 
0.0122 
±0.0012 
102 
±2 
2.1 
±0.06 
217± 
6 
CHU 
(n=13) 
135 
±2.9 
391 
±10** 
1.60 
±0.1 
0.0119 
±0.00062 
101 
±2 
1.85 
±0.05** 
186 
±4.2** 
2 DPCPX 
N  
(n=4) 
135 
±10 
407 
±11 
1.58 
±0.16 
0.0122 
±0.0022 n/a n/a n/a 
CHU 
(n=6) 
136 
±4.1 
456 
±7* 
1.95 
±0.24 
0.0146 
±0.0022 n/a n/a n/a 
3 
L-NAME 
SNAP 
DPCPX 
ZM241385 
N 
(n=12) 
134 
±3.3 
427 
±8 
1.64 
±0.09 
0.0122 
±0.00063 
103 
±3 
1.91 
±0.1 
197 
±14 
CHU 
(n=14) 
134 
±3.8 
414 
±7 
1.53 
±0.13 
0.01145 
±0.00096 
104 
±2 
1.83 
±0.04 
191 
±6 
 
Baseline cardiovascular and respiratory  variables recorded in N and CHU rats in 
groups one, two and three. 
ABP; arterial blood pressure, HR; heart rate, FBF; femoral blood flow, FVC; femoral 
vascular conductance, RF; respiratory frequency, VT; ventilatory tidal volume, VE; 
ventilatory minute ventilation.  
*, ** - p<0.05, p<0.01 respectively CHU vs N 
 
??? 
Table 4.2 – Arterial blood gasses during normoxia and hypoxia in N and CHU rats in 
study 1 
 
Condition Group PaO2 PaO2 PaCO2 PaCO2 PHa PHa 
  Normoxia Hypoxia Normoxia Hypoxia Normoxia Hypoxia 
Control 
N 
(n=12) 
82.8 
±1.2 
33.4 
±4.5 
44.1 
±0.8 
29.6 
±1.7 
7.427 
±0.008 
7.515 
±0.016 
CHU 
(n=13) 
80.7 
±1.3 
28.4 
±1.2 
44.6 
±0.5 
28.3 
±0.7 
7.410 
±0.006 
7.524 
±0.017 
+L-NAME 
N 
(n=12) 
81.0 
±2.1 
31.7 
±0.8 
40.3 
±1.3 
28.0 
±0.6 
7.433 
±0.011 
7.434 
±0.015 
CHU 
(n=13) 
78.8 
±2.8 
27.4 
±1.0 
41.4 
±0.9 
28.5 
±1.0 
7.398 
±0.011 
7.420 
±0.013 
+SNAP 
N 
(n=12) 
96.4 
±2.6 
34.9 
±0.8 
34.1 
±1.2 
25.6 
±0.7 
7.472 
±0.008 
7.501 
±0.016 
CHU 
(n=13) 
90.1 
±5.0 
32.6 
±1.6 
34.0 
±0.8 
26.1 
±0.7 
7.446 
±0.007 
7.481 
±0.011 
+DPCPX 
N 
(n=12) 
95.6 
±1.7 
32.0 
±0.7 
33.1 
±0.9 
24.3 
±0.5 
7.50 
±0.009 
7.555 
±0.018 
CHU 
(n=13) 
96.6 
±1.6 
30.5 
±1.0 
32.1 
±0.5 
23.0 
±1.4 
7.474 
±0.005 
7.515 
±0.010 
 
 
Arterial blood gasses during normoxia (21% O2) and during the 5th minute of hypoxia 
(8%O2) in study 1, under control conditions, following L-NAME, during SNAP 
infusion, and following DPCPX.  
 
PaO2; arterial oxygen partial pressure, PaCO2; arterial carbon dioxide partial 
pressure, PHa; arterial PH.  
??? 
Table 4.3 - Arterial blood gasses during normoxia and hypoxia in N and CHU rats in 
study 3 
 
Condition Group PaO2 
mmHg 
PaO2 
mmHg 
PaCO2 
mmHg 
PaCO2 
mmHg 
PHa PHa 
Normoxia Hypoxia Normoxia Hypoxia Normoxia Hypoxia 
Control N 
(n=5) 
75.3 
±2.5 
24.8 
±1.5 
43.0 
±1.4 
25.1 
±0.79 
7.41 
±0.009 
7.561 
±0.016 
CHU 
(n=10) 
75.6 
±1.15 
25.7 
±0.9 
41.3 
±1.5 
27.6 
±1.0 
7.42 
±0.010 
7.523 
±0.013 
+L-NAME N 
(n=5) 
83.8 
±3.6 
25.2 
±1.8 
36.8 
±0.8 
24.6 
±1.1 
7.44 
±0.007 
7.51 
±0.012 
CHU 
(n=10) 
75.9 
±1.7 
25.6 
±0.8 
38.2 
±0.8 
24.4 
±0.9 
7.41 
±0.006 
7.47 
±0.017 
+SNAP N 
(n=5) 
95.2 
±3.4 
33.8 
±2.7 
30.5 
±1.2 
22.5 
±0.9 
7.48 
±0.009 
7.53 
±0.012 
CHU 
(n=10 
91.2 
±1.9 
30.3 
±1.1 
30.4 
±0.8 
21.3 
±0.6 
7.47 
±0.008 
7.49 
±0.011 
+ZM241385 N 
(n=5) 
82.5 
±2.3 
28.8 
±2.2 
32.6 
±1.1 
22.0 
±0.6 
7.46 
±0.009 
7.55 
±0.020 
CHU 
(n=9) 
86.2 
±1.7 
30.8 
±1.3 
31.3 
±0.6 
21.4 
±0.6 
7.45 
±0.007 
7.50 
±0.011 
+DPCPX N 
(n=5) 
89.7 
±1.6 
26.2 
±1.3 
29.0 
±0.7 
21.0 
±0.9 
7.50 
±0.008 
7.60 
±0.017 
CHU 
(n=9) 
89.1 
±2.3 
26.1 
±1.0 
28.5 
±0.8 
22.2 
±0.7 
7.48 
±0.009 
7.53 
±0.013 
 
Arterial blood gasses during normoxia (21% O2) and in the 5th minute of hypoxia 
(8%O2) in N and CHU rats in study 3, under control conditions, following L-NAME, 
during SNAP infusion, following ZM241385, and following DPCPX. 
 
Abbreviations as per table 4.2 
  
??? 
Figure 4.1 – Cardiovascular responses to acute systemic hypoxia in N and CHU rats 
in study group 1. 
 
Mean cardiovascular variables recorded during normoxia (21% O2, black bars) and 
acute systemic hypoxia (8% O2, open bars) in N (left hand side) and CHU (right hand 
side) rats. Values shown are mean±SEM for N (n=12) and CHU (n=14), represent 
mean values recorded over the 5-minute periods of hypoxia. ∆intFVC represents the 
increase in intFVC recorded during hypoxia from the preceding normoxic baseline. 
 
ABP; mean arterial blood pressure, HR; heart rate, intFVC; integrated femoral 
vascular conductance, FBF; femoral blood flow, ∆intFVC; change in integrated 
femoral conductance during acute systemic hypoxia.   
 
*** - p<0.001 – Between L-NAME and Control condition 
§, §§, §§§ - p<0.05, p<0.01, p<0.001 respectively between L-NAME+SNAP and 
control conditions 
††, ††† - p<0.01, p<0.001 respectively between L-NAME+SNAP+DPCPX and L-
NAME+SNAP conditions.  
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Figure 4.2 – The effect of an adenosine A1 receptor antagonist on cardiovascular 
responses evoked by adenosine or acute systemic hypoxia. 
 
Data presented as mean±SEM changes from baseline during adenosine infusion (left 
hand side of panels) and acute systemic hypoxia (Right hand side of panels) in N 
(left column of graphs) and CHU rats (right column of graphs), under control 
conditions (solid bars) and following administration of the adenosine A1 receptor 
antagonist DPCPX (patterned bars) 
 
Abbreviations as per figure 4.1 
 
*, ** - p<0.05, p<0.01 respectively between control and +DPCPX conditions 
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Figure 4.3 - Cardiovascular responses to acute systemic hypoxia in N and CHU rats 
in study group 3. 
 
Mean cardiovascular variables recorded during normoxia (21% O2, black bars) and 
acute systemic hypoxia (8% O2, open bars) in N (left hand side) and CHU (right hand 
side) rats. Values shown are mean±SEM for N (n=12) and CHU (n=14), represent 
mean values recorded over the 5-minute periods of hypoxia. ∆intFVC represents the 
increase in intFVC recorded during hypoxia from the preceding normoxic baseline. 
 
Abbreviations as per figure 4.1 
 
*** - p<0.001 between control and +L-NAME conditions 
§§§ - p<0.001 between control and +L-NAME+SNAP conditions 
††,††† - p<0.01, p<0.001 respectively between +L-NAME+SNAP and L-
NAME+SNAP+DPCPX conditions 
#, ##, ### - p<0.05, p<0.01, p<0.001 respectively between +L-NAME+SNAP and +L-
NAME+SNAP+DPCPX+ZM241385.   
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Figure 4.4 - Cardiovascular responses to adenosine infusion in N and CHU rats in 
study group 3. 
 
Mean cardiovascular variables recorded under baseline conditions (black bars) and 
during infusion of adenosine (open bars) in N (left hand side) and CHU (right hand 
side) rats. Values shown are mean±SEM for N (n=12) and CHU (n=14), and 
represent mean values recorded over the 5-minute periods of hypoxia. ∆intFVC 
represents the increase in intFVC recorded during hypoxia from the preceding 
normoxic baseline. Statistical tests on baseline values are not shown in this figure, as 
similar comparisons were displayed in Figure 4.3. 
 
Abbreviations as per Figure 4.1 
 
*** - p<0.001 between control and +L-NAME conditions 
§§, §§§ - p<0.01, p<0.001 respectively between control and +L-NAME+SNAP 
conditions 
††† - p<0.001 between +L-NAME+SNAP and L-NAME+SNAP+DPCPX conditions 
### - p<0.001 respectively between +L-NAME+SNAP and +L-
NAME+SNAP+DPCPX+ZM241385.  
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Figure 4.5 – Schematic representation of the possible mechanisms of hypoxia-
induced vasodilatation in the hindlimb following L-NAME and during SNAP infusion.  
 
It is proposed that in the presence of DPCPX, the mechanisms in the green shaded 
area have the potential to be responsible for hypoxia-induced vasodilatation, and that 
in the presence of ZM241385, the mechanisms in the area shaded red that have the 
potential to be responsible for hypoxia-induced vasodilatation. When DPCPX is given 
in the presence of ZM241385, the hypoxia-induced vasodilatation is significantly 
reduced in N and CHU rats. The pathways outlined are based on those described by 
Ray & Marshall (2006) and Edmunds et al., (2003) 
 
A1 – adenosine A1 receptor subtype, A2A; adenosine A2A receptor subtype, COX; 
cyclooxygenase, PGI2; prostacyclin, PKA; protein kinase A, KCa; Calcium-sensitive 
potassium channel, KATP; ATP-sensitive potassium channel, Ca2+; calcium ion, Gs; 
stimulatory G-protein subunit, Gi; inhibitory G-protein subunit. 
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4.4 Discussion 
4.4.1 Main findings 
In the present study, it was shown that restoring baseline FVC by infusion of the NO 
donor SNAP following NOS inhibition, resulted in a larger hypoxia-induced increase 
in intFVC in CHU rats, but not in N rats. Following NOS inhibition and during SNAP 
infusion, inhibition of the adenosine A1 receptor with DPCPX had no effect on the 
hypoxia-induced increase in intFVC in N or CHU rats, contrary to previous findings in 
N rats. Nevertheless, DPCPX, given alone, was shown to be an effective adenosine 
A1 receptor antagonist in N and CHU rats, and significantly reduced the adenosine- 
and hypoxia-induced increases in intFVC in both N and CHU rats. In a further study, 
following NOS inhibition and SNAP infusion, the adenosine A2A receptor antagonist 
ZM241385 had no significant effect on the hypoxia-induced increase in intFVC in N 
or CHU rats, but when DPCPX was subsequently given, the hypoxia-induced 
increase in intFVC was reduced in both groups. 
 
The discussion that follows considers the disparities with the findings of previous 
studies, and considers the present results in relation to the hypotheses proposed in 
the introduction. The baseline levels of respiratory and cardiovascular variables were 
comparable in CHU and N rats, except that in particular groups presented in this 
chapter, HR was in some cases different between CHU and N rats, as was VT. 
However, baseline blood gas values were comparable in N and CHU, as were the 
cardiovascular responses, and changes in blood gasses, induced by acute systemic 
hypoxia. Thus, the emphasis in the discussion that follows is on changes in femoral 
??? 
vascular conductance (∆intFVC), as this was the emphasis of the hypotheses 
proposed.  
 
4.4.2 The role of NO in Hypoxia induced hind limb vasodilatation during acute 
systemic hypoxia 
In the N rats in the present study, the effect of the NOS inhibitor L-NAME was 
consistent with previously published data (Skinner & Marshall, 1996) in that it 
reduced both baseline hind limb vascular (FVC) tone as well as reducing the 
increase in FVC evoked by acute systemic hypoxia (groups 1 and 3) and during 
adenosine infusion (group 3). Whilst preliminary evidence from a pilot study on a 
small number of rats had suggested that L-NAME had less of a blunting influence on 
the hypoxia-induced increase in FVC in CHU rats than in N rats (Rook et al., 2008a), 
the results of the present study indicate this is not the case, as L-NAME had similar 
effects on baseline FVC and hypoxia-induced increases in FVC in N and CHU rats 
(Figure 4.1). 
 
In N rats, when baseline FVC was restored with SNAP infusion after L-NAME the 
magnitude of increase in intFVC evoked by breathing 8%O2 was restored to a level 
similar to that recorded before NOS inhibition, as has previously been observed in N 
rats (Edmunds et al., 2003). In N rats it was deduced that providing the tonically-
generated level of NO was restored, this restored both the ability of hypoxia to 
release adenosine from the endothelium, and also the dilator action of adenosine 
(See General Introduction). 
??? 
In contrast, in CHU rats, restoration of baseline intFVC with the NO donor resulted in 
the increase in intFVC evoked by breathing 8%O2 being significantly greater than the 
response before NOS inhibition (Figure 4.1J). The results of Chapter 3 suggested 
that there is a tonic level of oxidative stress in CHU rats, but that the H2O2 tonically 
generated from this O2- causes an ongoing vasodilatation, and hence baseline FVC 
is similar to that of N rats. It is known that uncoupled NOS is a source of reactive 
oxygen species (Andrew & Mayer, 1999; Landmesser et al., 2003; Chen et al., 2008). 
Thus, it is possible that one of the sources of oxidative stress in CHU rats is 
uncoupled eNOS, such that it generates not only NO, but also O2-. Given that O2- 
decreases the bioavailability of NO by producing ONOO- it might be expected that in 
CHU the competition between O2 and NO for the complex IV binding site in the 
mitochondria, described by Edmunds et al., (Edmunds et al., 2003), would be less 
pronounced and less sensitive to the fall in O2 induced by hypoxia, and would lead to 
less adenosine release. With NOS inhibition followed by infusion of SNAP, the eNOS 
source of O2- would be abolished, but a tonic level NO would be provided, and as 
such the competition between NO and O2 would be increased relative to that before 
L-NAME and SNAP infusion in CHU rats. Therefore, it could be deduced that the 
release of adenosine from endothelial cells during hypoxia would be increased. The 
fact that NOS inhibition had a similar effect on baseline FVC in CHU as in N rats is 
consistent with this interpretation, for NOS inhibition would have decreased tonic 
generation of NO, and also decreased the level of the dilator H2O2 generated from 
the O2- produced by eNOS. Thus, the finding that NOS inhibition with SNAP infusion 
accentuated the hypoxia-induced increase in FVC is consistent with the results 
presented in Chapter 3, suggesting that there is ongoing oxidative stress in the 
??? 
muscle vasculature of CHU rats. The results of the present study suggest that one of 
the sources of this oxidative stress is uncoupled eNOS.  
 
4.4.3 The role of the adenosine A1 receptor subtype 
In the present study it was hypothesised that in CHU rats, when background levels of 
NO were restored after NOS blockade, the bioavailability of NO in CHU rats would be 
increased sufficiently that the release mechanism for adenosine described by 
Edmunds et al., (2003), and thought to be absent in CHU rats by Coney & Marshal 
(2010), would be restored. In this setting the role of the adenosine A1 receptor in 
mediating hypoxia-induced vasodilatation would be restored.  
 
However, in the present study, when background levels of NO were restored in the 
presence of NOS inhibition, there was no significant effect of DPCPX on the hypoxia-
induced increase in FVC in either CHU or N rats (Figure 4.1 I&J). Considering N rats: 
what might explain this disparity with previously published findings? Firstly it was 
important to confirm that the DPCPX used in the present studies effectively inhibited 
the action of the adenosine A1 receptor. The experiments performed in study 2 were 
designed to address this. The results obtained in the N rats showed that DPCPX 
markedly reduced the increase in intFVC evoked by infusion of adenosine and during 
systemic hypoxia in N rats, and indicate that DPCPX, at the dose chosen in this 
study was effective in inhibiting the adenosine A1 receptor. Notably, the same dose 
has previously been shown to abolish the response evoked by the selective 
adenosine A1 receptor specific agonist CCPA (Bryan & Marshall, 1999a). On this 
basis the possibility that DPCPX did not provide effective A1 receptor inhibition in this 
??? 
study can be discounted. Interestingly, the experiments of study 2 were also carried 
out in CHU rats, and the results obtained were remarkably similar to those found in N 
rats, in contrast to the findings of Coney & Marshall (2010). The possible 
explanations for this are discussed below.  
 
If it is true in N rats, that during NOS inhibition with SNAP infusion, the mechanism by 
which NO allows for release of adenosine from endothelial cells is restored 
(Edmunds et al., 2003), then mechanism by which adenosine evoked vasodilatation 
in the present study must be different. Adenosine can act via different pathways; A1 
receptors (Dart & Standen, 1993) via the opening of KATP channels on vascular 
smooth muscle, and via direct action on vascular smooth muscle A2A receptors, 
which evoked vasorelaxation via an increase in [cAMP]i. Thus, the fact that following 
restoration of the adenosine release mechanisms, A1 receptor blockade with DPCPX 
had no significant blunting effect on the hypoxia-induced vasodilatation suggests that 
even after the loss of A1 mediated vasodilatation, there is a sufficient degree of 
redundancy that even though A1 mediated vasodilatation is important under normal 
conditions, under these conditions the other mechanisms are capable of producing 
adequate hypoxia-induced vasodilatation. This possibility graphically represented in 
Figure 4.5, indicated by the mechanisms highlighted in green. In other words, the 
present results allow the new hypothesis, that the A2A mechanism is stronger in the N 
rats of the present study than the N rats of previous studies (Edmunds et al., 2003) 
 
Moving on to consider the CHU rats, the results obtained in study 2 showed that in 
contrast to the findings of Coney & Marshall (2010), DPCPX did significantly blunt the 
??? 
hypoxia- as well as the adenosine-induced increase in intFVC in CHU rats. The 
reasons for this disparity are unclear. Under the conditions used in this study, it is 
clear that during hypoxia, the adenosine A1 receptor plays an important role in 
vasodilatation in the rat hindlimb in N and CHU rats, and it is clear from the results of 
the adenosine infusions, that DPCPX did block the A1 receptor. The anaesthetic 
regimen was similar, although this study is carried out under Alfaxan (alfaxolone 
only) infusion, whilst Coney and Marshal (2010) used Saffan (a mixture of alfaxolone 
and alfadolone). These two anaesthetics have similar mechanisms of action. It is 
technically possible that this is the reason for the disparity, but it seems unlikely. The 
age of rats used in the two studies was similar, as were the baseline cardiovascular 
variables. Thus, the exact reasons for this disparity remain unclear. However, in the 
study of Coney & Marshall (2010) the adenosine receptor antagonist 8-SPT which is 
non-selective between A1 and A2A receptors tended to reduce the hypoxia-induced 
vasodilatation in CHU rats (see Figure 2 of their study), suggesting that there may 
have been an underlying role for adenosine receptors in hypoxia-induced hindlimb 
vasodilatation in CHU rats.  
 
4.4.4 The role of the adenosine A2A receptor 
The present finding, in CHU rats, that during SNAP infusion following NOS inhibition 
the increase in FVC evoked by breathing 8%O2 was significantly larger than in N rats 
has been discussed above. However, as in N rats, DPCPX had no blunting affect on 
the hypoxia-induced hindlimb vasodilatation. At this stage in the discussion, these 
findings cannot be interpreted any further.  
 
??? 
In light of the results obtained in study groups 1 and 2 of this study, the aim of study 
3 was to investigate whether there was a role for the adenosine A2A receptor 
following NOS inhibition and during SNAP infusion in N or CHU rats. It should be 
noted that previously the A2A receptor was shown not to have a role in hypoxia-
induced vasodilatation evoked by breathing 8%O2, although blockade of the 
adenosine A2A receptor in this setting did significantly blunt the vasodilatation evoked 
by breathing 12%O2 (Edmunds & Marshall, 2001). Adenosine can induce an A2A 
receptor-mediated vasodilatation in the rat hindlimb (Bryan & Marshall, 1999a).  
 
The protocol in used in study 3 was initially similar to that used in study 1; responses 
evoked by systemic hypoxia were recorded under control conditions, following NOS 
inhibition, and then during SNAP infusion, but in addition, responses evoked by 5 
minute infusion of adenosine were also tested at each stage, to ensure that 
adenosine receptor blockade was achieved. Following responses under the first 
three conditions, responses during A2A receptor blockade with ZM241385, and then 
finally responses following A2A and A1 receptor blockade with DPCPX were tested. 
The control responses evoked by acute systemic hypoxia and by adenosine infusion 
were similar to those described in studies 1 and 2, and similar to those previously 
described (See Coney & Marshall, 2010). However, following NOS inhibition, when 
SNAP was infused, the matching of baseline FVC to the control FVC before NOS 
inhibition was not as good as in study 1. This was because once the baselines had 
been matched, the SNAP infusion rate after NOS inhibition was not changed for the 
rest of the protocol, and FVC tended to gradually fall with time. This was probably 
because the protocol in study 3 was more than twice as long as that of study 1. 
??? 
Consequently, the baseline FVC presented for N and CHU rats, following NOS 
inhibition and during SNAP infusion tended to be lower than before NOS inhibition.  
Thus, it is not surpising that although the intFVC evoked by breathing 8%O2 was 
significantly enhanced in CHU rats following SNAP infusion in study 1, in study 3 this 
was not the case. Indeed, it may be that as a consequence of not as adequately 
restoring FVC to control levels with an NO donor, there was less bioavailable NO, 
and as such the same effect was not observed.  
  
Although the FVC baselines were not as effectively matched, the results of study 3 
do allow comments to be made on mechanisms underlying the hypoxia-induced 
muscle vasodilatation. Firstly, it should be noted that L-NAME greatly attenuated the 
vasodilatation induced by exogenous adenosine, just as it did the hypoxia-induced 
vasodilatation, i.e. both responses were, at least, NO-dependent in both N and CHU 
rats, and had potential to be NO-mediated. Then, addressing the potential role for the 
A2A receptor, following NOS inhibition and SNAP infusion, the adenosine A2A receptor 
antagonist ZM241385 was effective in reducing the restored increase in FVC evoked 
by exogenous adenosine in both N and CHU rats. It had no significant effect on the 
restored increase in FVC evoked by breathing 8%O2 in N or CHU rats. However, 
when DPCPX was given following ZM241385, the increase in FVC evoked by 
exogenous adenosine was further reduced in both groups, and there was a 
significant reduction in the increase in FVC evoked by breathing hypoxia in both 
groups. These results are consistent with the idea that, following NOS inhibition and 
during SNAP infusion, both the adenosine A1 and A2A receptors are capable of 
producing vasodilatation in skeletal muscle vasculature. This is presumably by acting 
??? 
directly on A1 or A2A receptors on vascular smooth muscle, providing that a tonic level 
of cGMP is present (the second messenger for NO, see de Wit et al., (1994)), or by 
releasing something other than NO from the endothelium.  
 
Further, it seems that the A2A receptors alone play no significant role in hypoxoa-
induced muscle vasodilatation in either N or CHU rats, given ZM241385 had no 
effect on this vasodilatation. However, the fact that DPCPX in the presence of 
ZM241385 did attenuate the hypoxia-induced vasodilatation indicated, firstly that 
infusion of NO did restore adenosine release mechanisms that operate during 
hypoxia in both N and CHU rats, and secondly, that when A2A receptors were 
blocked, the vasodilator action of adenosine on A1 receptors during hypoxia was 
revealed in both N and CHU rats. [This is illustrated in figure 4.5; during SNAP 
infusion after NOS inhibition, blockade of either the A1 or the A2A receptor mediated 
pathways reveals the contribution of the opposite pathway.] 
 
In conclusion, evidence presented in this chapter further adds to a mass of evidence 
that there is ongoing oxidative stress in the skeletal muscle vasculature of CHU rats. 
The results suggest that uncoupled eNOS may be a source of oxidative stress in 
CHU rats, as NOS inhibition with SNAP infusion appears to allow hypoxia-induced 
vasodilatation to be accentuated, and hence ameliorate the effects of oxidative 
stress.  
 
Further, the evidence presented here indicates some differences between the CHU 
rats studied in this thesis, and the CHU rats studied previously (Coney & Marshall, 
??? 
2007), particularly in relation to the role of adenosine. In the present study the role of 
adenosine in hypoxia-induced vasodilatation was similar in N and CHU rats. There 
are some disparities with previously published experimental data that have been 
discussed.   
 
 
  
??? 
  
??? 
Chapter 5 – Sympathetic control of muscle vasculature following chronic 
hypoxia in utero 
 
  
??? 
5.1 Introduction 
In humans, the association between being small for gestational age and developing 
hypertension in adult life is well established (See Huxley et al., (2000) for systematic 
review of the literature). However, the mechanisms underlying this are not well 
understood. One of the few points that is well established is that prenatal insult 
during the crucial developmental window for nephrogenesis can lead to a reduction in 
nephron number, leading to renal-induced hypertension (Ojeda et al., 2008).   
 
Importantly, there is also evidence suggesting that sympathetic nerve activity may be 
increased. Thus, IJzerman et al., (2003) showed that there was an inverse 
association between tertile of birth weight and the degree of ongoing cardiac 
sympathetic control, as measured by analysis of cardiac pre-ejection period and 
respiratory sinus arrhythmia traces in young adult humans. Moreover, direct 
recordings of en masse muscle sympathetic nerve activity from the peroneal nerve in 
young adult humans (16-17 years of age) who were born small for gestational age 
(SGA) showed that there is an inverse correlation between birth weight and MSNA. 
The MSNA burst frequency and incidence was higher in the SGA group than in a 
control group of young adults from normal sized births, and even at this young age, 
ABP tended to be higher in the SGA group than their control equivalents.  
 
Several states of cardiovascular disease are associated with alterations in the control 
of sympathetic nerve activity. For example, Goso et al., (2001) found that in patients 
with congestive heart failure there was a loss of lung inflation mediated reflex 
inhibition of sympathetic nerve activity. Further, by using the working heart-brainstem 
??? 
preparation, Simms et al., (2009) recorded ongoing activity in the preganglionic 
sympathetic nerves of the lumbar sympathetic chain of the spontaneously 
hypertensive (SHR) rat, and found that the SHR rat had augmented coupling of 
sympathetic outflow to the respiratory cycle relative to control rats, and proposed that 
this may be a cause of the underlying the hypertension.  
 
Not only sympathetic nerve activity, but also the density of sympathetic innervation 
are important in determining how blood vessels are controlled. Of note in the present 
context, a study by Rouwet et al., (2002) showed that in isolated mesenteric arteries 
taken from chick embryos made hypoxic during development (see General 
Introduction), basal vascular tone was increased, responses to α-adrenoreceptor 
antagonist phentolamine were enhanced, but sensitivity to topically applied 
noradrenaline was comparable to that of normoxic chick embryos. However, 
responses to tyramine, which releases sympathetic neurotransmitters from the nerve 
varicosities were enhanced relative to a normal embryo. They therefore concluded 
that there must be a higher density of sympathetic nerves on the surface of the 
mesenteric arteries of chronically hypoxic chick embryos, or that the nerves contain 
more noradrenaline than the normoxic embryos. This suggestion accords with 
another study carried out on the hypoxic chick embryo, which showed that just before 
hatching the femoral artery had a higher density of sympathetic innervation relative to 
that of a normoxic chick embryo (Ruijtenbeek et al., 2000). It is well known that in 
mammals the development of fully functional sympathetic innervation continues well 
after birth in mammals (Gootman et al., 1972; Gootman et al., 1978). Thus, it cannot 
be deduced what the functional consequences of this increase in sympathetic 
??? 
innervation density in a bird might be for mammals, particularly as the offspring 
develop post-natally.  
 
It has been suggested that in the spontaneously hypertensive rat (SHR), the 
increased sympathetic hyperinnervation observed in the cerebral arteries during most 
of postnatal development may be causal in the hypertension they develop (DhÌtal et 
al., 1988; Albert & Campbell, 1990; Kondo et al., 1992). On the other hand Smeda et 
al., (1990) presented evidence that this cerebral hyperinnervation may actually 
represent a mechanism of protection from stroke.  
 
Thus, even though there is indirect evidence that there is a role for the sympathetic 
nervous system in the generation of cardiovascular disease following a suboptimal in 
utero environment, there has not yet been a study to examine the effects of hypoxia 
in utero on ongoing, or reflex stimulated activity in individual postganglionic 
sympathetic neurones of any vascular bed. As indicated in the General Introduction, 
firing frequency, patterning and reflex modulation of individual sympathetic neurones 
is a major determinant of neurotransmitter release, and of the relative contribution of 
the different cotransmitters in the evoked vasoconstriction.  Recent studies 
performed on the rat have shown the relative importance of ATP, NA and NPY in 
vasoconstriction evoked by different patterns of activity in hindlimb muscle 
vasculature (Johnson et al., 2001; Coney & Marshall, 2007). Moreover, a recent 
study showed that it was possible to record sympathetic nerve activity from single 
sympathetic neurones on the surface of arterial vessels of the spinotrapezius muscle 
of the rat, and show how single unit nerve activity changes with stimulation of the 
??? 
baroreceptors and peripheral chemoreceptors (Hudson et al., 2011). No such studies 
have been yet been performed on CHU rats.  
 
Further, there has been no study of the effect of hypoxia in utero on the density of 
vascular sympathetic innervation in the adult offspring, or in fact, in any mammalian 
model at any stage of development. It is known that some of the factors that regulate 
sympathetic nerve density and function, such as NGF and VEGF also play a role in 
regulating ongoing activity (Raucher & Dryer, 1995; Lei et al., 2001; Ford et al., 
2008), and as such it was important to examine both innervation density, and nerve 
activity. In addition, the density of sympathetic innervation would be expected to 
influence the amount of the different neurotransmitters released per unit area, and to 
the vascular smooth muscle of blood vessels. Therefore, in light of this literature, the 
studies described in this chapter tested the hypothese that young adult CHU rats; 
 
1. Have higher levels of ongoing MSNA than N rats 
2. Have more high frequency couplets and triplets of activity in individual 
neurones innervating the blood vessels supplying skeletal muscle.  
These hypotheses were tested using the experimental preparation for 
recording MSNA in the vasculature of the spinotrapezius muscle, described by 
Hudson et al., (2011) 
3. Have greater sympathetic innervation density on the surface of arteries 
supplying skeletal muscle relative to N rats. 
 
??? 
In addition, the reflex increases in MSNA during baroreceptor and chemoreceptor 
stimulation were tested in N and CHU rats.   
  
??? 
5.2 Methods 
Baseline recordings of MSNA were attempted in 59 N and 40 CHU rats, and were 
successful in 27 N rats (343±22g) and 17 CHU rats (351±18g, 10 litters), giving 
success rates of 46% and 43% respectively.  
 
5.2.1 Preparation for recording of MSNA 
The regimen for induction and maintenance of anaesthesia, and the methods of 
preparation for measurement of cardiovascular variables, administration of drugs, 
and for sampling arterial blood are described in detail in chapter 2. In particular, ABP 
was recorded from the right femoral artery, whilst arterial blood was sampled from 
the left femoral artery. Drugs were administered via the left femoral artery.  
 
The surgical preparation used for recording of MSNA from the surface of blood 
vessels supplying the spinotrapezius muscle was based on the preparation decribed 
by several authors for in vivo microscopy on individual vessels of the vascular bed 
supplying the muscle (Zweifach & Metz, 1955; Gray, 1973; Marshall, 1982), with the 
modifications recently described by Hudson et al., (2011). The spinotrapezius muscle 
is a thin superficial muscle attached along the thoracic and upper lumbar vertebral 
column and inserting onto the scapula. In brief, with the rat lying prone, the overlying 
skin was removed, and the connective tissue between spinotrapezius and the 
underlying muscle was carefully dissected away by gently lifting the lateral border of 
the spinotrapezius muscle with covered forceps, and removing the underlying 
connective tissue. Several 6/0 sutures were then looped around the thin strip of 
muscle that adjoins spinotrapezius on its lateral border. The rat was then placed on 
??? 
its left side and the sutures were used to arrange the spinotrapezius muscle over a 
Perspex stage, ventral surface uppermost. Under a dissecting microscope, the 
muscle was further isolated from the underlying muscle as far medial as possible, 
without interfering with nerves, blood vessels or tendons, ensuring  that the control of 
the blood vessels remains as physiologically intact as possible, but allowing the 
majority of the muscle to be arranged in the horizontal plane. Using Superglue 
(Loctite, Henkel Ltd., Hertfordshire, UK) a template of Saran Wrap (SC Johnson, WI, 
USA) was attached to the lateral border of the spinotrapezius muscle, and used to 
form the base of a three-sided watertight bath that was constructed using dental 
impression material (President light body surface activated dental impression 
material, Coltene/Whaledent AG, Alstatten, Switzerland). This material is a soft 
mixture that was moulded to the contours of the rat’s dorsal surface to form a seal, 
such that the rat’s dorsal surface formed the fourth side of the bath (See Hudson et 
al., 2011) 
 
The layer of very fine connective fascia was then removed from the ventral surface of 
the muscle to more clearly expose the blood vessels. Throughout the preparation the 
tissue was kept moist with physiological saline (0.9% NaCl in dH2O). Once the 
muscle was cleared of all connective tissue, the constructed bath was filled with 
physiological saline for the remainder of the experiment, during which nerve 
recordings were made.  
 
5.2.2 Focal recording electrode 
 
??? 
As described by Johnson et al (1996) and Hudson et al., (2011), borosilicate capillary 
tubes (GC150T-10, ID=1.17mm, OD=1.5mm, Harvard, Holliston, MA, USA) were 
pulled on a vertical electrode puller (Ealing, UK). Electrodes were made, such as to 
have a short, very fine tip, and then the tip was gently broken back with fine forceps 
under a microscope (Zeiss ACP microscope, 10x eye piece, 32x objective with 
graticule) to a tip diameter of 50-100μm. Tips were smoothed by advancing a headed 
platinum filament towards the tip to leave a tip of 20-40µm internal diameter.  
 
It became clear that the shape of electrodes was critical to the success rate of  
recording MSNA from the preparation. Electrodes with a long tapered point produced 
a noisy recording, but often produced a high signal to noise ratio. Electrodes with a 
short ‘blunt’ tapered point, gave lower noise, lower signal to noise ratios, but higher 
success rates. The latter electrodes also gave more stable recordings. It was 
established that they had to have a sufficiently small aperture to allow spikes to be 
reliably discriminated from the background noise. Thus, the general aim was to 
produce an electrode with a small aperture and a short tapered point, to produce 
reliable, stable recordings with a sufficiently high signal to noise ratio.  
 
 
5.2.3 Recording MSNA 
 
The methodology used to record MSNA is base on that described by Hudson et al., 
(2011). In order to record MSNA, the focal recording electrode was mounted in a 
microelectrode holder (MEH2SW15, World Precision Instruments, USA). This 
??? 
allowed a fine silver electrode to be placed within the shaft of the recording pipette, 
and a tight seal to be formed around the shaft. Suction was applied via a 10ml 
syringe connected with flexible tubing to the barrel of the microelectrode holder. The 
microelectrode holder was connected to a Neurolog head-stage pre-amplifier 
(NL100AK Neurolog, Digitimer Ltd. UK), which was mounted on a micromanipulator 
which allowed for very careful positioning of the recording electrode on the surface of 
individual blood vessels. A silver reference electrode was loosely coiled around the 
shaft of the recording electrode with its tip placed in close proximity to that of the 
focal recording electrode. It was found that by keeping the recording and reference 
electrodes close together ECG-related interference was minimised. Further, all 
recordings were attempted with the confines of a custom built faraday cage, to 
minimize external electrical interference.  
 
For recording purposes, normal saline was drawn up ∼two thirds of the way up the 
barrel of the recording pipette from the organ bath constructed around the 
spinotrapezius muscle. Under the dissecting microscope, the tip of the electrode was 
gently placed onto the surface of an arterial vessel supplying the muscle, gentle 
suction being applied to aid stability of the recordings. Recordings were most 
successful from sites that were around branch points of the main feed artery that 
supplies the spinotrapezius muscle at its rostral end, and on the 2nd or 3rd branches 
of this artery.  
 
5.2.4 Data acquisition 
 
??? 
For the experiments described in this Chapter, physiological variables including 
nerve activity were recorded using a NeuroLog system (Digitimer Ltd, Hertfordshire, 
UK). ABP and tracheal pressure (TP) were recorded via pressure amplifiers (NL108, 
NeuroLog, UK), using pressure transducers (DTX Plus disposable pressure 
transducer, BD Biosciences, Oxford, UK). The head-stage pre-amplifier used for 
recording was connected to the NeuroLog system via a HumBug (Quest scientific, 
Vancouver, BC, Canada) to reduce electrical interference caused by 50/60Hz 
oscillations in mains electricity. This was in turn connected to a second pre-amplifier 
(NL104, NeuroLog, Digitimer Ltd, Hertfordshire, UK). Signals were amplified (10k 
gain), and filtered (150Hz-1kHz band pass, NL125 filter, NeuroLog, Digitimer, 
Hertfordshire, UK). Raw data was digitalised and sampled via the micro1401 
(Cambridge Electronic Design, Cambridge, UK) at 20,000Hz, connected to a 
computer running Windows XP (Apple Inc, California, USA). ABP and TP information 
was sampled at 100Hz. 
 
5.2.5 Off-line analysis 
 
HR was derived from the peaks in the ABP wave using the memory buffer function. 
Respiratory frequency (RF) was similarly derived, using the nadir of the tracheal 
pressure trace. Both were written to new channels and manually checked for correct 
triggering.  
 
5.2.6 Spike discrimination 
 
??? 
Raw multiunit recordings of MSNA were analysed using the wavemark facility with 
Spike2 software (Version 7, Cambridge Electronic Design, Cambridge, UK). Single 
unit MSNA, representative of ongoing activity in a single sympathetic neurone, was 
discriminated based on the amplitude, duration and shape. Templates were 
constructed from spikes that were triggered by the raw data recording passing below 
a set voltage. Spikes were considered to match a template when 70% of points in a 
spike matched the template. New templates were created when a minimum of 8 
spikes not already matched to a template were found to have 70% of points within 
similarity boundaries. During discrimination, the ‘auto-fix’ function was used, i.e. as 
the shape of a spike evolved with time due to slow movement of the blood vessel, or 
slow loss of suction, the shape of the template evolved to reflect this. Each ‘auto-
fixed’ template was based on the previous 64 spikes matched to that template. 
Principal component analysis was used when spikes appeared to have different 
templates but be of similar shape to test whether they represented two different units, 
or were in fact the same unit.  
 
When all templates were created and confirmed, each one was allocated a 
hexadecimal code and written to a new Wavemark channel. All single units were 
confirmed as representing MSNA by their tri- or bi-phasic shape, and by the fact they 
had cardiac- and respiratory-rhythmicity, confirmed using cross correlation histogram 
analysis from the derived HR and RF channels (See figures 5.2 & 5.4). This 
methodology is similar to that described by Hudson et al., (2011). The nerve activity 
presented in this chapter all conformed to the principles just described.  
 
??? 
5.2.7 Experimental protocol 
Recordings of MSNA were not considered for experimentation unless they were 
stable for at least 5 minutes of baseline recording. After 5 minutes of stable baseline 
recording the animal was randomly selected to receive either graded levels of 
systemic hypoxia, or baroreceptor unloading. Graded systemic hypoxia was induced, 
following a 5 minute period breathing 21%O2 in N2, by switching the inspirate to 
12%O2 in N2 for 2 minutes, then to 10%O2 in N2 for 2 minutes and finally to 8% O2 in 
N2 for 2 minutes sequentially. Baroreceptor unloading was achieved by giving a bolus 
injection of sodium nitroprusside (SNP, ≈60µg.kg-1 i.a.), to induce a fall in ABP similar 
to that seen during the final stages of graded hypoxia (8%FiO2). If the recording was 
stable after the first stimulus, at least another 10 minutes of baseline recording was 
made, whilst breathing 21%O2 before the other stimulus was attempted. Where 
successful recordings of MSNA during graded systemic hypoxia were made, hypoxic 
arterial blood was sampled for blood gas analysis immediately following the final 
minute of breathing 8%O2, before switching back to normoxic inspirate. Normoxic 
blood gas analysis was carried out on blood samples in the same rat, at least 5 
minutes following the end of the graded systemic hypoxia, whilst breathing 21%O2. 
 
5.2.8 Cardiac and respiratory cycle modulation of MSNA 
As indicated above, the presence of cardiac and respiratory rhythmicity was a 
requirement for inclusion in analysis of MSNA. Cardiac rhythmicity was assessed 
using stimulus-triggered histogram analysis. The HR trigger channel was used as a 
trigger for sweeps of 1s of discriminated, single unit MSNA. Spikes occurring in this 
1s sweep were placed in one of 100 bins according to where they occur. When 
??? 
compared to a waveform average of the ABP trace, of the same width, and triggered 
by the same trigger, an assessment of whether cardiac rhythmicity was present was 
made. Examples are presented in figure 5.2C&D and 5.4C&D. Similar analysis was 
carried out to assess the presence of respiratory rhythm, using the respiratory 
frequency channel as a trigger, and making sweeps of 3s, with 100 bins. The 
stimulus trigger histograms generated in this fashion were compared to the tracheal 
pressure waveform average. Examples of these can be found in Figure 5.2 A&B and 
5.4 A&B.  
 
In a further development of the method described by Hudson et al., (2011) it was 
considered important to assess the strength of the cardiac and respiratory 
rhythmicity; the degree of augmentation during the excitement phase, and the degree 
of silencing during the inhibition phases. The extent of cardiac and respiratory 
modulation of the ongoing sympathetic nerve activity was quantified in N and CHU 
rats by using phase histogram analysis. For analysis of the cardiac cycle phase 
relationship, the HR trigger derived from the ABP trace was used to trigger each 
cycle. Discriminated single unit activity was swept from the trigger point, and each 
spike was placed into one of 360 bins, with the end of the phase occurring at the next 
trigger. Examples of this analysis in N and CHU rats are shown in Figure 5.5 A-D. 
The equivalent analysis was carried out using the respiratory rate trigger from the 
tracheal pressure trace. Examples of this can be found in Figure 5.6 A-D. In order 
quantify, and compare cardiac and respiratory modulation of MSNA, the proportion of 
activity in each unit occurring within + or - 60° of the peak in activity, and the 
proportion falling outside these boundaries. The exact phase relationship of each unit 
??? 
varied slightly, and hence for graphical representations of mean data, the mean 
values for the phase histograms were aligned so that their peaks were all aligned, 
and then the data was averaged (see Figures 5.5 and 5.6). 
 
5.2.9 Estimation of sympathetic innervation density in skeletal muscle vasculature 
The studies of sympathetic innervation density were carried out on tibial arteries 
isolated from 10 N rats (416±9g) and 13 CHU rats (5 litters, 359±13g). Following 
cervical dislocation under isofluorane anaesthesia (3.5% isofluorane in 5L O2 BOC 
Gasses, Worsley, Manchester, UK), the deep tibial arteries, which supply the 
hindlimb skeletal muscles, were very carefully freed from the surrounding skeletal 
muscle, and excised using fine scissors, to ensure as little disruption of the artery 
structure as possible. Sympathetic noradrenergic fibres were then stained using the 
staining procedure that has previously been described by Furness & Costa (1975). In 
short, the excised vessels were immediately placed in the staining solution: 2% (w/v) 
glyoxylic acid (Sigma Aldrich, MO, USA) in 0.1M phosphate buffer, with pH adjusted 
to pH 7 with 10M NaOH. Vessels were incubated in this solution for 45 mins, before 
being placed onto glass slides and air-dried as a whole vessel preparation. The 
whole vessels were then dried onto the glass slide with the aid of a cool fan, giving a 
drying time of around 5 minutes. To develop the catecholamine fluorescence, slides 
were heated in an oven for 4 minutes at 100°C, after which they were removed, and 
covered with a small amount of mineral oil to exclude moisture from the air. A 
temporary coverslip was placed on to the slide to protect the stained vessels and 
they were kept in the dark at ≤4°C to maintain stability.   
 
??? 
5.2.10 Visualisation 
Stained vessels were viewed using an Olympus confocal microscope using a 40X oil 
immersion objective. The excitation wavelength was 395-440nm, and emission 
bandwidth 450-550nm. Owing to the three dimensional structure of blood vessels, 
the upper and lower bounds of the perivascular nerve plexus were found by manually 
adjusting the focal plain. Images were then acquired at 800x800 pixels at 1μm slice 
intervals. Typically ∼80 slices were acquired. Images were acquired from at least 3 
different areas of each vessel imaged. 
 
5.2.11 Analysis 
For analysis, all slices acquired of a single vessel were compiled into a z-stack using 
ImageSXM software and the resulting image was saved as a TIFF file (see figure 
5.12 for examples).  
 
For analysis of ‘fluorescent intensity’, many ‘non-stained’ areas on a given image 
were selected, and their mean image density and standard deviation noted. This 
represented a ‘background’ fluorescence level for each individual image. 
“Thresholding” was then used, to reveal all staining for which intensity was more than 
3 standard deviations above the mean background fluorescence. Staining of this 
intensity and above was deemed representative of catecholamine-induced 
fluorescence. The proportion of the area above the threshold was then calculated as 
a percentage of the whole vessel area.  
 
??? 
For analysis of ‘sympathetic nerve density’, a grid with horizontal and vertical lines 
spaced at 44 pixels intervals was overlayed on the image, such that each square 
represented 2000 pixels. The grid was arranged such that the vertical lines ran 
parallel to the border of the vessel. A count was then made of the number of times 
that sympathetic nerve intersected the grid lines. The outermost horizontal and 
vertical lines were not included, as they often represented many nerves overlaying 
each other, because of the wall of the vessel folding around, and as such would 
misrepresent the nerve density. This methodology for analysis was used by Omar & 
Marshall (2010).  
 
5.2.12 Statistical analysis 
 
All numerical data is given as mean±SEM. Students paired or unpaired t-test was 
used to make single comparisons of paired or unpaired data respectively, such as 
baseline comparisons or comparisons of variables before and during baroreceptor 
unloading. Where appropriate a repeated measures ANOVA was used to make 
multiple within group comparisons, such as comparing MSNA during the stages of 
graded systemic hypoxia to the baseline values. A Dunnets post hoc test was used to 
determine statistical significance. Results were considered statistically significant 
when p<0.05.  
 
  
??? 
5.3 Results 
 
5.3.1 In vivo experiments - General characteristics of the experimental group 
Recordings were attempted in 59 N and 40 CHU rats. Recordings of muscle 
sympathetic nerve activity (MSNA) were successfully made in 27 N and 17 CHU rats 
(success rate 46% and 43% respectively). ABP, HR and RF were similar between N 
and CHU rats (Table 5.1). However, in both N and CHU rats, ABP was tended to be 
lower than that reported in Chapters 3 and 4, although baseline HR and RF were 
similar. Arterial blood gasses measured in a small number of N and CHU rats are 
reported in Table 5.2. PaO2 was significantly lower in the 5 N rats from which it was 
sampled, compared to the 9 CHU rats (p<0.05), but PaCO2 and pH were similar 
(Table 5.2).  
 
Recordings were obtained in 27 N rats, 5 of which appeared to be single-unit, and 39 
multi-unit. In total, 198 single units were discriminated from the raw single and 
multiunit MSNA recordings, and the mean ongoing firing frequency was 0.33±0.03Hz 
(range 0.02-1.41Hz, Table 5.1). Examples of single units recorded from a single 
recording of MSNA are shown in Figure 5.1. By stimulus triggered histogram analysis 
of single unit activity, each unit included in the analysis contained cardiac rhythmicity, 
comprising augmented activity during the diastolic phase, and lower activity during 
the systolic phase (Figure 5.2 cf. C & D). Similar analysis using the respiratory cycle 
demonstrated that each unit contained activity that was augmented during the post-
expiratory and pre-inspiratory phase, and suppressed during the inspiratory and post-
inspiratory phases, indicating respiratory rhythmicity (See figure 5.2 A & B).  
??? 
 
In 17 CHU rats 5 single unit, and 30 multiunit recordings were made. In total, 157 
single units were discriminated from raw MSNA, and the mean ongoing firing 
frequency was 0.56±0.07Hz (range 0.02-2.41). In all single units analysed there was 
cardiac and respiratory rhythmicity, which was of a similar nature to that described 
above for N rats (Figure 5.4 A-D).  
 
The mean firing rates in N and CHU rats were not normally distributed (Shapiro-Wilks 
test) and hence non-parametric statistics were used for comparison of mean ongoing 
firing rate between N and CHU rats. The mean, ongoing firing rate in CHU rats, whilst 
breathing 21% O2 under baseline conditions, was substantially higher than that 
recorded in N rats (p=0.001, Mann-Whitney U test, Table 5.1). 
 
5.3.2 Cardiac and respiratory modulation 
All units were recorded for at least 5 minutes in order to be included in these 
analyses, and all units analysed contained cardiac and respiratory rhythmicity (See 
Figure 5.2 and 5.4). To assess the degree to which activity was augmented during 
the post-expiratory phase, and reduced during the inhibitory phase of the respiratory 
cycle, mean phase histograms were computed (Figure 5.6 E and F, see methods). 
The proportion of the spikes falling within the augmented phase (considered to be 
±60° of the respiratory cycle), and the proportion falling in the inhibited phase are 
presented in Figure 5.6 G. The strength of respiratory and of cardiac modulation in 
single unit MSNA was similar in CHU and N rats (see figure 5.6). Similar analysis of 
the strength of cardiac-related modulation of single unit MSNA was carried out (see 
??? 
Figure 5.5), and no significant difference in the strength of cardiac rhythmicity was 
found between N and CHU rats. 
 
5.3.3 Instantaneous frequencies recorded in baseline MSNA 
The interspike intervals in ongoing, discriminated single unit MSNA was analysed, 
and is presented as the proportion of all interspike intervals recorded in a single unit 
falling into bins represented by the frequencies shown in Figure 5.7. It can be seen 
that the proportion of spikes recorded in MSNA with instantaneous frequencies in the 
1-10Hz band was significantly greater in CHU rats than in N rats (Figure 5.7A). 
Further, of these spikes, there were significantly more spikes representing 
instantaneous frequencies of 1-5Hz (Figure 5.7B) in CHU rats than N rats. 
 
5.3.4 MSNA during baroreceptor unloading 
In 7 N rats, infusion of a bolus of SNP was used to cause a fall in ABP and hence to 
unload baroreceptors. The fall in ABP was accompanied by a reflex rise in HR, and 
an increase in RF (see Figure 5.8 for example and Figure 5.9 for mean data). During 
infusion of SNP, MSNA firing rate, recorded in 37 discriminated single units was 
significantly elevated relative to baseline conditions (Figure 5.9). 
 
In the 6 CHU rats in which recordings of MSNA during SNP infusion were made, 
baseline MSNA firing frequency tended to be higher than in the 7 N rats (p=0.057, 28 
discriminated single units). Infusion of SNP also caused the expected significant fall 
in ABP reflex increase in HR, and increased RF.  In contrast to N rats, in rise in 
MSNA firing rate during SNP infusion did not reach statistical significance (p=0.056). 
??? 
Considering these results in more detail, in 3 CHU rats, SNP bolus caused firing rate 
to more than double, and in 2 rats, firing rate was increased by ~50%. On the other 
hand, in N rats, in four of the seven successful recordings, firing rate was more than 
doubled, and in two cases tripled, whilst one rat showed less than a 50% increase in 
single unit MSNA.  
 
5.3.5 MSNA during graded systemic hypoxia 
 
Owing to the large number of augmented breaths that occurred during systemic 
hypoxia (see Figure 5.10), and the difficulty in completely isolating the spinotrapezius 
muscle from movement during such augmented breaths, recordings during graded 
hypoxia were difficult to achieve and were often lost soon after the onset of hypoxia.  
Isolating the muscle, and the vessels within it, from the movement associated with 
augmented breaths was particularly challenging, particularly as the frequency of 
these is markedly increased during acute hypoxia (Marshall & Metcalfe, 1988b). 
Significant pressure on the thorax was required, achieved with a rounded metal 
block, so as to stop the spinotrapezius muscle moving relative to the rest of the body. 
This was undesirable as it restricted respiratory effort, and so a balance between 
pressure and free respiratory movement was found.  
 
Some discriminated units contained both cardiac and respiratory rhythmicity, but 
showed no change at all during graded systemic hypoxia. These neurones were not 
included in the analysis as they didn’t fulfill the previously described characteristics of 
MSNA (Hudson et al., 2011) or muscle vasoconstrictor neurones (Janig, 1985; 
??? 
Habler et al., 1993, 1994).Thus, it was only possible to record MSNA reliably for the 6 
minutes of graded hypoxia in a small number of rats. 
 
In N rats, graded hypoxia caused the expected reduction in PaO2 and PaCO2, and 
caused a small increase in pHa (Table 5.2). During graded hypoxia there was a 
graded fall in ABP and rise in HR, although this did not reach statistical significance 
(see Figure 5.10 for example and Figure 5.11 for mean data). Further, RF increased 
from the onset of graded hypoxia, and waned somewhat when breathing 8%O2. 
Graded hypoxia induced a graded increase in MSNA firing rate, recorded in 27 
individual units from 6 N rats, and the change achieved statistical significance when 
breathing 8%O2.  
 
In 5 CHU rats in which recordings were stable during hypoxia, graded hypoxia also 
caused a large fall in PaO2, a fall in PaCO2 and a small rise in pHa (See Table 5.2). 
Graded hypoxia induced the expected graded fall in ABP (Figure 5.11), although 
ABP reached a significantly lower level than that recorded in the N rats during 
systemic hypoxia (p<0.001, Figure 5.11A). Graded hypoxia evoked a significant 
increase in RF and HR (Figure 5.11). Graded hypoxia induced a graded rise in MSNA 
firing rate in the 24 units analysed, which achieved significance when breathing 
8%O2. 
 
5.3.6 In vitro studies - The effect of CHU on sympathetic nervous innervation of the 
anterior tibial artery 
 
??? 
The fluorescent intensity of isolated anterior tibial arteries was markedly higher in 
CHU rats than N rats (Figure 5.12 for example, 5.13 for mean data) indicating 
increased levels of catecholamine-related fluorescence. The innervation density, i.e. 
the number of intersects per unit area on the surface of the anterior tibial artery, was 
also markedly higher in CHU rats relative to N rats (Figure 5.13B).  
  
??? 
Table 1 – Baseline characteristics of N and CHU rats used for recordings of MSNA 
 
Group MABP (mmHg) 
HR 
(bpm) 
RF  
(bpm) 
Single 
units 
analysed 
Mean 
Firing Rate 
(Hz) 
Range 
(Hz) 
N  
(n=27) 122±2  430±6 104±2 198 0.33±0.036 0.02-1.41 
CHU 
(n=17) 117±2  421±7 105±12 157 
0.56±0.075 
*** vs N 0.02-2.41 
 
General characteristics of the N and CHU rats that MSNA was recorded from. Data is 
presented as mean±SEM. ABP, HR and RF were similar between the two groups. 
Mean firing frequency was significantly higher in CHU relative to N. Range indicates 
the range of mean, ongoing frequencies recorded in discriminated single units.  
 
*** - p<0.001, Students t-test between groups. 
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Figure 5.1 – Example baseline MSNA recording in an N rat 
 
A: Example recording of baseline cardiorespiratory variables (ABP, Tracheal 
pressure, HR, RF) and ongoing multiunit MSNA in an N rat. Raw MSNA signal is 
displayed (labeled MSNA), along with discriminated spikes (all units) and rate 
histograms for individual units.  
B: Spike templates and overdrawn spikes discriminated from the raw multiunit 
recording.  
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Figure 5.2 – Analysis of cardiac and respiratory rhythm in an MSNA recording from 
an N rat 
 
A: Stimulus triggered histogram of baseline MSNA shown in figure 5.1, triggered from 
the peaks in tracheal pressure (expiration), demonstrating respiratory rhythmicity in 
multiunit activity and each discriminated unit (60 bins, 0.05s bin width) 
 
B: Wave form average of tracheal pressure triggered from peaks in tracheal pressure 
(1s width).  
 
C: Stimulus triggered histogram of baseline MSNA shown in figure 5.1, triggered from 
the peak of the arterial pressure wave, demonstrating cardiac rhythmicity in multiunit 
MSNA and each discriminated unit (100 bins, 0.01s bin width)  
 
D: Waveform average of ABP pressure wave triggered from the peak of the arterial 
pressure (1s width). 
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Figure 5.3 – Example baseline MSNA recording in a CHU rat. 
 
A: Example recording of baseline cardiorespiratory variables (ABP, Tracheal 
pressure, HR, RF) and ongoing multiunit MSNA in a CHU rat. Raw MSNA signal is 
displayed (labeled MSNA), along with discriminated spikes (all units) and rate 
histograms for individual units.  
B: Spike templates and overdrawn spikes discriminated from the raw multiunit 
recording.  
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Figure 5.4 - Analysis of cardiac and respiratory rhythm in an MSNA recording from a 
CHU rat 
 
A: Stimulus triggered histogram of baseline MSNA triggered from the peaks in 
tracheal pressure, demonstrating respiratory rhythmicity in each discriminated unit 
(60 bins, 0.05s bin width) 
 
B: Wave form average of tracheal pressure triggered from peaks in tracheal pressure 
(1s width).  
 
C: Stimulus triggered histogram of baseline MSNA shown in figure 5.3, triggered from 
the pressure wave of ABP, demonstrating cardiac rhythmicity in each discriminated 
unit (100 bins, 0.01s bin width)  
 
D: Waveform average of ABP pressure wave triggered from peaks in arterial 
pressure (1s width). 
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Figure 5.5 – Phase histogram analysis of cardiac rhythmicity in MSNA in N and CHU 
rats 
A: Phase histogram of multiunit MSNA in an N rat triggered from peak of the arterial 
pressure wave (180bins, HR trigger begins and ends cycle, 0.3s max cycle).  
 
B: Phase histogram of multiunit MSNA in a CHU rat triggered from peak of the 
arterial pressure wave (180bins, HR trigger begins and ends cycle, 0.3s max cycle).  
 
C: Waveform average of ABP pressure wave in the same N rat, triggered from the 
peak in ABP (width 0.25s).  
 
D: Waveform average of ABP pressure wave in the same CHU rat, triggered from the 
peak in ABP (width 0.25s).  
 
 
E & F: Mean phase histograms of all single units analysed in N (panel E) and CHU 
(panel F) rats, triggered by peaks in the arterial pressure wave. All histograms are 
realigned to peak at 180°, and displayed as percentage of total spikes analysed in 
each bin (360 bins per cycle). Grey area represents ±60° of the cycle peak.  
 
G: Proportion of MSNA falling within and outside ±60° of the peak of MSNA in the 
cardiac triggered phase histogram in N and CHU rats, demonstrating the strength of 
cardiac modulation in single unit MSNA from each group. 
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Figure 5.6 - Phase histogram analysis of respiratory rhythmicity in MSNA in N and 
CHU rats 
 
A: Phase histogram of multiunit MSNA in an N rat triggered from peak of the tracheal 
pressure wave (180bins, HR trigger begins and ends cycle, 0.3s max cycle).  
 
B: Phase histogram of multiunit MSNA in a CHU rat triggered from peak of the 
tracheal pressure wave (180bins, HR trigger begins and ends cycle, 0.3s max cycle).  
 
C: Waveform average of tracheal pressure wave in the same N rat, triggered from 
the peak in tracheal pressure (width 0.25s).  
 
D: Waveform average of tracheal pressure wave in the same CHU rat, triggered from 
the peak in tracheal pressure (width 0.25s).  
 
 
E & F: Mean phase histograms of all single units analysed in N (panel E) and CHU 
(panel F) rats, triggered by peaks in the tracheal pressure wave. All histograms are 
realigned to peak at 180°, and displayed as percentage of total spikes analysed in 
each bin (360 bins per cycle). Grey area represents ±60° of the cycle peak.  
 
G: Proportion of MSNA falling within and outside ±60° of the peak of MSNA in the 
respiratory triggered phase histogram in N and CHU rats, demonstrating the strength 
of respiratory modulation in single unit MSNA from each group. 
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Table 5.2 – Arterial blood gasses in N and CHU rats before, and at the end of graded 
systemic hypoxia 
 Normoxia  
(N; n=5, CHU; n=9) 
End of graded hypoxia  
(N; n=3, CHU; n=7) 
 PaO2 PaCO2 pHa PaO2 PaCO2 pHa 
N 78±2 44±2 7.42±0.08 28.6±4 29±2 7.54±0.05 
CHU 87±2* 40±2 7.42±0.01 24.4±3 23±1 7.57±0.008 
 
Baseline arterial blood gasses (PaO2, PaCO2, pH) in N and CHU rats during normoxia 
(left) and at the end of a 6 minute period of graded hypoxia. Blood gasses were 
sampled in only a small number of experiments for technical reasons. Data 
presented are mean±SEM. 
 
* - p<0.05 vs N.   
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Figure 5.7 – Analysis of the instantaneous frequencies generated by MSNA recorded 
in N and CHU rats 
 
A: Histogram showing the proportion of all action potentials recorded in each single 
unit with interspike intervals producing instantaneous frequencies of 1-10Hz, 10-
20Hz, 20-40Hz and 40-80Hz in N and CHU rats. * - p<0.05 vs N. 
 
B: Histogram showing the proportion of all action potentials recorded in each single 
unit with interspike intervals producing instantaneous frequencies of 1-5Hz and 5-
10Hz in N and CHU rats. *** - p<0.001 vs N. 
 
  
1-10Hz 10-20Hz 20-40Hz 40-80Hz
0
10
20
30
40
%
 
o
f
 
a
l
l
 
s
p
i
k
e
s
N
CHU
??
???????????
1-5Hz 5-10Hz
0
10
20
30
%
 
o
f
 
a
l
l
 
s
p
i
k
e
s
????
????
A B 
??? 
Figure 5.8 – Example recording of MSNA during bolus infusion of SNP to unload the 
arterial baroreceptors in an N rat 
 
Example recording of cardiorespiratory variables (ABP, HR, tracheal pressure), raw 
MSNA, multiunit discriminated MSNA (all units), and rate histogram (spikes/5s) for 
the multi unit MSNA in an N rat during baroreceptor unloading with a bolus of SNP 
(time marked by solid arrow).  
 
§ and arrow indicates movement artifact, causing electrical interference in the nerve 
activity recording.  
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Figure 5.9 – The effect of unloading the arterial baroreceptors on cardiovascular 
variables, including MSNA, in N and CHU rats.  
 
Mean±SEM data in N and CHU rats during baseline and during baroreceptor 
unloading with SNP 
 
A: Mean ABP during baseline and following administration of SNP in N (red lines, red 
squares) and CHU rats (blue lines, blue circles). SNP caused a significant fall in ABP 
in N and CHU rats. *** and ††† - p<0.001 from respective baselines.  
 
B: Mean MSNA firing frequency during baseline and following administration of SNP 
in N (red lines, red squares) and CHU rats (blue lines, blue circles). SNP caused a 
significant rise in firing frequency in N rats (** - p<0.01), but no significant rise in CHU 
rats.  
 
C: Mean HR during baseline and following administration of SNP in N (red lines, red 
squares) and CHU rats (blue lines, blue circles). Administration of SNP induced a 
significant rise in HR in N (* - p<0.05) and CHU rats (††† - p<0.001).  
 
D: Mean RF during baseline and following administration of SNP in N (red lines, red 
squares) and CHU rats (blue lines, blue circles). SNP induced a significant rist in RF 
in N and CHU rats (*, † - p<0.05 vs respective baselines). 
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Figure 5.10 – Example recording of MSNA during graded systemic hypoxia in an N 
rat. 
 
Example recording of cardiorespiratory variables (ABP, tracheal pressure, HR, RF), 
raw multiunit MSNA, multiunit discriminated MSNA (all units) and rate histogram for 
discriminated multiunit MSNA (spikes/5s) during baseline and 6 minutes of graded 
hypoxia (12%, 10%, 8% FiO2, 2 minutes each).  
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Figure 5.11 - The effect of graded systemic hypoxia on cardiovascular variables, 
including MSNA, in N and CHU rats. 
 
Mean±SEM data in N and CHU rats during baseline and 6 minutes of graded hypoxia 
A: Mean ABP during normoxia, and graded hypoxia in N (red lines, red squares) and 
CHU (blue lines, blue circles). * - p<0.05 vs normoxia, ***, ††† - p<0.001 vs 
normoxia.  
 
B: Mean MSNA firing frequency during normoxia, and graded hypoxia in N (red lines, 
red squares) and CHU (blue lines, blue circles). *,† - p<0.05 vs normoxia. 
 
C: Mean HR during normoxia, and graded hypoxia in N (red lines, red squares) and 
CHU (blue lines, blue circles). †, †† - p<0.05 and p<0.01 respectively vs normoxia in 
CHU. 
 
D: Mean RF during normoxia, and graded hypoxia in N (red lines, red squares) and 
CHU (blue lines, blue circles). ††† - p<0.001 vs normoxia in CHU.  
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Figure 5.12 – Example photomicrographs of glyoxylic acid staining of tibial arteries in 
an N and a CHU rat. 
 
 
A: Photomicrograph of stained preparations of a section of tibial artery from an N rat 
showing the sympathetic noradrenergic innervation on the surface of the blood 
vessel, visualized under fluorescent confocal microscopy using the glyoxilic acid 
method.  
 
B: Photomicrograph of stained preparations of a section of tibial artery from a CHU 
rat showing the sympathetic noradrenergic innervation on the surface of the blood 
vessel, visualized under fluorescent confocal microscopy using the glyoxilic acid 
method.  
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Figure 5.13 – The effect of CHU on sympathetic innervation density in the tibial artery 
 
A: Mean fluorescent density of catacholamines stained on the surface of the tibial 
artery in N and CHU rats, indication the noradrenaline content on the surface of the 
blood vessel. * - p<0.05 vs N.  
 
B: Mean innervation density of catacholaminergic neurones on the surface of the 
tibial artery in N and CHU rats, indicating the number of neurones present per unit 
area. *** - p<0.001 vs N.  
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5.4 Discussion 
 
5.4.1 Main findings 
The results presented in the present study demonstrate that in CHU rats, ongoing 
MSNA in fibres supplying spinotrapezius muscle vasculature was substantially higher 
than N rats, reflecting an increase in the single units with instantaneous firing 
frequencies between 1 and 10Hz. However, the increase in activity in single post-
ganglionic sympathetic neurones supplying skeletal muscle that was evoked by SNP 
infusion was similar in CHU and N rats, as were the increases in MSNA evoked by 
graded levels of systemic hypoxia. The density of sympathetic noradrenergic 
neurones on the surface of the tibial artery was significantly higher in CHU rats than 
N rats.  
 
5.4.2 MSNA Recordings 
Recording MSNA from the surface of the spinotrapezius arterial vessels by using the 
focal recording technique presented many technical challenges. In more than half of 
the preparations, no recordings of MSNA were achieved. It is possible that this was 
due to damage to the paravascular nerve fibres or the nerve plexus during surgical 
isolation of the muscle, or to damage more proximal at the neurovascular bundle 
supplying the muscle, even though great care was taken to avoid this. Alternatively, it 
may simply be that by chance, the recording electrode was not placed sufficiently 
close to fibres or fibre bundles with ongoing activity to detect nerve activity. The 
density of sympathetic nerves on the surface of skeletal muscle vasculature is low, 
??? 
and much lower than that found in the caudal ventral tail artery, where this 
preparation has been successfully used with a success rate >60% (Johnson & 
Gilbey, 1994, 1996).  
 
There were significant difficulties associated with electrical isolation of the recording 
setup from background noise, caused particularly by the anaesthetic infusion pump, 
the homeothermic blanket, ECG interference, and interference associated with the 
proximity of the operators’ hands. As indicated in the methods, this was minimised 
with the aid of a Faraday cage, through which all cannulae, and electrical cables 
were passed.   
 
5.4.3 Characterisation of the recorded nerve activity 
Moving on to consider the successful recordings of MSNA made using the focal 
recording electrode from the surface of arterial vessels supplying the spinotrapezius 
muscle: These were expected to be of sympathetic origin due to their location 
(Furness & Costa, 1975; Marshall, 1982). However, this expectation was verified by 
ensuring that all units included in the analysis contained cardiac and respiratory 
rhythmicity, as has been previously described for muscle vasoconstrictor (MVC) 
fibers in cats and rats (Janig, 1985; Habler et al., 1994), and for MSNA recorded 
recently from the spinotrapezius muscle (Hudson et al., 2011). In N rats the mean 
firing rate, and range of firing rates recorded were similar to those found in single 
fibres discriminated from whole nerve recordings in rats (Habler et al., 1994), and to 
those units discriminated from MSNA recordings in spinotrapezius (0.33±0.036 vs 
0.28±0.07 or 0.2±0.1, see Hudson et al., 2011). Further evidence that the nerves 
??? 
recorded from are sympathetic is that when recordings were maintained long 
enough, unloading the baroreceptors by infusing the NO donor SNP, produced a 
marked increase in nerve activity (see below). The recent study performed on the 
same experimental preparation of the spinotrapezius found that recordings of 
presumed sympathetic nerve activity, of a nature similar to that recorded in this study 
were also sensitive to the ganglionic transmission blocker trimetaphan, producing 
further evidence that they were indeed sympathetic in nature. The recordings made 
from CHU rats had similar firing characteristics (cardiac and respiratory rhythmicity 
and the activity was augmented during SNP infusion). In light of these findings, it 
seems reasonable to conclude that all discriminated units recorded in both N and 
CHU rats, that contained cardiac and respiratory rhythmicity were indeed 
sympathetic neurones. 
 
It should be noted that the sites from which the recordings were made from were 
generally on larger diameter arteries (estimated ∼300µm, see Marshall 1982). One of 
the advantages of this preparation of the spinotrapezius muscle, is that it is clear 
where the arterial vessels going. Hence, we assumed that the nerves on the surface 
of an arterial vessel were predominantly supplying that vessel and its branches. 
However, the possibility that some of the neurones recorded from were in fact 
supplying fat or connective tissue around the blood vessels cannot be excluded. .  
 
5.4.4 Comparisons of ongoing MSNA in N and CHU rats 
An important new finding of the present study was that ongoing firing frequency in 
MSNA recorded spinotrapezius muscle vasculature in CHU rats is significantly higher 
??? 
than that recorded in N rats. Further, when instantaneous frequencies of the ongoing 
MSNA were analysed it was found that the proportion of the interspike intervals 
giving rise to firing frequencies of 1-10Hz was significantly higher in CHU than N rats. 
Given that ongoing sympathetic nerve activity contributes to the ongoing vascular 
tone it can be concluded that the sympathetic nerve activity directed to the vascular 
smooth muscle is accentuated as a consequence of chronic hypoxia in utero.  
 
Considering the instantaneous frequencies in more detail, spikes in single unit MSNA 
appear stochastically, and not in a uniform manner. i.e single unit activity contains 
doublets or triplets of spikes at much higher instantaneous frequencies than the 
interval for the subsequent spike. Indeed, it is an advantage of the focal recording 
technique, that it allows analysis of the instantaneous frequencies of individual 
neurones to be calculated more easily than conventional techniques. Analysis of 
ongoing activity in both N and CHU rats revealed that the number of spikes that 
occurred with very short interspike intervals was low, as previously reported (Hudson 
et al., 2011). However, the present analyses revealed that there were more medium 
length interspike intervals, corresponding to frequencies of 1-10Hz, in CHU rats. In 
fact, the proportion of interspike intervals producing instantaneous firing frequencies 
of 1-5Hz and 5-10Hz were higher in CHU than N (∼25% vs ∼18% with instantaneous 
frequencies of 1-5Hz in N and CHU rats respectively, see Figure 5.7). This is of 
course consistent with the higher ongoing mean firing rate, and helps explain the 
finding that CHU rats had higher ongoing activity in the sympathetic neurones 
supplying the spinotrapezius muscle vasculature. It also leads to a reasonable 
??? 
expectation that the neurotransmitters released by sympathetic nerve varicosities to 
act on the vascular smooth muscle may be different in N and CHU rats.  
 
Considering the potential consequences of higher instantaneous frequencies in 
ongoing MSNA, there is evidence that ATP is particularly important in 
vasoconstriction evoked by couplets of activity (Sneddon & Burnstock, 1984; 
Sneddon & Burnstock, 1985; Kennedy et al., 1986a), and that noradrenaline 
becomes more important in vasoconstriction evoked by more sustained sympathetic 
nerve firing. Johnson et al. (2001) questioned this conclusion in their findings made in 
vivo, showing that ATP and NA were both important in the vasoconstriction evoked in 
the hindlimb muscle of the rat by stimulation of the sympathetic chain with couplets 
and trains of pulses. Coney et al., (2007) suggested that there is only a role for NPY 
in sympathetically evoked vasoconstriction during stimulation at higher frequencies 
(>20Hz).  
 
Thus, whilst ongoing activity in CHU rats is unlikely to induce release of NPY, it is 
possible that there may be increased release of both noradrenaline and ATP in CHU 
rats relative to N rats.  Other models of the consequences of hypoxia during 
pregnancy have found evidence of increased basal levels of catecholamine in the 
plasma (Gagnon et al., 1994; Simonetta et al., 1997), and thus, it will be important 
that future work considers the possible effects of increased NA and ATP release and 
its consequences for in vivo vascular regulation of skeletal muscle and other vascular 
beds.  
 
??? 
At this stage, it can be stated that even thought he present study provides evidence 
of raised MSNA and particular increases in the instantaneous frequencies achieved 
within this MSNA in CHU rats, the tonic level of FVC was comparable between N and 
CHU rats (see Chapters 3 & 4). Thiu, it seems that the influence of the raised MSNA 
may be counterbalanced by greater tonic vasodilator influences in CHU rats, for 
example the influence of H2O2, as discussed in Chapter 3. 
 
 
5.4.5 Mechanisms underling the increased ongoing firing rate in MSNA of CHU rats 
As described in the Methods and Results, average phase histograms of phase-
aligned phase histograms, triggered by the ABP and tracheal pressure traces in N 
and CHU rats, were compared to allow assessment of the extent of modulation of 
MSNA by the cardiac and respiratory cycle. Evidence in the literature shows that 
modulation of MSNA by these cycles, particularly the respiratory cycles, is altered in 
states of disease such as hypertension or congestive heart failure. For example, 
Goso et al., (2001) found that in patients with congestive heart failure there was a 
loss of lung inflation mediated reflex inhibition of sympathetic nerve activity, whilst 
Simms et al., (2009) found that the cyclic increase in lumbar sympathetic nerve 
activity during the respiratory cycle was enhanced in the spontaneously hypertensive 
rat relative to its normotensive control. Presenting data in this manner allows the 
assessment of the degree of neural silence during the expiratory phase of the 
respiratory cycle, and the ‘post-systolic’ phase of the cardiac cycle, as well as the 
periods of augmented MSNA. When such analysis were performed on the present 
??? 
data there was no apparent difference in the patterning of MSNA relative to the 
respiratory cycle, or to the cardiac cycle, between N and CHU rats.  
 
It might have been preferable to use power spectral analysis as a further assessment 
of the degrees of cardiac and respiratory modulation. However, because the 
recorded periods of baseline activity were relatively short (usually around 6-7 mins) 
the number of spikes occurring over this time was too low to create a reliable power 
spectrum. Power spectral analysis of some of the multiunit recordings which 
contained highest number of units was possible, but there were not sufficient 
numbers of these to allow for reliable conclusions.  
 
5.4.6 Response to baroreceptor unloading 
Bolus infusion of the NO donor SNP was given at a sufficient dose to simulate the fall 
in ABP induced by graded systemic hypoxia (see below), and the fall in ABP induced 
in N rats of the present study was comparable to that reported by Hudson et al., 
(2011). The SNP infusion induced a significant rise in MSNA in N rats, comparable to 
that reported recently (Hudson et al., 2011). There was also an increase in single unit 
activity recorded from CHU rats, but this did not achieve statistic significance 
(p=0.056); in 3 rats SNP infusion caused average single unit firing rate to more than 
double, but in 2 rats, firing rate was only increased by ~50%. By comparison, in N 
rats, in four of seven successful recordings, firing rate was more than doubled, and in 
three cases tripled, whilst only one rat showed less than a 50% increase in single unit 
MSNA. The absolute level of firing frequency attained during SNP infusion was not 
??? 
statistically different between N and CHU rats (p=0.18) although this is likely due to 
the small number of recordings achieved.  
 
Thus, whilst it is possible that there is a mild impairment in the reflex response to 
baroreceptor unloading in CHU rats, it is more likely that the reason the increase in 
MSNA during SNP infusion did not reach statistical significance was due to the small 
number of rats studied. Further, as baseline MSNA in CHU rats was higher, MSNA 
would have had to reach a higher level than in N rats in order to achieve statistical 
significance. Consistent with these conclusions, it was clear that the HR of the 
response to infusion of SNP was fully comparable between N and CHU suggesting 
that the activation of the cardiac sympathetic nerves, and inhibition of the cardiac 
vagal neurones, by baroreceptor unloading was fully comparable in N and CHU rats.  
 
5.4.7 Response evoked by graded systemic hypoxia 
During graded systemic hypoxia, a similar graded augmentation of MSNA was 
observed in both N and CHU rats, that became statistically significant in both groups 
when breathing 8% O2. In the present study, CHU rats showed a smaller fall in ABP, 
and a more pronounced tachycardia than the N rats, but the data reported in the 
previous chapters showed that in larger groups of animals, the falls in ABP induced 
by systemic hypoxia were similar in N and CHU rats. Thus, it is likely that is finding 
represents the natural variability seen in individual animal experiments with such a 
small group size.  
 
??? 
The fall in ABP induced by systemic hypoxia in this particular group of CHU rats 
would have been expected to lead to a smaller baroreceptor-mediated increase in 
MSNA in CHU rats. However, the fact that the increase in RF induced by hypoxia was 
greater in this particular group of CHU rats than in the N rats, it would have been 
expected to lead to a greater respiratory-dependent increase in MSNA in CHU rats, 
irrespective of any increase in MSNA that might be evoked by peripheral 
chemostimulation independently of the respiratory-dependent effects (Guyenet, 
2000). Thus, it is difficult to deduce from the present findings whether systemic 
hypoxia causes greater or smaller reflex increases in MSNA in CHU rats than in N 
rats. All that can be stated is that under the conditions of the experiments of the 
present chapter, the level of MSNA achieved in N and CHU rats whilst breathing 
8%O2 was very similar.  
 
5.4.8 Sympathetic innervation density  
There are several limitations of the glyoxylic acid staining technique which must be 
considered before interpreting the results obtained with the technique. Firstly, 
shrinking of the artery occurs when drying the artery onto the glass slide. The tibial 
artery is a relatively small artery, and as such has less smooth muscle and elastic 
tissue, and is less prone to shrinking than some of the larger caliber arteries used in 
previous studies (Furness & Costa, 1975; Omar & Marshall, 2010). Further, all 
arteries were treated equally, and so whilst the innervation density observed may not 
represent the absolute density in vivo, the data does allow comparison of the relative 
density of innervation the N and CHU rat, unless there is a subtle difference in the 
??? 
extent of shrinkage in small arteries of N and CHU rats that is not apparent from 
gross observation of size and shape.  
 
The use of a confocal microscope to image the whole vessel preparations represents 
an improvement on use of conventional light microscopes used in previous studies 
(Ruijtenbeek et al., 2000; Omar & Marshall, 2010), for confocal microscopy allows for 
much improved focus on the three dimensional structure of the whole artery. The 
ability to z-stack images based on the focal plane improves the accuracy of the 
fluorescent intensity measurement, because blurring that occurs when viewing with 
conventional microscopy on a vessel with significant thickness in the Z plane 
markedly increases the perceived intensity.  
 
A limitation of the method generally used for analysis of innervation density, the grid 
intersect method, is that when two fibers run very close to each other in a bundle, it 
can be difficult to differentiate them from a single larger fiber. Because the use of 
confocal microscopy improved resolution of individual fibers, this less of a problem. 
Nevertheless, in order to minimize the errors that might be introduced, all counts 
were made three times on separate occasions, and the mean result was used. The 
results obtained were very consistent between counts. If significant error was 
introduced by mistaking two closely apposed fibres for a single fibre, it would have 
been likely affect the results recorded in CHU more than N rats, simply because 
there were more fibres present on the surface of the CHU arteries. Thus, it is unlikely 
that this limitation represents a large source of error, and any error was likely to have 
resulted in underestimation of the difference between N and CHU. 
??? 
 
This study marks the first time that the sympathetic innervation of arterial vessels has 
been investigated in adult mammals following hypoxia in utero. The results clearly 
show, by two separate methods of analysis, that there is a substantially greater 
sympathetic innervation density on the surface of the tibial artery, which supplies hind 
limb skeletal muscle, in CHU rats than N rats. Previous studies have provided 
evidence for increased innervation density in the femoral artery of the hypoxic chick 
embryo at hatching (Ruijtenbeek et al., 2000), but now it is clear that whatever 
hyperinnervation may be present at birth  in CHU rats persists into adulthood in 
mammals. The only other study that can be compared to the present on is a study of 
the postnatal effect of reduced nutrient delivery on sympathetic nerve density by 
Sanders et al., (2004). They found that femoral, saphenous and mesenteric arteries 
from young rat offspring (at 21 days old) from mothers subjected to uterine artery 
ligation showed no difference in sympathetic innervation density. However, little detail 
on their method of analysis is provided, nor are there any sample images. Thus, it is 
very difficult to make comparisons between the present data and the data presented 
in their study.  
 
In light of the fact that the ongoing firing rate in the individual sympathetic neurone 
supplying skeletal muscle was enhanced in CHU rats, it seems likely that the 
vascular smooth muscle of skeletal muscle arteries from CHU rats is exposed to 
chronically higher levels of sympathetic neurotransmitter. Further, it is reasonable to 
propose that when MSNA is increased by reflex stimulation, this would result in 
increased release of sympathetic cotransmitters onto the vascular smooth muscle of 
??? 
CHU rats. Thus, studies of vascular sensitivity to sympathetic nerve activity in 
skeletal muscle vascular beds are required to ascertain the exact consequences of 
this for basal vascular tone. At this point, it is important to note that at the age 
studied, the CHU rats were not hypertensive relative to N rats, and baseline FVC was 
similar. This, it would appear that compensatory mechanisms may be present in CHU 
rats. Thus, vascular responses measured in the femoral artery to stimulation of the 
lumbar sympathetic chain are investigated in N and CHU rats in chapter 6. 
  
??? 
  
??? 
Chapter 6 – Responses evoked by sympathetic nerve stimulation 
following chronic hypoxia in utero 
 
  
??? 
6.1 Introduction 
In Chapter 5, evidence was presented that levels of ongoing activity in the 
sympathetic nerves innervating skeletal muscle vasculature are higher in young adult 
CHU rats than in N rats, but this does not lead to hypertension at this age. There has 
been little attempt to examine the manner in which the vascular response to 
sympathetic nerve activity may be affected by hypoxic insult during fetal life.  
 
In a study comparing newborn lambs born of high altitude sheep who underwent 
gestation at high altitude (3600m) with those born of normal sheep at sea level, 
Herrera et al., (2007) found that isolated small femoral arteries of the high-altitude 
lambs showed augmented vascular reactivity to noradrenaline and phenylephrine, 
relative to sea level lambs. Further, during systemic hypoxaemia (10% FiO2, 60 
mins), there was an augmented increase in femoral vascular resistance in the high 
altitude lambs relative to the sea level lambs, suggesting that the increase in 
vasoconstrictor tone during systemic hypoxia is higher in the high altitude newborns 
than in sea level newborns. What is not known is whether these indices of increased 
vasoconstrictor responsiveness persist into adult life, and hence have long term 
consequences. Further, it is not clear whether the differences seen were the result of 
the 50+ generations the high altitude sheep have spent at high altitude, or of the 
particular conditions the lambs experienced during pregnancy.  
 
Further, in a study of juvenile and adult rats that had been subjected to reduced 
uterine perfusion for the latter stage of pregnancy, Anderson et al., (2006) found that 
responses in isolated mesenteric arteries to the α-adrenoreceptor agonist were 
??? 
augmented in the direct male and female offspring, and the next generation of 
offspring relative to responses in arteries from control rats. Thus, this study also 
raises the possibility that low O2 levels in utero may increase arterial responsiveness 
to adrenoreceptor stimulation.   
 
It is known that in control rats, stimulation of the lumbar sympathetic chain with 
doublets at 20Hz or with a train of impulses at 20Hz results in vasoconstriction in the 
hindlimb, in vivo (Johnson et al., 2001). They found that noradrenaline was the major 
neurotransmitter mediating this vasoconstriction, as the α-adrenoreceptor antagonist 
phentolamine markedly reduced the magnitude of vasoconstriction evoked by each 
type of stimulation by ∼80%. Suramin, the purinergic P2 receptor antagonist had a 
smaller effect in reducing responses by ∼40%. Thus, the authors concluded that it is 
likely that ATP plays a facilitatory role, rather than being the main neurotransmitter as 
has been suggested from in vitro studies of isolated vessels (Kennedy et al., 1986a; 
Sjoiblom-Widfeldt et al., 1990). In a later study performed on rats, Coney et al., 
(2007) tested hindlimb vasoconstrictor responses to stimulation of the lumbar 
sympathetic chain with 120 pulses in three different patterns; a constant train of 
pulses at 2Hz, 6 trains of 20 pulses at 20Hz, and 6 trains of 20 pulses at 40Hz, each 
given over 60 seconds. They found that the neuropeptide Y (NPY) Y1 receptor 
antagonist BIBP-3226 did not affect the vasoconstriction to constant stimulation at 
2Hz or burst stimulation at 20Hz, but significantly reduced the response to stimulation 
at 40Hz,indicating that in the hind limb of the control (N) rat, the sympathetic 
cotransmitter NPY only becomes important during high frequency nerve activity, as 
was previously suggested by Pernow et al., (1989).  
??? 
 
The studies of Chapter 5 have already described how there are more short interspike 
intervals in the MSNA recorded from CHU than N rats under baseline conditions, 
representing firing frequencies of 1-10Hz, and that MSNA was increased in both N 
and CHU rats by baroreceptor unloading and by graded systemic hypoxia. Thus, in 
light of the fact that baseline FVC recorded in anaesthetised CHU rats was similar to 
that recorded in N rats in the experiments of Chapters 3 and 4, but ongoing MSNA, 
and the sympathetic innervation density on the surface of an artery supplying skeletal 
muscle is higher in CHU rats, the present study sought to examine whether there are 
functional alterations in the response evoked by sympathetic nerve activation in CHU 
rats. 
 
Hypotheses 
1. Stimulation of the lumbar sympathetic chain causes larger hindlimb 
vasoconstrictor responses in CHU rats relative to N. 
2. As there are higher levels of high frequency doublets in the MSNA in CHU rats 
even under baseline conditions, the NPY mediated component of 
sympathetically mediated vasoconstriction in the hind limb is greater in CHU 
rats than N rats. 
 
  
??? 
6.2 Methods 
Experiments were performed on 12 N rats (343±9g, 71±2 days old) and 11 CHU rats 
(351±10g, 4 litters, 70±3 days). The anaesthetic regimen, and the basic surgical 
preparation used in the present study is that described in Chapter 2. Thus, 
cannulation of the left brachial artery was carried out for recording ABP, and the 
caudal ventral tail artery was cannulated for infusion of the NPY Y1 receptor subtype 
specific antagonist BIBP-3226. Femoral blood flow (FBF) was recorded from the right 
femoral artery in the manner described in Chapter 2. 
 
6.2.1 Lumbar sympathetic chain stimulation 
The surgical preparation used in the present study has been described previously 
(Johnson et al., 2001; Coney & Marshall, 2003). With the rat lying supine, a midline 
incision was made through the skin and abdominal muscle, for approximately two 
thirds of the length of the abdomen, beginning immediately superior to the penis. The 
incision was parted using metal retractors, and the majority of the small and large 
intestine was exteriorised and wrapped in gauze that was soaked in warm 
physiological saline to prevent drying. Using blunt ended, fine glass rods, the right 
sympathetic chain, running parallel to the abdominal portion of the vena cava at the 
level of the right renal vein, was isolated by very gentle blunt dissection. When a 2-
3mm portion was freed from connective tissue, two stimulating electrodes, 
constructed from 0.125mm fine sliver wire (Advent Research Metals, Oxford, UK) 
passed through PP10 polythene tubing (Scientific Laboratory Supplies, Wilford, 
Nottingham, UK) were looped under the sympathetic chain. Once passed around the 
sympathetic chain, the electrodes were carefully looped back, to encircle the 
??? 
sympathetic chain, and then secured in position using Kwic-Sil silicone elastomer 
compound (World Precision Instruments, Hitchin, Hertfordshire, UK). Electrodes were 
connected to a constant current stimulating unit (DS2A, Digitimer, Hertfordshire, UK). 
That the sympathetic chain could be successfully stimulated in this way was initially 
confirmed by the presence of testicular retraction upon stimulation with a single 
electrical pulse (1ms, 1mA). When this had been confirmed, the intestines were 
carefully placed back within the abdominal cavity, and the incision covered in saran 
wrap to ensure the area remained moist, but was not closed.  
 
6.2.2 Protocol 
The stimulation parameters used in the present study to stimulate the sympathetic 
chain have previously been published (Coney & Marshall, 2003). Thus, 3 different 
protocols of stimulation were used; a 60 second constant train of 120 pulses at 2Hz, 
6 bursts of 20 pulses at 20Hz at 10 second intervals, and 6 bursts of 20 pulses at 
40Hz, at 10 second intervals. Thus, each 60 second period of stimulation contained 
120 pulses. All pulses were 1ms in duration and given at 1mA, and were controlled 
using the ‘stimulator’ function in LabChart (ADInstruments, Oxford, UK) using the 
stimulator output on the PowerLab 4/20 (ADInstruments, Oxford, UK) that was also 
used for recording of cardiovascular variables. Each stimulation protocol was carried 
out twice, giving 6 stimulations in total, in a randomised order. At least 5 minutes of 
stable cardiovascular variables were recorded prior to each period of stimulation. 
Following control stimulations, infusion of the NPY Y1 subtype specific neuropeptide 
Y receptor antagonist BIBP-3226 (Tocris Biosciences, Bristol, UK) was commenced, 
at a dose of 10mg.kg-1.min-1 (Bischoff et al., 1997; Malmström et al., 1997). After 30 
??? 
minutes of infusion, the same three stimulation protocols were repeated twice each, 
again in a randomised order, during continued infusion of BIBP-3226.  
 
6.2.3 Data analysis and statistics 
All data is presented as mean±SEM. HR was computed from ABP as described in 
Chapter 2, and femoral vascular resistance (FVR) was calculated by dividing MABP 
by MFBF. FVC was also calculated as described in Chapter 3, but was not used in 
the quantative analysis. Data was extracted from raw recordings using the Data Pad 
function of the LabChart software (ADInstruments, Oxford, UK). The femoral vascular 
response to lumbar sympathetic chain stimulation are presented in two ways; first the 
change in the integral of FVR during the 60 second stimulation, relative to the 60 
seconds prior to stimulation (∆intFVR). Second, as the max∆FVC; For trains of 
stimulation at 2Hz, max∆FVR indicates the maximum change in FVR achieved during 
the 60 seconds of constant stimulation, relative to the mean FVR of the 60 seconds 
immediately preceding stimulation. Often, responses to constant stimulation at 2Hz 
were biphasic in nature, with an initial increase in FVR, which tended back towards 
baseline values towards the end of the period of stimulation. For bursts of stimulation 
at 20Hz and 40Hz, max∆FVR indicates the mean of the peaks in FVR achieved by 
each burst of pulses, relative to the mean FVR of the 60 seconds immediately 
preceding the first burst of pulses (see Figures 6.2 & 6.3 for example of these peaks). 
The maximum fall in mean FBF (MFBF) is calculated and presented in the same 
manner. The mean maximum increase in MFBF above baseline between bursts of 
stimulations at 20 or 40Hz is also calculated in a similar fashion, and termed ‘max 
hyperaemia’. The maximum increase in MFBF relative to baseline during the 60s 
??? 
period of stimulation at 2Hz is also calculated, and often indicated the biphasic 
response observed in many responses to stimulation with a constant train of pulses 
at 2Hz.  
 
Statistical analyses were carried out using Aable 20/20 Data Vision v3.0.5 software 
(Gigawiz, Tulka, OK, USA). Comparison of mean individual baseline variables was 
made by using the Students unpaired t-test. Comparison of responses between 
groups, and before and during administration of BIBP-3226 was made by using a 
mixed model ANOVA with Scheffés post hoc analysis. P<0.05 was considered 
statistically significant. Comparisons of baseline cardiovascular variables recorded in 
the present experiments with those recorded in the other groups of animals 
described in this thesis were made using a factorial ANOVA with Sheffés post hoc 
analysis. 
  
??? 
6.3 Results 
6.3.1 Comparison of cardiovascular baselines in N and CHU rats 
Baseline ABP, HR, FBF and FVR were not significantly different between N and CHU 
rats (Table 6.1). When baseline ABP was compared to the baseline ABP recorded in 
the groups of rats reported in Chapters 3 and 4, there were no significant differences 
between any of the groups of N rats used although MABP tended to be lower in the 
present study than in the N rats reported in Chapters 3 and 4. When making the 
same comparisons in CHU rats, baseline ABP was found to be significantly lower the 
rats of the present experiment than in the CHU rats of Chapter 3 (p<0.01), but not 
significantly different from the baseline ABP reported in the CHU rats of Chapter 4.  
 
6.3.2 Comparison of vasoconstrictor responses to lumbar sympathetic chain 
stimulation in N and CHU rats 
 
In N rats, continuous stimulation at 2Hz tended to cause an increase in intFVR 
(p=0.065, see Figures 6.1 and 6.4A), which caused a significant reduction in MFBF 
(p<0.01). Bursts of pulses at 20Hz and 40Hz caused significant increases in IntFVR 
(p<0.001, P<0.001, see Figures 6.2, 6.3 and 6.4A), which caused significant 
decreases in MFBF (p<0.001, p<0.001, Figure 6.4D).  
 
The responses evoked by sympathetic chain stimulation in CHU rats were 
qualitatively similar to those recorded in N rats. Continuous stimulation at 2Hz 
caused no significant change in IntFVR or MFBF, but pulses at 20Hz and 40Hz 
caused significant increases in IntFVR (p<0.001, p=0.003 respectively, see Figure 
??? 
6.4A), which caused significant reductions in MFBF (p<0.001, p<0.001, see Figure 
6.4D). 
 
Considering the magnitude of the responses evoked by continuous stimulation at 
2Hz, or burst stimulation at 20Hz and 40Hz, the maximum rise in FVR from baseline 
values during stimulation was significantly blunted in CHU rats during stimulation 
using 2Hz and 20Hz trains of pulses), and tended to be reduced when using 40Hz 
trains (see Figure 6.4B). There were no significant differences in the falls in MFBF 
evoked by sympathetic chain stimulation in N or CHU rats (Figure 6.4D).  
 
6.3.3 The effect of BIBP-3226 on vasoconstrictor responses to lumbar sympathetic 
chain stimulation.  
In one N rat win which a test was made, the hypertensive response evoked by the 
NPY receptor agonist leu-pro-NPY (128μg.kg-1 bolus i.a.) was markedly reduced by 
BIBP-3226 (Pre-BIBP:+28mmHg, during BIBP-3226: 15mmHg). It is therefore 
reasonable to assume that the NPY Y1 receptors were effectively antagonized, by ∼ 
50%, given that the dose of NPY raises plasma concentrations well above those 
previously recorded in human plasma (Pernow et al., 1987). Further, in a previous 
study, the regimen used for the dose of BIBP-3226 in the present study was shown 
to be an effective in inhibiting the NPY Y1 receptor (Coney & Marshall, 2007).  
 
In N rats, BIBP-3226 significantly blunted the increase in IntFVR to 2Hz and 20Hz 
trains of stimulation, and tended to do so when using 40Hz trains of stimulation 
(p=0.14, see Figure 6.5). However, maximum increases in FVR were not reduced by 
??? 
BIBP-3226 during any stimulation protocol. Further, the fall in MFBF was not 
significantly altered by BIBP-3226 (see Figure 6.5B-D).  
 
By contrast, in CHU rats, there was no blunting effect of BIBP-3226 on the increase 
in IntFVR by any pattern of stimulation, whichever index is used to describe the 
response (Figure 6.5 A&B). Further there was also no reduction in the maximum fall 
in MFBF (Figure 6.5D).  
??? 
Figure 6.1 – Original recording of cardiovascular variables during sympathetic chain 
stimulation with constant pulses at 2Hz. 
 
Original recording made in and N rat during stimulation of the sympathetic chain with 
a constant train of 120 pulses at 2Hz. Arterial blood pressure (ABP), femoral blood 
flow (FBF), electrical stimulus, mean femoral vascular conductance (FVC), mean 
femoral vascular resistance (FVR), mean arterial blood pressure (MABP), mean 
femoral blood flow (MFBF) and heart rate (HR) are shown. 
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Figure 6.2 - Original recording of cardiovascular variables during sympathetic chain 
stimulation with bursts of pulses at 20Hz 
 
Original recording made in and N rat during stimulation with bursts of 20 pulses at 
20Hz. Abbreviations as per Figure 6.1.  
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Figure 6.3 - Original recording of cardiovascular variables during sympathetic chain 
stimulation with bursts of pulses at 40Hz 
 
Original recording made in and N rat during stimulation with bursts of 20 pulses at 
40Hz. Abbreviations as per Figure 6.1.  
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Table 6.1 – Cardiovascular baselines in N and CHU rats used in experiments 
presented in the present study 
Group MABP (mmHg) 
HR  
(BPM) 
MFBF 
(ml.min-1) 
FVR 
(mmHg.ml-
1.min-1) 
N (n=12) 127±3 452±16 2.28±0.13 58±4 
CHU  
(N=4, n=11) 122±3 441±11 2.57±0.18 51±4 
N+BIBP 131±3 461±15 2.28±0.13 58±3 
CHU+BIBP 127±4 448±10 2.57±0.18 54±5 
 
Mean baseline cardiovascular variables recorded in N and CHU rats under control 
conditions, and during infusion of BIBP-3226 (+BIBP). MABP; mean arterial blood 
pressure, HR; heart rat, MFBF; mean femoral blood flow, FVC; femoral vascular 
resistance  
??? 
Figure 6.4 – Mean changes in cardiovascular variables evoked by stimulation of the 
sympathetic chain in N and CHU rats. 
 
All data is presented as mean±SEM. * - P<0.05 vs N, p=0.09 – CHU vs N 
 
A: Change from baseline in integrated femoral vascular resistance (∆intFVR) during 
the stimulation of the lumbar sympathetic chain with trains of pulses at 2, 20 and 
40Hz in N (filled columns) and CHU (open columns) rats.  
 
B: Maximum change from baseline in femoral vascular resistance (∆FVR) during the 
stimulation of the lumbar sympathetic chain with trains of pulses at 2, 20 and 40Hz in 
N (filled columns) and CHU (open columns) rats.  
 
C: Maximum rise in MFBF between trains of stimulation of the lumbar sympathetic 
chain with trains of pulses at 2, 20 and 40Hz in N (filled columns) and CHU (open 
columns) rats.  
 
D: Maximum fall from baseline in MFBF during stimulation of the lumbar sympathetic 
chain with trains of pulses at 2, 20 and 40Hz in N (filled columns) and CHU (open 
columns) rats.  
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Figure 6.5 – effect of an NPY Y1 receptor antagonist on mean changes in 
cardiovascular variables evoked by stimulation of the sympathetic chain in N and 
CHU rats. 
 
All data is presented as mean±SEM. * - P<0.05 vs control conditions, p=0.14 N vs 
N+BIBP-3226 
 
A: Change from baseline in integrated femoral vascular resistance (∆intFVR) during 
the stimulation of the lumbar sympathetic chain with trains of pulses at 2, 20 and 
40Hz in N (filled columns) and CHU (open columns) rats before (solid) and during 
(patterned) BIBP-3226 infusion. 
B: Maximum change from baseline in femoral vascular resistance (∆FVR) during the 
stimulation of the lumbar sympathetic chain with trains of pulses at 2, 20 and 40Hz in 
N (filled columns) and CHU (open columns) rats before (solid) and during (patterned) 
BIBP-3226 infusion.  
C: Maximum rise in MFBF between trains of stimulation of the lumbar sympathetic 
chain with trains of pulses at 2, 20 and 40Hz in N (filled columns) and CHU (open 
columns) rats before (solid) and during (patterned) BIBP-3226 infusion.  
D: Maximum fall from baseline in MFBF during stimulation of the lumbar sympathetic 
chain with trains of pulses at 2, 20 and 40Hz in N (filled columns) and CHU (open 
columns) rats before (solid) and during (patterned) BIBP-3226 infusion. 
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6.4 Discussion 
6.4.1 Main Findings 
This is the first study to examine the relationship between chronic hypoxia in utero 
and the coupling of sympathetic nerve activity to the vascular smooth muscle of 
blood vessels supplying the hindlimb vasculature. The results indicated maximum 
vasoconstriction during stimulation of the lumbar sympathetic chain was reduced in 
CHU rats relative to N rats during constant stimulation at 2Hz, or burst stimulation at 
20Hz, and tended to be reduced during burst stimulation at 40Hz. Further, the NPY 
Y1 antagonist BIBP-3226 reduced the increase in intFVR during stimulation with 
constant stimulation at 2Hz and burst stimulation at 20Hz trains in N rats, and tended 
to reduce the increase in intFVC during burst stimulation at 40Hz. However, the 
responses evoked by these patterns of stimulation in CHU rats were not altered by 
BIBP-3226.  
 
6.4.2 Comparison of the present N rats with those of previous studies 
The protocol used in the present study was based on that used by Coney & Marshall 
(2007) on N rats, thus it is important to compare the baselines in the two studies. 
Two groups of N rats were used by Coney & Marshall, one for testing the effects of 
inhibition of α2-adrenoreceptors, and the second for testing the effects of NPY Y1 
receptor inhibition. In the first group, MABP was markedly lower than that of the 
present study (106±5 vs 127±3mmHg), whilst FBF and HR was lower (1.26±0.08 vs 
2.28±0.13ml.min-1 and 419±19 vs 452±16bpm) and FVR was higher (86±6 vs 58±4 
mmHg.ml-1.min-1). However, in the second group, MABP was similar to that of the 
??? 
present study, as was FBF and HR, although FVR was slightly higher (69±10 vs 
58±4). Although arterial blood gasses were not recorded in the present study, the 
blood gasses reported by Coney & Marshall were similar to those reported in other 
Chapters of this thesis. 
 
It is difficult to make direct comparisons between the control responses to 
sympathetic chain stimulation presented by Coney & Marshall (2007) and those 
reported in the present study, as the units used to present intFVR are different. 
However, consistent with Coney and Marshall (2007), the present study showed that 
the largest increase in intFVR was obtained during stimulation with bursts of 40Hz, 
and the smallest increase with constant stimulation at 2Hz.  In other words, as 
described previously (Coney & Marshall, 2003), the same number of pulses delivered 
in bursts was more effective in producing vasoconstriction that stimulation at constant 
frequency.  
 
In the study of Coney & Marshall (2007), there was no effect of BIBP-3226 on the 
baselines of the cardiovascular variables measured, and the same finding was made 
in the present study. In particular, there was no effect of BIBP-3226 on baseline FVR 
in either study. Thus there is no reason to suppose that NPY acting on Y1 receptors 
contributes to basal vascular tone in rats (for further discussion see below). However, 
while Coney & Marshall (2007) found that BIBP-3226 had no significant effect on the 
increase in intFVR evoked by constant stimulation at 2Hz or burst stimulation at 20Hz 
(although there was a tendency for it to be reduced), it was found to significantly 
reduce the increase in intFVR during burst stimulation at 40Hz. Thus, they concluded 
??? 
that the cotransmitter NPY becomes important particularly during high frequency 
bursts of sympathetic nerve activity. In contrast, the present study found that BIBP-
3226 significantly reduced the increase in intFVR evoked by constant stimulation at 
2Hz and burst stimulation at 20Hz, and tended to reduce it during bursts of 
stimulation at 40Hz (p=0.14). Consistent with this, the study of Pernow et al., (1989) 
found that NPY was released continuous stimulation at 2Hz, and burst stimulation at 
2 and 6.9Hz, into the venous efflux of the dog gracillis muscle. It is not clear why the 
results of the present study differ from those of Coney & Marshall (2007) but the 
results of the present study appear to indicate that stimulation with constant low 
frequencies, as well as with bursts at high frequencies lead to significant release and 
vasoconstrictor activity of NPY in skeletal muscle vasculature of N rats.  
 
6.4.3 NPY in basal vascular tone 
Some degree of controversy exists over the role of NPY in control of basal vascular 
tone. Studies from the Shoemaker laboratory showed that in pentobarbital 
anaesthetised Sprague Dawley rats, a bolus of 100μg.kg-1 BIBP-3226 caused a 
significant rise in femoral vascular conductance, indicating a tonic vasoconstrictor 
influence of NPY Y1 receptors (Jackson et al., 2004). It is important to note however, 
that in that study, blood flow is very low compared with studies performed in this 
laboratory (Coney & Marshall, 2007), and much lower than studies of hindlimb blood 
flow in conscious animals (Amaral et al., 2000). Hodges et al., (2009) in a later study 
from the same laboratory put this disparity down to the sympathoactivation 
associated with pentobarbital anaesthetic (Hodges et al., 2009). Both the present 
study study, and previous studies (Pernow et al., 1987; Pernow et al., 1989; Coney & 
??? 
Marshall, 2007) have found that there is no role for NPY in basal vascular tone in 
rats. However, the results of Jackson et al., (2004), when taken with the assumption 
that the rats were in a state of sympathetic activation, provide further evidence that in 
conditions of sympathetic hyperactivity, NPY may become important in the setting of 
high vascular tone.  
 
 
6.4.4 Responses evoked by sympathetic chain stimulation in CHU rats 
The CHU rats, like the N rats, showed much larger vasoconstrictor responses to 
simulation of the sympathetic chain with bursts of pulses at 20Hz and 40Hz than with 
the same number of pulses delivered at a constant frequency of 2Hz. Thus, the 
muscle vasculature of CHU rats is similarly more sensitive to bursts of sympathetic 
stimulation. However, the CHU rats showed significantly smaller maximum 
vasoconstrictor responses to stimulation of the lumbar sympathetic chain with 
continuous pulses at 2Hz and bursts of pulses at 20Hz, and tended to show reduced 
maximal responses to burst stimulation at 40Hz. This is particularly interesting, given 
the data presented in Chapter 5 which shows that there is a higher density of 
sympathetic noradrenergic nerves and therefore more catecholamine on the surface 
of arteries supplying skeletal muscle in CHU rats. Given that the increases in MSNA 
evoked by baroreceptor unloading were as large in CHU rats as in N rats, it seems 
that these changes may be accompanied by a compensatory reduction in the 
sensitivity of the skeletal muscle vasculature to sympathetic activity at rest and during 
activation. This allows for baseline vascular tone in skeletal muscle to remain normal. 
??? 
This finding is also consistent with the fact that at 10-12 weeks of age, CHU rats 
have similar blood pressure to N rats.  
 
Considering previous studies, the late-stage hypoxic chick embryo, it was found that 
there was sympathetic hyperinnervation of the femoral artery, as the present study 
showed in 10 week old CHU rats (Chapter 5) but there was no alteration in the 
sensitivity to exogenously applied sympathetic agonists in isolated mesenteric 
arteries from the hypoxic chick embryo (Ruijtenbeek et al., 2000; Rouwet et al., 
2002). Published studies on mammals have not examined sympathetic innervation 
density in any model of insult during pregnancy but the responsiveness to 
sympathomimetic agonists was tested in isolated resistance arteries of adult rats 
subjected to placental insufficiency in utero and in lambs of high-altitude ewes. They 
both found that sensitivity to such sympathetic agonists was augmented (Anderson et 
al., 2006; Herrera et al., 2007). All of these studies failed to address the physiological 
role of sympathetic vasoconstriction, as they were carried out on large caliber 
arteries which are not necessarily representative of the whole vascular bed they 
supply. Further, they only examined the effects of catecholaminergic agonists, even 
though it is well known that sympathetic control of the vasculature involves complex 
interactions and feedback between a compliment of at least 3 neurotransmitters; 
noradrenaline, ATP and neuropeptide Y (see General Introduction). Further, these in 
vitro experiments were done in the absence of any ongoing vasodilator tone 
produced by NO generated by shear stress (see General Introduction), and they 
were performed in conditions relatively hyperoxic compared to the in vivo situation. 
This is important because local oxygen tension is known to be an important 
??? 
modulator of the actions of sympathetic neurotransmitters (Heistad & Wheeler, 1970; 
Coney & Marshall, 2007). This is an advance on these studies in being the first 
examination of the impact of chronic hypoxia in utero on responses evoked by 
sympathetic chain stimulation in skeletal muscle vasculature in offspring in vivo.  
 
Turning to effect of the NPY Y1 receptors antagonist BIBP-3226, in contrast to the 
effects seen in N rats, this antagonist had no effect on responses evoked by any 
pattern of sympathetic stimulation in CHU rats. Thus, not only are the vasoconstrictor 
responses to sympathetic stimulation blunted in CHU rats, but the role of the potent 
vasoconstrictor NPY is also impaired. This is a novel finding. Clearly, it would be 
interesting in future studies to test whether NPY is present in sympathetic nerve 
fibres of CHU rats, and whether it can be released by any mode of sympathetic 
stimulation, and to test whether the vascular smooth muscle of CHU rats is sensitive 
to NPY.  
 
6.4.5 The use of lumbar sympathetic chain 
Obviously, stimulation of the lumbar sympathetic chain activates sympathetic nerves 
innervating the tail, sacral regions as well as the hind limbs.  Thus, it activates all, or 
at least a large proportion of the fibres contained in the sympathetic chain in an en 
masse fashion, with no particular specificity for fibers supplying any individual 
vascular bed or tissue.  
 
By contrast, ongoing sympathetic nerve activity does not activate all fibers at the 
same time; rather it is a stochastic, although highly organised, pattern of firing. 
??? 
Further to this, it is uncommon for individual neurones to show bursts of activity at 
higher firing frequencies, as they tend to fire in doublets or triplets at most, within the 
cardiac and respiratory patterning that is present (Macefield & Wallin, 1999; Murai et 
al., 2006; Hudson et al., 2011). However, preliminary experiments performed in the 
present study, it was found that attempting to model this by using doublets at higher 
frequencies (20, 40 and 60Hz) as recorded in Chapter 5, was not viable  for the 
purposes of the present protocol because the vasoconstrictor response produced fell 
within the range of normal fluctuations in FVR. Such fluctuations in FVR are 
particularly evident in Figures 6.2 and 6.3. Thus, in order to produce responses that 
were consistent and outside the range of normal fluctuations, 20 pulses given at 20 
or 40Hz, 6 times over 60 seconds were used, as was described in previous studies 
(Johnson et al., 2001; Coney & Marshall, 2007).  
 
Stimulation of the lumbar sympathetic chain using constant pulses at 2Hz, and with 
bursts of pulses at 20Hz and 40Hz was chosen as they represented average 
frequencies, and instantaneous frequencies in the range recorded in single units in 
the present study and others (Macefield & Wallin, 1999; Hudson et al., 2011). 
Stimulation with the same total number of impulses over a 60 seconds period for all 
stimulation patterns meant that the mean responses over these time period were 
comparable, and allowed demonstration of the importance of patterning and not just 
of mean firing rate in MSNA. It should be noted that the majority of studies on the 
vascular responses evoked by sympathetic stimulation, impulses are generally 
delivered at constant frequencies ranging from 1-20Hz, thus ignoring the irregular, 
rhythmic activity that is present in MSNA under physiological conditions.  
??? 
 
Thus, on balance, whilst stimulation of the lumbar sympathetic chain in the manner 
presented in this study is unphysiological in stimulating many fibres simultaneously, 
and the number of pulses delivered per unit time, it is an appropriate method for 
examining in vivo vascular responsiveness to sympathetic nerve activity. Further, 
given that an important part of the hypotheses tested involves the different 
sympathetic co-transmitters, and notably the role of NPY, other methods discussed 
earlier such as field stimulation applied to larger arterial vessel in vitro, or application 
of agonists to isolated vessels were not appropriate.  
 
6.4.6 BIBP-3226 as an NPY Y1 receptor antagonist 
As mentioned in the Results, BIBP-3226, used as an infusion at 10μg.min-1.kg-1 has 
been demonstrated to cause potent selective inhibition of the neuropeptide Y Y1 
receptor (Bischoff et al., 1997), and has been shown to significantly attenuate the 
hypertensive response to exogenous infusion of the NPY receptor agonist leu-pro-
NPY (Coney & Marshall, 2007). This was checked, and confirmed, in a control rat in 
this study. Thus, it is reasonable to assume that it was effective as an NPY Y1 
receptor antagonist in the present experiments on N rats, and given that the regimen 
was similar, there is no reason to suggest this was not also true of the experiments in 
CHU rats.  
 
It is important to note that, whilst BIBP-3226 has classically been understood to be a 
specific NPY Y1 receptor antagonist, recent work has shown that it also inhibits the 
neuropeptide FF (NPFF) receptors (Mollereau et al., 2002; Fang et al., 2006). 
??? 
Indeed, it has been used as a putative NPFF receptor antagonist in preparations of 
mouse colon (Fang et al., 2005). Given that the role for NPFF in the vasculature, 
particularly in the skeletal muscle vasculature, is not well characterised, it is not 
possible to rule out inhibition of this receptor as a confounder for these results. 
Future studies describing the role of NPFF in vascular regulation will see this concern 
addressed, but as such, at present, little further comment can be made.  
 
In conclusion, by using lumbar sympathetic chain stimulation the experiments of the 
present study examined the functional consequences of chronic hypoxia in utero for 
sympathetic vasoconstriction in the hind limb. The findings indicate a reduction in 
vasoconstrictor responses to sympathetic stimulation with impulses at constant low 
frequency and with bursts of high frequency in CHU rats relative to N rats. Further, 
BIBP-3226 has no effect on the magnitude of vasoconstriction in CHU rats, whereas 
it reduced it in N rats, suggesting a blunted role for NPY in mediating 
vasoconstriction evoked by sympathetic stimulation in CHU rats. 
 
As suggested above, future experiments should seek to examine whether the loss of 
the NPY component of vasoconstriction is due to failure of release of NPY, a change 
in receptor density, or a failure of synthesis of NPY. The results of the studies 
described so far in this thesis suggest that in the face of increased ongoing MSNA, 
increased innervation density, and a reduced sensitivity to increases in MSNA, 
ongoing femoral vascular resistance (and therefore also conductance) is maintained 
at a basal level similar to that of N rats. Further, studies so far were performed on 10-
12 week old N and CHU rats. The question arises as to whether basal levels of FVR, 
??? 
vascular responses to sympathetic stimulation, or the role of NPY change during 
aging. Thus, in Chapter 7 the responses evoked by sympathetic chain stimulation 
were tested in 36 week old CHU and N rats.  
 
 
 
 
 
 
 
  
??? 
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Chapter 7 – Cardiovascular aging following chronic hypoxia in utero 
  
??? 
 
7.1 Introduction 
The offspring born of women who were pregnant during the Dutch famine of 1944 
suffer from angina pectoris on average 3 years earlier than those born in the same 
area of Holland, but of pregnancies during times of plenty (Painter et al., 2006). 
Further, preeclampsia is associated with higher childhood blood pressure (Geelhoed 
et al., 2010). Indeed, preeclampsia, and the consequences of this for the offspring as 
they age, leave them with permanent systemic and pulmonary vascular dysfunction 
(Jayet et al., 2010). The exact mechanisms leading to this are unclear.  
 
It is also known that in humans, with age, the role of the sympathetic nervous system 
in controlling basal vascular tone and in responses to cardiovascular stressors can 
become perturbed, and the risk of cardiovascular disease increases (Lakatta, 2002; 
Seals & Dinenno, 2004). Seals & Dinenno (2004) reported that in aging humans, 
there is chronic sympathetic overactivity, which leads to reduced baroreflex buffering 
capability, conduit artery hypertrophy, and reduced systemic α-adrenergic sensitivity 
This study has shown that such overactivity exists in the MSNA of young CHU 
offspring (Chapter 5).  
 
Furthermore, Wilson et al., (2004) found that following inhibition of presynaptic 
release of noradrenaline with bretylium, sensitivity of cutaneous blood flow to 
intradermal microdialysis of exogenous noradrenaline was reduced in aged subjects. 
Moreover, Dinenno et al., (2002) found that the decrease in forearm vascular 
conductance elicited by intravascular tyramine, to release endogenous stores of 
??? 
noradrenaline, was blunted in aged subjects, and that is was due to reduced 
sensitivity of the α1, not α2 adrenoreceptor subtype. There are many other studies of 
aged human subjects confirming that vascular sensitivity to noradrenaline, 
exogenous and endogenously released, is blunted in aged subjects (Richardson et 
al., 1992; Davy et al., 1998; Frank et al., 2000; Jones et al., 2001).  
 
The rate-limiting step in catecholamine synthesis is tyrosine hydroxylation by the 
enzyme tyrosine hydroxylase (TH), which requires tetrahydrobiopterin (BH4) as an 
essential cofactor (Zigmond et al., 1989; Kumer & Vrana, 1996). Thus, in aged 
individuals loss of BH4, by its interaction with superoxide may be a mechanism by 
which sympathetic vasoconstriction becomes impaired (Moens & Kass, 2007). 
Indeed, administration of BH4 in older subjects can ameliorate the difference in 
sympathetic vasoconstriction between young and old subjects in the cutaneous 
circulation (Eskurza et al., 2005; Lang et al., 2009).  
 
In Chapters 3 and 4, evidence is presented supporting the hypothesis that there is a 
chronically high level of oxidative stress in CHU rats. One possible source of 
oxidative stress in those studies is superoxide anions produced by uncoupled eNOS, 
the uncoupling of which is known to be caused by reductions in the bioavailability of 
its cofactor BH4. Further, its uncoupling may impact upon BH4 availability through 
generation of superoxide anions, which oxidize BH4. It is therefore possible this same 
oxidative stress may also have consequences for the synthesis and hence release of 
catacholamines from the sympathetic nerve varicosities in CHU rats.  
??? 
Chapter 6 detailed how maximum vasoconstrictor responses to lumbar sympathetic 
chain stimulation were blunted in CHU rats. It seems reasonable to anticipate that 
this may be further exacerbated in aged CHU rats.   
 
As in skeletal muscle, along with ATP and NA, NPY, has been demonstrated to be 
important in control of cutaneous vasculature (Stephens et al., 2004), and it has been 
demonstrated that in aging subjects, the role of NPY in cutaneous vasoconstriction 
can be lost (Thompson & Kenney, 2004). The evidence presented in Chapter 6 of the 
present study suggested that NPY is released during stimulation of the sympathetic 
chain with pulses at 2, 20 and 40Hz in young N rats, but that there is a reduced role 
for NPY in CHU rats.  
 
This raises the question as to whether the role of NPY in sympathetic 
vasoconstriction is increased in rat skeletal muscle vasculature in older CHU rats, 
given the possibility that the role for noradrenaline may be blunted, and the 
expectation that hypertension develops with age in CHU rats.   
 
It was therefore hypothesised that: 
1. As a consequence of the ongoing high levels of sympathetic nerve activity 
found in young CHU rats, older CHU rats will be hypertensive relative to older 
N rats at the same age. 
2. Sensitivity to sympathetic nerve activity is reduced in aged CHU rats, either 
due to decreased vascular sensitivity, or because of reduced catecholamine 
release due to oxidative stress 
??? 
3. On the basis that the role of NA in sympathetic vasoconstriction in older CHU 
rats may be decreased, NPY may make a larger contribution as a sympathetic 
cotransmitters in aged CHU rats than aged N rats.  
4. Given the evidence of oxidative stress presented in Chapters 3 and 4, this 
study sought to assess vascular oxidative stress in skeletal muscle small 
arteries to determine if there is direct evidence of formation of peroxynitirite.  
 
Further to the above, a recent study, Hauton and Ousley (2009) found that there was 
a higher proportion of adipose tissue in the 10-12 week old CHU rat relative to the N 
rat, but that many of the other organ masses were similar to N rats. The exception 
was that the adrenal glands were significantly smaller in N rats than in CHU rats. It is 
known that growth restricted newborn rats develop metabolic syndrome and obesity 
(Mcmillen & Robinson, 2005), which is known to be a risk factor for cardiovascular 
disease (Franks et al., 2010). Therefore body mass and the proportional contribution 
of major tissues to total body mass, including adipose tissue, was measured in older 
N and CHU rats.  
 
  
??? 
7.2 Methods 
7.2.1 Generation of aged N and CHU Rats 
These experiments were carried out on 12 older CHU rats (age 264±7 days, 
320±30g, 6 litters) and 13 older N rats (age 252±2 days, 666±24g). The older N rats 
were born and raised under standard laboratory conditions at Charles River 
Laboratories, Margate, UK), fed the VRF1 pelleted diet (4.75% crude oil, 19.11% 
crude protein, 3.85% crude fibre, SDS Diets, Lillico Biotechnology, Horley, UK) with 
water ad libitum. They were transported to The Biomedical Services Unit (BMSU), 
University of Birmingham 4 weeks prior to the acute experiment. During these four 
weeks, the 12 N rats were fed the slightly different RM1 pelleted diet (2.71% crude 
oil, 14.38% crude protein, 4.65% crude fibre, SDS Diets, Lillico Biotechnology, 
Horley, UK). One N rat died during the aging period whilst at Charles River 
laboratories.  
 
12 male CHU offspring, bred as described in Chapter 2, from 6 litters (2 from each) 
that were housed in the BMSU, University of Birmingham, under standard laboratory 
conditions and fed the RM1 diet (SDS Diets, Lillico Biotechnology, Horley, UK) and 
water ad libitum. These animals were housed as littermate pairs from weaning 
onwards. None of the CHU rats died during the aging period.  
 
7.2.2 Animal preparation 
The animals were anaesthetised as described in Chapter 2, and the surgical 
preparation was the same as that presented in Chapter 6, for electrical stimulation of 
??? 
the lumbar sympathetic chain. Interestingly, the infusion rate of Alfaxan that was 
required to maintain surgical anaesthesia in older N and CHU rats was approximately 
half that of their young counterparts, rates of 0.5-0.8ml.hr-1 being required. In addition 
to the cardiovascular variables measured in Chapter 6, arterial blood was sampled 
from the left brachial artery under baseline conditions for blood gas analysis, in the 
same way described for analysis of normoxic blood gasses described in Chapter 3. 
Unfortunately, due to technical problems with the blood gas analyser, arterial blood 
gas analysis was only possible in 5 of the 12 older CHU rats described in this 
Chapter. 
 
ABP and FBF were recorded in the same way decribed in Chapter 6, and the 
calculations of HR and FVR were also the same. Similarly to Chapter 6, the 
sympathetic chain was stimulated with 3 patterns of impulses, each containing 120 
pulses in total; continuous stimulation at 2Hz for 60 seconds, and 6 bursts of 20 
pulses at 20 or 40Hz, separated over 60 seconds. Each protocol was repeated twice, 
in a randomized order, before and during infusion of the NPY Y1 receptor antagonist 
BIBP-3226, as described in Chapter 6. 
  
Comparison between responses in young N and CHU and older N and CHU rats 
were made using a factorial ANOVA, with Scheffés post hoc analysis with p<0.05 
considered statistically significant. Comparisons of responses recorded before and 
during infusion of BIBP-3226 were made using a repeated-measures ANOVA with  
Scheffés post hoc analysis.  
 
??? 
7.2.3 In vitro analysis of oxidative stress in skeletal muscle vasculature 
The method used for assessing the degree of oxidative stress in the small arteries 
supplying skeletal muscle in N-A and CHU-A rats were the same as that described in 
Chapter 3. Briefly, the proximal portion of the tibialis anterior muscle was removed 
from the older N and CHU rats at the end of the in vivo experiment (see above), 
mounted and frozen in liquid N2. 10µm cross sectional sections were stained with 
antibodies to show 3NT and αSMA and viewed under fluorescent microscopy. The 
method of analysis is the same as that described in Chapter 3. Staining was carried 
out simultaneously in all sections from all four groups analysed (young adult and 
older adult N and CHU rats), and as such are directly comparable  
 
7.2.4 Body composition 
At the end of each in vivo experiment, major body tissues were weighed. In the dead 
rat the mass of one TA muscle, the liver, one kidney, the spleen, bilateral adrenal 
gland, bilateral epididymal fat and perirenal fat were removed and weighed.  
??? 
7.3 Results 
7.3 1 General characteristics of the rats used 
Total body weight was similar between the older N and CHU rats. The weight of the 
tissues detailed in Table 7.3 were not significantly different between groups, whether 
analysed as absolute weight (Table 7.3), or as proportion of total body mass (data 
not shown).  
 
7.3.2 Baseline cardiovascular characteristics 
Under baseline conditions, ABP was significantly higher in older CHU rats than older 
N rats (p<0.01, Table 7.1). However, baseline HR, FBF and FVR were similar 
between the two groups (Table 7.1). The baseline values of PaO2, PaCO2 and pHa, 
which were sampled after the series of control stimulations of the sympathetic chain, 
but before administration of BIBP-3226, were also not different between groups 
(Table 7.2).  
 
7.3.3 The effect of lumbar sympathetic chain stimulation in older N and CHU rats 
Stimulation of the lumbar sympathetic chain had no significant effect on ABP or HR in 
older N or CHU rats when using 2Hz, 20Hz or 40Hz trains of pulses (data not 
shown). In neither group did stimulation of the sympathetic chain at a constant 
frequency of 2Hz have a significant effect on intFVR over the duration of the 
stimulation (figure 7.1A), and there was no change in MFBF. However, FVR did 
transiently rise by a similar amount before falling back to baseline levels in both older 
N and CHU rats (Figure 7.1B). 
??? 
 
Stimulation of the lumbar sympathetic chain using bursts of impulses at 20Hz tended 
to cause a rise in intFVR in older N (p=0.08) and older CHU rats (p=0.11, figure 
7.1A), whilst stimulation of the sympathetic chain with bursts of impulses at 40Hz 
caused a significant rise in intFVR in older N (p<0.01) and older CHU rats (p<0.05). 
There were no significant differences between the responses evoked by sympathetic 
chain stimulation in older N and CHU rats by any pattern of stimulation. 
 
7.3.4 Effect of BIBP-3226 on cardiovascular baselines 
The effect of BIBP-3226 on the baseline ABP, HR, FBF and FVR is displayed in 
Table 7.1. There was no significant change in any of the baselines compared to 
control baselines.  
 
7.3.5 Effect of BIBP-3226 on responses to lumbar sympathetic chain stimulation 
Following administration of BIBP-3226 there was still no significant increase in 
intFVR during constant stimulation at 2Hz in older N or CHU rats (Figure 7.2A). 
There was a small transient increase in FVR (fig 7.2B), but this was not different to 
that of control conditions in either group, and the same was true of the mean 
maximum fall in MFBF (Figure 7.3D).  
 
BIBP-3226 had no significant effect on the responses evoked by stimulation of the 
sympathetic chain in older N or CHU rats, except that the maximum increase in FVC 
evoked by stimulation of the sympathetic chain with bursts of impulses at 20Hz in 
older CHU rats was significantly higher during infusion of BIBP-3226.  
??? 
 
 
7.3.6 Comparison of responses to lumbar sympathetic chain stimulation in young and 
middle aged N and CHU rats 
Comparisons were made between the older N and CHU rats presented in this 
chapter and the results from young adult N and CHU rats presented in Chapter 6. 
Baseline ABP was similar between N and N-A rats, but baseline ABP was 
significantly higher in CHU-A rats than CHU rats (p<0.01). Baseline FVR was similar 
between N and N-A rats, and between CHU and CHU-A rats, as was baseline FBF 
and baseline HR. There was no effect of age the increase in intFVR evoked by 
stimulation of the sympathetic chain with impulses at a constant 2Hz or with bursts of 
impulses at 20 or 40Hz in. Similarly, the mean maximum increase in FVR evoked by 
sympathetic chain stimulation with any of the described patterns of stimulation was 
not changed with increasing age. However, comparison of the data obtained in young 
adult and older N and CHU rats (cf Figures 6.4 and 7.1) indicates that the responses 
evoked in the older N and CHU rats had much greater variance than in young adult N 
and CHU rats. Thus, larger group sizes would have been required to discriminate any 
difference.    
 
7.3.7 Vascular oxidative stress in the skeletal muscle small arteries of middle aged N 
and CHU rats 
Representative photomicrographs of arterial vessels within the TA muscle of older N 
and CHU rats are found in Figure 7.3. Thus, Figure 7.3 A-D shows staining in a 
section from an older N rat with DAPI, SMA and 3-NT staining, whilst Figure 7.3D 
??? 
shows a merged image, where yellow staining represents colocalisation of SMA and 
3NT staining. Figure 7.3 E-H represent the equivalent photomicrographs in an older 
CHU rat. 
 
The level of 3-nitrotyrosine immunoreactivity in identified areas of αSMA 
immunoreactivity was similar between older N and older CHU rats (Fig. 7.4B), and 
was similar to the levels observed in young N and CHU rats (7.4A, same graph as 
Figure 3.8). 
 
??? 
Table 7.1 – Baseline cardiovascular variables in 36 week old N and CHU rats before 
and during infusion of the NPY Y1 receptor antagonist BIBP-3226. 
 
Group 
 ABP 
(mmHg) 
HR 
(bpm) 
FBF 
(ml.min-1) 
FVR  
(mmHg.ml-1.min-1) 
Older N 
Control 126±3 430±5 2.3±0.2 65±7 
+BIBP 123±3 397±10 1.9±0.1 61±4 
Older 
CHU 
Control 139±3** 432±12 2.5±0.2 59±4 
+BIBP 126±3 396±13 2.0±0.2 60±5 
 
Baseline cardiovascular variables in older N and older CHU rats before (control) and 
during infusion of the NPY Y1 receptor antagonist BIBP-3226 (+BIBP). Mean±SEM 
data under control conditions, and during infusion of BIBP-3226. 
 
** - p<0.01 – difference between group baselines 
  
??? 
Table 7.2 – Arterial blood gasses measured in older N and CHU rats under baseline 
conditions. 
 
Group PaO2 PaCO2 pHa 
Older N 
(n=12) 85.6±1.8 37.1±0.7 7.48±0.006 
Older CHU 
(n=5) 84.8±1.9 34.8±1.9 7.46±0.008 
 
 
 
PaO2, PaCO2 and pH in older N and CHU rats sampled after control stimulations of 
the sympathetic chain, but before infusion of BIBP-3226, whilst breathing room air. 
There are no significant differences in PaO2, PaCO2 or pHa between groups.  
  
??? 
Table 7.3 – Body mass characteristics in older N and CHU rats 
 
Older N Older CHU 
Age (days) 257±2 264±7 
Total Body mass (g) 666±24 651±30 
Tibialis Anterior (mg) 1014±32 983±30 
Liver (g) 19±0.6 18±0.9 
Kidney (g) 1.85±0.08 1.67±0.06 
Spleen (g) 1.36±0.07 1.44±0.09 
Adrenal gland (mg) 65.0±3.8 66.7±6.7 
Epididymal Fat (g) 17.5±1.1 17.7±1.3 
Perirenal Fat (g) 21.6±3.0 23.4±3.5 
 
 
 
Mean±SEM data for body composition characteristics in 36 week old N and CHU rats 
Total Body mass, mass of one tibialis anterior skeletal muscle, liver, one kidney, 
spleen, bilateral adrenal glands, bilateral epididymal adipose tissue, bilateral 
perirenal adipose tissue. There were no significant differences in the weight of any 
tissue measured between groups. 
 
  
??? 
Figure 7.1 – Mean changes in cardiovascular variables evoked by stimulation of the 
sympathetic chain in older N and CHU rats. 
 
Mean±SEM data for the cardiovascular responses evoked by lumbar sympathetic 
chain stimulation in older N (Closed bars) and oler CHU rats (open bars), using 
patterns of stimulation at 2Hz, 20Hz and 40Hz frequencies.   
 
A: ∆intFVR during lumbar sympathetic chain stimulation in N and CHU rats 
B: Mean Maximum ∆FVR during lumbar sympathetic chain stimulation in N and CHU 
rats. Each ∆FVR represents a significant increase from baseline.  
C: Maximum rise in FBF from baseline during the lumbar sympathetic chain 
stimulation protocols in N and CHU rats 
D: Maximum fall in MFBF during the lumbar sympathetic chain stimulation protocols 
in N and CHU rats 
 
 
There were no significant differences between the responses seen in N-A and CHU-
A rats.  
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Figure 7.2 – Effect of an NPY Y1 receptor antagonist on mean changes in 
cardiovascular variables evoked by stimulation of the sympathetic chain in N and 
CHU rats. 
 
 
Mean±SEM data for the cardiovascular responses evoked by lumbar sympathetic 
chain stimulation in older N (Closed bars) and older CHU rats (open bars), using 
patterns of stimulation at 2Hz, 20Hz and 40Hz frequencies, before and during 
(patterned bars) infusion of the NPY Y1 receptor antagonist BIBP-3226 
 
A: ∆intFVR during lumbar sympathetic chain stimulation in N and CHU rats before 
and after infusion of BIBP-3226. 
B: Maximum ∆FVR during lumbar sympathetic chain stimulation in N and CHU rats 
before and after infusion of BIBP-3226. 
C: Maximum rise in FBF from baseline during the lumbar sympathetic chain 
stimulation protocols in N and CHU rats before and after infusion of BIBP-3226. 
D: Maximum fall in MFBF during the lumbar sympathetic chain stimulation protocols 
in N and CHU rats before and after infusion of BIBP-3226. 
 
† - p<0.05 vs control stimulation 
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Figure 7.3 – Examples of 3-Nitrotyrosine staining in the vascular smooth muscle of 
small arteries of the tibialis anterior muscle in older N and CHU rats. 
 
Representative dual α-SMA and 3-NT staining of arterial vessels within transverse 
sections of the TA from 36 week old N and CHU rats 
 
A & E: DAPI staining in N and CHU rats respectively 
B & F: α-SMA staining in N and CHU rats respectively 
C & G: 3-NT staining in N and CHU rats respectively 
D & H: Merge of all three staining images. Yellow denotes combined α-SMA and 3-
NT staining, indicating vascular interaction with peroxynitrite.  
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Figure 7.4 – Mean 3-Nitrotyrosine staining the small arteries of young and older N 
and CHU rats 
 
Fluorescent intensity in selected ‘regions of interest’ (See section 3.3, arbitrary units, 
mean±SEM) of 3-NT staining in young adult and older N and CHU rats, indicative of 
the level of peroxynitrite present in the vessels wall of arterial vessels of TA muscle. 
Fluorescent intensity is similar in N and CHU rats. There was no significant difference 
in fluorescent intensity measured in older N and CHU rats, or between young and 
older rats in either group.  
 
A: Fluorescent intensity (arbitrary units, mean±SEM) of 3-NT staining in young adult, 
10-12 week old N and CHU rats, indicating the level of peroxynitrite present in the 
skeletal muscle vasculature. Fluorescent intensity is similar in N and CHU rats 
 
B: Fluorescent intensity (arbitrary units, mean±SEM) of 3-NT staining in older 36 
week old N and CHU rats, indicating the level of peroxynitrite present in the skeletal 
muscle vasculature. Fluorescent intensity is similar in N and CHU rats. 
  
N CHU
0
20
40
F
l
u
o
r
e
s
c
e
n
t
 
I
n
t
e
n
s
i
t
y
 
(
A
.
U
.
)
N-AGED CHU-AGED
0
20
40
F
l
u
o
r
e
s
c
e
n
t
 
I
n
t
e
n
s
i
t
y
 
(
A
.
U
.
)
Figure 7.4 
A B 
??? 
7.4 Discussion 
7.4.1 Main Findings 
The main findings of the present study are that older CHU rats were hypertensive 
relative to aging N rats. However, while responses measured in the hindlimb evoked 
by stimulation of the sympathetic chain were blunted in young CHU rats relative to 
young N rats, they are similar between aged CHU and N rats, and there was no 
significant effect of BIBP-3226 on responses evoked by lumbar sympathetic chain 
stimulation in ageing N or CHU rats.   
 
7.4.2 Aging, CHU and Hypertension 
Evidence in Chapters 3 and 4, and from other authors (Williams et al., 2005b; Franco 
et al., 2007) suggests that in the hindlimb vasculature there is ongoing oxidative 
stress in CHU rats relative to N, but that this does not have obvious effects on 
ongoing vascular tone at 10-12 weeks of age. It was reported in Chapter 6 that 
generally, in the surgical preparation used for stimulation of the sympathetic chain 
resulted in lower baseline ABP than the preparations used in the experiments in 
Chapters 3 and 4. Thus, comparisons of ABP are only made between groups of N 
and CHU rats presented in Chapter 6 and in this chapter, when the same surgical 
preparation.  
 
One of the important findings of the present study is that older CHU rats were 
hypertensive relative to older N rats (Table 7.1), and relative to young CHU rats. 
Evidence is presented in Chapter 4 demonstrating that in young CHU rats ongoing 
??? 
MSNA is higher in CHU rats than N rats, and also that sympathetic innervation 
density in the tibial artery, supplying skeletal muscle, was markedly higher in CHU 
rats than N rats. However, the evidence of Chapter 6 suggested that the sensitivity to 
experimental stimulation of the lumbar sympathetic chain, measured by responses in 
the hindlimb muscle vasculature, were reduced in young adult CHU rats, and thus 
normal vascular conductance remained. The findings of the present study suggest 
the possibility that raised MSNA at the younger age in CHU may be instrumental in 
contributing to raised ABP in middle-aged CHU rats, and therefore it will be important 
that future studies examine levels of ongoing MSNA in older CHU rats.   
 
However, in contrast with the results of Chapter 6, the present study found that in 36-
week old CHU rats, the vasoconstrictor responses evoked by stimulation of the 
lumbar sympathetic chain were similar to those evoked in older N rats of the same 
age. At the same time, there is a trend for vasoconstrictor responses in the middle 
aged N rats to be blunted relative to young adult N rats. Previous evidence has 
shown that in aging humans, cutaneous vascular sensitivity of adrenergic 
neurotransmitters reduces with age (Richardson et al., 1992; Davy et al., 1998; Frank 
et al., 2000; Jones et al., 2001). Indeed the same is true of leg vasculature, which 
predominantly supplies skeletal muscle (Smith et al., 2007). In this study, there were 
no significant effects of age on the response to lumbar sympathetic chain stimulation 
at any of the frequencies used, in N rats. There were non significant effects in CHU 
rats, the result of which was that whilst at 10-12 weeks of age CHU rats have 
significantly lower responses to stimulation than N rats, at 36 weeks of age, the 
magnitude of effect is the same. However, it is difficult to comment confidently on the 
??? 
statistical significant of the data presented in this chapter. The variance experienced 
in the results of sympathetic chain stimulation were far greater than expected. 
Retrospective statistic power analysis suggests that, for example, to reliably reject 
the null hypothesis, that the response to stimulation at 20Hz is not different between 
middle aged N and CHU rats, measured as ΔintFVC, given the increased variation in 
the results, a sample size of 75 would be required. Thus, future experiments must 
consider increasing the sample size appropriately in order to be statistically sure of 
the findings.  
 
In Chapter 6, the idea that in young CHU rats, the reduced sensitivity to sympathetic 
nerve stimulation may be a mechanism that compensates for the ongoing increase in 
MSNA and increased sympathetic innervation density, was discussed. If this 
‘compensated state’ was present in young adult CHU rats, the evidence in the 
present Chapter suggests it is no longer present in older, 36 week old CHU rats. This 
of course assumes that ongoing MSNA is still increased relative to N rats, as it was in 
CHU rats at 12 weeks of age, but evidence shows that MSNA tends to increase with 
age, at least in humans (Dinenno et al., 2000; Seals & Dinenno, 2004). This is of 
course only representative of the vasculature supplying skeletal muscle, but this may 
explain why at 12 weeks of age, CHU rats had similar ABP to N rats, whereas at 36 
weeks of age, CHU rats are relatively hypertensive.  
 
Measuring MSNA by the method described in Chapter 5 was not attempted in older, 
36 week old rats. There are significant practical difficulties that would be associated 
with attempting to do so as their size and increased adiposity would make it very 
??? 
difficult to maintain a physiologically viable anaesthetised preparation whilst placed 
on the side without mechanical ventilatory support. It is likely that ‘bulk’ recordings 
from the lumbar sympathetic chain would be more appropriately suited to examining 
levels of sympathetic nerve activity in older rats given these limitations. Analysis of 
sympathetic innervation density was also not carried out on aged N or CHU rats in 
the present study. However, previous work showed that sympathetic innervation 
density markedly increases in the femoral artery with age in normal rats (Omar & 
Marshall, 2010). Further work characterising the time course of changes in 
sympathetic innervation density following chronic hypoxia in utero would be 
particularly useful, as they may provide insight into how hypertension develops in this 
model.  
 
7.4.3 The role of NPY 
Previous work has shown that in humans, aging is associated with loss of NPY-
mediated vasoconstriction in the cutaneous circulation during sympathetic nerve 
activation (Thompson & Kenney, 2004). In Chapter 6, evidence is presented showing 
that in young adult N, there is a role for NPY in mediating vasoconstriction evoked by 
stimulation of the lumbar sympathetic chain at constant low frequency or with higher 
frequency bursts of impulses. The evidence presented in this Chapter suggests that 
this contribution is no longer evident in older N rats and is also not evident in older 
CHU rats, in agreement with the aforementioned study, that the role of NPY in 
sympathetic vasoconstriction is reduced by aging. Clearly, NPY does not become 
more important during ageing in CHU rats than in N rats for maintenance of vascular 
tone, as it was hypothesised. Indeed, if NPY makes no contribution to the regulation 
??? 
of hindlimb vascular tone in middle-aged CHU rats, it would appear that in CHU as in 
N rats, NA makes a major contribution. The role of ATP as a sympathetic 
cotransmitter was not examined, and further experiments could test its relative 
contribution in young and older N and CHU rats.  
 
7.4.4 Oxidative stress  
Colocalisation of 3-NT and α-SMA immunoreactivity was carried out in older N and 
CHU rats in the same manner described in chapter 3. The limitations of this approach 
were discussed in Chapter 3. There was no difference in the levels of 3-NT staining 
in the vascular wall of small arteries in the TA muscle in older N and CHU rats, and 
indeed no difference between young and older N or CHU rats (Figure 7.3 and 7.4). 
Thus, there is no reason to suggest that the level of oxidative stress in the vascular 
smooth muscle is changed with aging in N or CHU rats. A different approach, using 
opened vessels, or using homogenized conduit vessels and other markers of 
oxidative stress, such as levels of glutathione peroxidase, may be more appropriate 
to provide information about changes in the level of oxidative stress with age.  
 
In summary, evidence presented in this Chapter show that older CHU rats are 
hypertensive relative to older N rats, at 36 weeks of age. There is no evidence that 
oxidative stress in the vascular smooth muscle of the skeletal muscle vasculature is 
increased. The reasons that older CHU rats are hypertensive relative to older N rats 
are not clear. However, evidence in young adult CHU rats, presented in Chapters 3-
6, has shown that there is increased ongoing MSNA, higher sympathetic innervation 
density in skeletal muscle vasculature, and increase oxidative stress in young adult 
??? 
CHU rats, and any number of these factors may persist during aging, and could 
represent an underlying mechanism contributing to increased blood pressure. 
Evidence in this chapter has shown that responses evoked by lumbar sympathetic 
chain stimulation are similar in 36-week old N and CHU rats, but CHU-A rats are 
hypertensive relative to N-A rats. The NPY Y1 receptor antagonist had no significant 
effect on the vasoconstrictor responses.  
 
7.4.5. Effect of CHU on body mass 
In an extension of the findings of Hauton & Ousley (2009) the total body mass, and 
relative contributions of a number of major organs to total body composition were 
examined. However, whilst Hauton & Ousley found that total body mass, and relative 
contribution of white adipose tissue was substantially higher in those rats exposed to 
CHU as measured at 12 weeks of age, this study has found that by 36 weeks of age, 
these differences have become normalised. Further, the adrenal glands, and all other 
major organs, appeared to be of similar size in 36-week old CHU rats as in age-
matched normal rats. Thus, any gross differences appear to have become 
normalised by this stage. However, this does not rule out the possibility that the 
microstructure or function are not substantially altered in the CHU rats relative to N, 
and this may well warrant further investigation in the future.   
  
??? 
  
  
??? 
Chapter 8 – General discussion 
  
??? 
8.1 Summary of findings 
The studies that are presented in this thesis were designed to explore various 
components of cardiovascular and respiratory regulation in rat offspring, following 
exposure to chronic hypoxia in utero, with particular focus on the regulation of 
vascular tone in skeletal muscle vasculature, oxidative stress, and the role of the 
sympathetic nerves that innervate the blood vessels supplying skeletal muscle. 
Evidence has been presented that there are tonically increased levels of ROS in the 
hind limb vasculature of young adult male CHU rats, as indicated by the 
vasoconstrictor effect of a SOD inibitor in CHU rats, and the effect of NOS inhibition 
followed by infusion of an NO donor on hypoxia-induced muscle vasodilatation. The 
role of adenosine, and its action upon the A1 and A2A receptor subtypes was found to 
be broadly similar to that found in N rats.  
 
It was also found that ongoing levels of MSNA were increased in CHU rats relative to 
N rats, as was the innervation density on the surface of blood vessels supplying 
skeletal muscle, although reflexly-evoked increases in MSNA by baroreceptor 
unloading or by graded systemic hypoxia were unchanged in young CHU rats relative 
to N rats. On the other hand, maximum vasoconstrictor responses evoked in the 
hindlimb muscle by stimulation of the lumbar sympathetic chain with different 
patterns of impulses were blunted in CHU rats, and in contrast to the N rat, inhibition 
of NPY Y1 receptors had no blunting effect on these responses. Finally, it was found 
that by early middle age, CHU rats are hypertensive relative to age-matched N rats, 
but showed similar responses to lumbar sympathetic chain stimulation. Ie. responses 
??? 
are no longer blunted in CHU rats relative to N rats. Further, by this age, inhibition of 
NPY Y1 receptors did not blunt the responses in either N or CHU rats.  
 
8.2 Modeling the consequences of fetal programming 
As discussed in Chapter 1, a number of different animal models have been 
developed with the aims of simulating the adverse conditions to which a human fetus 
may be subject, and modelling the consequences of these, both at birth and in the 
developing offspring. The direct consequences of the model used in the present 
study, pregnant dam breathing 12%O2, are not clear. To the author’s knowledge, no 
attempt has yet been made to elucidate whether the developing fetuses in the 
hypoxic dam actually become hypoxic, or whether the consequences observed in the 
offspring are a result of the adaptations made by the mother and fetus to maintain 
oxygen delivery. A study by Postigo et al., (Postigo et al., 2009) found that there were 
adaptations in pregnant Europeans undergoing pregnancy at high altitude that 
served to maintain O2 delivery. Whilst absolute O2 delivery was reduced in the group 
of pregnancies at altitude, the fetuses were smaller than those at sea level, and as a 
result, O2 delivery per unit body mass was normalised. It is not practical to make 
such measurements in rats, due to their size, and no attempt at measuring such 
variables has been made in larger animals such as sheep. It is known that in rodents, 
chronic hypoxia in utero does lead to IUGR (Williams et al., 2005a; Morton et al., 
2011), which in humans, is a common consequence of obstetric complications. What 
is important to consider is that this study, and others, are attempting to simulate 
pathological conditions in humans, particularly pre-eclampsia. Pregnancy at altitude 
represents a small number of cases compared to the number of women who suffer 
??? 
pre-eclampsia during pregnancy. Thus, whether the fetus becomes hypoxic or not 
may not be of such importance, as regardless, there are a range of reflex and 
hormonal adaptations which may well have distinct effects. What is key is that the 
IUGR phenotype is produced, and thus, there is relevance to human disease 
processes. Experiments examining whether or not the rodent fetus becomes hypoxic 
would be relatively simple, assaying levels of hypoxia inducible factor (HIF) in fetal 
tissues for example, and would represent a useful advance in the future.  
 
Turning to the particular use of rodents to model hypoxia-induced fetal programming, 
the rat is a particularly useful model for several reasons. Firstly, there is extensive 
knowledge of the normal functioning of rat cardiovascular physiology, and its 
similarities with that of the human. Secondly, there are a large number of successful 
rodent models of cardiovascular disease which induce similar mechanisms of 
disease in rats and humans (Hasenfuss, 1998). Thirdly, in modeling fetal 
programming, rodent models are a relatively inexpensive way to model fetal 
programming in the offspring, as they have a relatively short gestation period. From a 
cost and scientific point of view, it is also an advantage that they have a relatively 
short life span, for this opens the possibility for investigation effects of fetal 
programming on the ageing process. Further, there are many well-developed surgical 
preparations, a number of which have been demonstrated in experiments in this 
study, which allow for invasive measurements of cardiovascular parameters that are 
not otherwise possible in humans, or large mammalian models for reasons of cost 
and ethics! However, that is not to say that rodent models are without limitation. 
Human pregnancies predominantly result in singletons, whereas rat pregnancies 
??? 
result in a much larger numbers of offspring, often 10-15 pups. Thus, the placental 
adaptations to maternal hypoxia seen in the rat may be different from the manner in 
which the human placenta adapts to similar conditions. From a cardiovascular point 
of view, it is worth noting that rats are quadrupeds, and therefore not subject to the 
gravitational, and subsequent orthostatic responses that effect cardiovascular 
regulation. Also, the central nervous system is less highly developed in rats, and so 
any attempt to study influences of higher brain function on the cardiovascular system, 
such as that of emotional stress, are limited in the rat. However, as indicated above 
adverse conditions in either humans or rats do produce the IUGR phenotype. In this 
particular respect, the sheep models of reduced fetal oxygen supply are useful, but 
are less extensively used for various reasons, not least cost.  
 
On balance, the rat model of chronic hypoxia in utero represents a very useful, cost-
effective, repeatable and widely available model of fetal programming of 
cardiovascular disease. As the body of evidence indicating dysfunctional vascular 
regulation in the offspring of hypoxic pregnancies grows, attempts must be made to 
translate these findings to humans. This represents a significant challenge, as there 
are serious ethical considerations to be made when studying already babies that are 
already compromised or unhealthy. Studies performed in later stages in development 
and in adulthood are more likely to be acceptable. However, the aim of the animal-
based experiments is to elucidate the mechanisms of cardiovascular disease 
resulting from chronic hypoxia in utero. Thus, developing treatments for the 
consequences must be the ultimate aim.  
 
??? 
8.3 Fetal programming of oxidative stress 
Turning to discuss the experimental observations made in the present study, at least 
two key pieces of evidence presented in this study, which adds to a mounting body of 
evidence that vascular oxidative stress is a major consequence of chronic hypoxia in 
utero. First, the SOD inhibitor DETC reduced baseline hind limb vascular tone in 
young adult male CHU rats, suggesting that there is ongoing dismutation of O2- by 
SOD which, when blocked by DETC, leads to increasing O2- levels and thus, to 
vasoconstriction, probably by decreasing NO bioavailability. Second, following NOS 
inhibition infusion of the NO donor SNAP significantly increased the magnitude of 
hind limb vasodilatation during acute systemic hypoxia, indicating that under control 
conditions in CHU rats, NO bioavailability may be impaired, and limiting the release 
mechanism for adenosine and or its own dilator activity. In the absence of ROS 
generated by uncoupled eNOS, due to NOS inhibition, and in the presence of SNAP-
derived NO, the mechanisms of hypoxia-induced adenosine release, and thus, 
vasodilatation are restored. This adds to evidence presented by Williams et al., 
(2005b) and Morton et al., (2011) indicating oxidative stress impairs endothelial 
dilator function in isolated mesenteric arterial vessels of CHU rats by suggesting that 
oxidative stress disrupts normal functioning in the wholehind limb vasculature in vivo.  
 
Oxidative stress is a risk factor for cardiovascular disease (Heitzer et al., 2001) and is 
well implicated in development of atherosclerosis (Miller et al., 1998; Harrison et al., 
2003). Chronic intrauterine hypoxia has recently been shown to lead to classic 
indications of developing atherosclerosis in the rat offspring (Wang et al., 2009). This 
is particularly significant because rodent models do not normally develop significant 
??? 
atherosclerosis as humans do (Folkow & Svanborg, 1993). Indeed, the oxidative 
stress demonstrated by the present study study and others, if translated to humans, 
may well go some way to explain the increased incidence of coronary heart disease 
in those offspring of mothers who were pregnant during the Dutch famine (Barker, 
1995). The exact source of the vascular oxidative stress suggested by the present 
study is not completely clear, although the present study has provided evidence that, 
at least in larger vessels in skeletal muscle, it is not the vascular smooth muscle. 
Studies in opened isolated vessels in which the endothelium as a source of ROS can 
may be more easily investigated, or of markers of oxidative stress in venous efflux 
may provide further insight into the source of ROS, and give independent verification 
of the presence of enhanced levels of ROS. 
 
8.4 The role of Adenosine 
There is much evidence that the muscle vasodilatation that occurs in systemic 
hypoxia in N rats is largely due to adenosine being released from endothelial cells as 
a consequence of a change in the balance between O2 and NO at the common 
binding site on mitochondrial cytochrome oxidase, and acting on endothelial A1 
receptors to release NO. This whole process is blocked when NOS is inhibited but 
release can be restored when a tonic level of NO is provided and then, again 
adenosine induces vasodilatation in hypoxia by acting on A1 receptors that are 
presumed to be on the vascular smooth muscle. The results of the present study 
confirmed these findings in N rats and also indicated fully comparable process 
underlies hypoxia-induced muscle vasodilatation in CHU rats. This finding is 
particularly significant because in a recent study in this laboratory, adenosine was 
??? 
found to play no role in the hypoxia-induced vasodilatation in CHU rats. There is no 
obvious reason for this disparity, but it does raise the possibility that the levels of 
oxidative stress may have been greater in the CHU rats of the study by Coney & 
Marshall (2007), if it is assumed that O2- limits the NO available to compete with O2 at 
cytochrome oxidase and so limits or prevents the release of adenosine. This 
possibility requires investigation in future studies.  
 
8.5 Fetal programming of the sympathetic nervous system 
A major new important finding in the present study is that ongoing MSNA recorded 
from individual post-ganglionic sympathetic neurones on the surface of blood vessels 
supplying skeletal muscle is significantly increased in young male CHU rats relative 
to N rats. Further, the density of sympathetic neurones on the surface of the tibial 
artery, supplying skeletal muscle, is increased. This is interesting particularly 
because baseline vascular tone in skeletal muscle, albeit in the presence of the 
vasodilator effects of H2O2 (see above), is similar to N rats. Thus, an obvious 
question arises about the vascular sensitivity to sympathetic nerve activation in CHU 
rats. In fact, the present study showed for the first time that muscle vasoconstrictor 
responsiveness to sympathetic stimulation with a train of constant impulses at 2Hz, 
and with bursts of pulses at 20 and 40Hz, was substantially blunted in CHU rats 
relative to N. Thus, one can argue that a degree of compensation occurs, such that 
the effects of increased MSNA and sympathetic nerve density is counterbalanced by 
a reduction in the effectiveness of the sympathetic neurotransmitters. Indeed it 
seems that part of that compensatory mechanism is a reduction in the role of the 
sympathetic cotransmitter NPY.  
??? 
 
That said, the results of Chapter 5 indicate that the change in MSNA induced by 
unloading of the baroreceptors, and by graded systemic hypoxia are similar between 
N and CHU rats, whilst the results of Chapters 3 and 4 indicate that that the 
increases in FVC evoked by systemic hypoxia are comparable between N and CHU 
rats. Thus, whilst Chapter 6 suggests that responses to sympathetic nerve 
stimulation are reduced in CHU rats, functional increases in FVC during systemic 
hypoxia, which activates the sympathetic nervous system are comparable. It is 
possible that effect of the increase in MSNA induced by hypoxia is blunted, and the 
fact that the increase in FVC is similar in N and CHU rats indicates that the 
vasodilator influences of hypoxia are smaller in CHU rats, and this has been hidden 
by the fact that the effectiveness of increase vasoconstrictor activity is also reduced.  
 
The mechanisms that lead to increased MSNA and increased sympathetic 
innervation density are not clear. This study tested the possibility that it may be due 
to a failure of cyclic inhibition by the cardiac or respiratory cycles, or indeed an 
enhanced cyclic augmentation, but showed that the degree of cardiac and respiratory 
rhythmicity occurring in the MSNA of N and CHU rats was similar. This leaves the 
possibility that the increased MSNA in CHU rats is of central origin, but it appears not 
to involved in the interactions of the baro- and chemo-reflex with the central 
generation of autonomic outflow.  
 
A further possibility is that MSNA is increased as a result of increased peripheral 
firing probability due to changes in ion-channel expression on pre- or post-ganglionic 
??? 
neurones. The maintenance and control of sympathetic innervation density is 
controlled by a number of factors, discussed in Chapter 5, but importantly it is 
controlled by NGF signalling (Storkebaum & Carmeliet, 2011). Alterations in NGF 
signaling have been shown to change the expression of ion channels in sympathetic 
neurones in vitro (Luther & Birren, 2009). Thus, expression of NGF receptors and 
production of NGF by skeletal muscle vasculature at various time points during 
development may be useful in elucidating possible mechanisms that lead to increase 
MSNA and innervation density in CHU rats.  
 
The consequences of increased MSNA and sympathetic innervation density for the 
vascular wall of skeletal muscle arteries are, as yet, unknown. Wang et al., (2009) 
showed thickening of the aortic wall in 16 month old CHU rat offspring.Thus, it would 
be interesting to establish whether this finding extends to the feed arteries and 
resistance vessels. It is also known that arterial stiffness increases with age, partly as 
a consequence of enhanced tonic sympathetic activation (Dinenno et al., 2000; Seals 
& Dinenno, 2004). It is possible that the increase in sympathetic innervation density 
in CHU rats simply reflects the fact that more vascular smooth muscle is present in 
the arterial wall, and thus, greater levels of sympathetic neurotransmitter must be 
present to exert the same level of control. On the other hand, it may be that vessel 
walls are thickened in response to increased sympathetic nerve activity, and that the 
thickening reflects increased connective tissue. .  
 
Work prior to this study, published in abstract form (Rook et al., 2008b) showed that 
there is a marked increase in the capillary:fibre (C:F) ratio in the extensor digitorum 
??? 
longus muscle, a muscle of mixed fibre type like the TA, of the rat hindlimb in CHU 
rats. Thus, either the number of capillaries supplied by each arteriole, or the number 
of arterioles must be increased in CHU relative to N rats. If the latter is true, then it is 
possible that the increase in sympathetic innervation density measured in the tibial 
artery reflects the fact that the same sympathetic nerves must go on to innervate a 
large number of arterioles. Analysis of the morphology of the whole vascular bed 
supplying the rat hindlimb, as well as analysis of arteriolar sympathetic innervation 
density may go some way to addressing the likelihood of these possibilities.  
 
8.6 Wider implications of the present study 
 
The vast majority of studies of the cardiovascular effects of chronic hypoxia in utero 
thus far, have been carried in out preparations of isolated blood vessels (Rouwet et 
al., 2002; Williams et al., 2005b; Herrera et al., 2007; Morton et al., 2010, 2011).  The 
evidence presented in this study, that in skeletal muscle of CHU rats, ongoing 
sympathetic control of the vasculature is altered, demonstrates the need for more 
studies to be carried out in conscious, or anaesthetised whole animals, as in isolated 
preparations the complex interplay of the sympathetic nervous system, local 
endothelial control and local O2 tension is lost. Thus, the impact of these studies is 
limited. For mechanistic insight, studies of isolated vessels are useful. However, in 
future work, careful consideration must be given to the consequences of the lack of 
ongoing sympathetic tone in the isolated preparation; the results should be presented 
with this as a significant limitation.   
 
??? 
8.7 Summary and conclusion 
The present study presents evidence that in intact, anaesthetised CHU rats there is 
tonic oxidative stress in the blood vessels supplying the skeletal muscle of the hind 
limb, and the ongoing sympathetic nerve activity in the neurones innervating these 
vessels is increased. Further, the sympathetic innervation density of arteries 
supplying hind limb skeletal muscle is increased. However, vasoconstrictor 
responses to sympathetic stimulation via the lumbar sympathetic chain stimulation 
are reduced. This is the first study examining the role of the sympathetic nervous 
system in cardiovascular regulation in the whole animal following in utero hypoxic 
insult, and is the first study to demonstrate that the aging CHU rat is hypertensive. 
Further, it adds important information to the body of evidence indicating that chronic 
hypoxia in utero leads to oxidative stress. The consequences of this oxidative stress, 
autonomic dysfunction and hypertension must now be examined both in animal 
models, and in humans.  
  
??? 
 
  
??? 
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